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Introduction 

Chapter 1 
Introduction and Aims of the Studies 
1.1 ASTIIMA 
Asthma is one of the most common chronic disorders in the Western world, 
particularly in children, and its prevalence, morbidity and mortality seem to 
increase 12333844, The Greek ternl o:crSJ,lO: means short-drawn breath or panting 
and was used to embrace several disorders characterized by breathlessness or a 
pain in the chest. Although the meaning is now limited to airway disease, asthma 
has proven difficult to define, probably because of lack of understanding of the 
disease mechanism(s), In a recent international consensus report on diagnosis 
and treatment of asthma, however, the different aspects of the disease were drawn 
together into an operational definition: 
'Asthma is a chronic injlammatOl)' disorder of the airways in which many cells 
playa role, including mast cells and eosinophils, In susceptible individuals this 
injlammation causes symptoms which are usually associated with widespread 
but variable ai/flow obstruction that is often reversible either spollfaneousiy or 
with treatment, and causes an associated increase in ainvay responsiveness to a 
variety of stimuli' 38, 
The increased airway responsiveness of the tracheobronchial tree mentioned in 
the above definition is defined as an increased tendency of the airways to nar-
row to a variety of clinical, pharmacological or physical stimuli 38, The major 
clinical symptoms of asthma are recurrent episodes of cough, dyspnoea, 
tachypnoea, wheezing, and chest tightness, often provoked by exogenous fac-
tors such as allergens, irritants, exercise, and viral infections 36-38, Asthma symp-
toms are episodic, and many patients have a poor perception of the severity of 
their disease 43, In addition, signs and symptoms do not correlate with the inten-
sity of the attack 13, Therefore, objective measures of airflow obstruction and its 
variability are crucial in establishing the diagnosis 36 38, Demonstration of aller-
gen-specific IgE, and a positive bronchoprovocation test may support the diag-
nosis 36 38, 
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Histologic evaluation of asthmatic airways shows a chronic inflammation in the 
airway wall 1625. There is a complex interaction between mediators and cytokines 
and inflammatory cells leading to a local reaction that may be neurally ampli-
fied 3 5 6 162541 42. The mediators involved cause epithelial shedding, smooth 
muscle contraction, enhanced mucus production, and enhanced vascular per-
meability with mucosal edema; pathological changes that contribute to the air-
flow obstruction in asthmatic patients. In addition, some of these mediators and 
cytokines elicit an influx of inflammatory cells 3 162542. A subset of CD4+ helper 
T-cells, termed Th2-cells, may playa central role in the patho-physiology of 
asthma by the production of cytokines that contribute to abelTant IgE produc-
tion, growth and differentiation of eosinophils, isotype-switching of B-
lymphocytes and the evolution of naive T-Iymphocytes into the Th2 pheno-
type 3 142542. 
Asthmatic airways are cln'onically inflamed, even when patients are asympto-
matic 32, and therefore antiinflammatory drugs such as glucocorticoids should 
be used early in the course of the disease II 37384044. Indeed, treatment with 
inhaled steroids not only improves clinical signs of asthma, but also reduces the 
frequency of acute episodes of asthma, the requirements for B2-adrenergic 
receptor agonists and oral steroids, the level of bronchial responsiveness, the 
number of mast cells and eosinophils in bronchial biopsies, and the number of 
hospital admissions 8 17282948. The long-term effects of inhaled corticosteroids 
on the morbidity and outcome of asthma, however, await further observation. 
1.2 BACKGROUND AND AIMs OF THE STUDIES 
In 1900 the Gelman pathologist Frankel described epithelial shedding in the 
airways of patients who died during an asthmatic attack 21: 
' .. ein gemeillsames, die Faile verknllp!endes Band: 
das isl die reichliche Epilheldesqllamalion.' 
His observations were disregarded until the early sixties, when Dunnill reported 
similar findings in asthmatic patients at autopsy 18. More recent studies involv-
ing both bronchoalveolar lavage and endobronchial biopsies showed epithelial 
damage or -shedding and infiltration of inflammatory cells in the airway epithe-
lium in most patients, even when they appeared to be asymptomatic 8 9 27 313239. 
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Figure 1, Putative mechanisms explaining the relationship between epithelial damage and 
airway hyperresponsiveness. EpDRF = epithelium derived relaxing factor. 
One of these inflammatory cells, the eosinophil, may play an important role in 
these pathophysiological changes in asthma: The presence of eosinophils and 
their products correlates with the degree of epithelial damage and with the level 
of bronchial hyperresponsiveness in a given patient 5 10 27 39, The eosinophil 
produces cationic proteins such as major basic protein (MBP) and eosinophil 
cationic protein (ECP) and reactive oxygen species which are highly toxic to 
respiratory epithelium 1 5 22, Reactive oxygen species are also produced by 
neutrophils 258 and macrophages 37, Exposure of airways to these products causes 
epithelial damage and airway hyperresponsiveness in vivo and in vitro 192347, It 
is not clear how epithelial damage causes airway hyperresponsiveness, Several 
mechanisms have been proposed such as a reduced production of epithelium-
derived relaxing factors 2 20 or decreased metabolization of contractile agonists 
1530 by the damaged epithelial cells (figure I), Alternatively, loss of epithelial 
integrity may increase airway permeability, and provide easy access of 
bronchoactive mediators to the airway smooth muscle 24 46 49, Finally, epithelial 
damage may expose intraepithelial, nonmyelinated, sensory C-fibers which con-
tain neuropeptides (tachykinins) such as substance P (SP) and neurokinin A 
(NKA) 7 34 35, Excitation of C-fibers by inflammatOlY mediators such as brady-
kinin might produce a retrograde conduction with local release of ueuropeptides, 
a hypothetical mechanism called the 'local axon reflex' 4 (figure I), After re-
15 
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lease, neuropeptides may cause smooth muscle contraction, microvascular leak-
age and tracheobronchial vasodilatation, a process called 'neurogenic inflam-
mation' 73545. Axon reflex mechanisms have been demonstrated in the rodent 
trachea 26, but it is not known whether these reflexes occur in human airways, 
and whether or not they are relevant to asthma. 
Because of the supposed modulatOlY role of the airway epithelium and peptidergic 
nerves in airway responsiveness in human asthma, our studies addressed the 
following questions: 
1. To what extent is human airway responsiveness to contracting and relaxing 
agonists modulated by the airway epithelium? 
What is the mechanism of this epithelial modulation? 
What is the effect of epithelial damage on airway responsiveness? 
2. Is it possible to demonstrate the presence of sensory (peptidergic) nerves in 
human isolated airways by functional studies? 
Is it possible to measure tachykinin release from these peptidergic nerves? 
Can the so-called 'axon reflex mechanism' be demonstrated in isolated hu-
man airways? 
Part I of this thesis encomprises a review of the literature. Part 2 contains a 
review on the methodology of studies on human airways in vitro. In addition, 
we describe a new model that we developed to answer our questions. Part 3 is a 
compilation of original articles which address the questions raised above. Part 4 
includes the general discussion, directions for future research, and a summary 
of the thesis. 
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Airway Mucosa: Structure, Physiology, 
and Pathophysiology in Asthma 
2.1 IN'rRODUCTION 
The ahway mucosa consists of a lining layer of ciliated and nonciliated cells, 
the basement membrane and the lamina propria 6. The submucosa of the air-
ways contains cartilage, glands and smooth muscle (figure 1). In large bronchi, 
ducts of submucosal glands penetrate the mucosa and open at the mucosal sur-
face. This chapter desctibes the histological and ultrastmctural features as well 
as functional aspects of the epiihelial cells, the basement membrane and the 
lamina propria of the human airway. In addition, pathophysiologic changes in 
asthma are discussed. 
2.2 HISTOLOGY AND ULTRASTRUCTURE OF THE AIRWAY EPITHELIUM 
In man, the stratified squamous epithelium lining the larynx becomes pseudo-
stratified columnar ciliated epithelium in the trachea and cuboidal ciliated epi-
thelium in the bronchioles 101. The telm pseudostratified is used because basal 
cells are interposed between columnar cells and the basement membrane 71. 
The tubulo-acinar submucosal glands in the airways are derived from mucosal 
cells that migrate during foetal development beneath the lamina propria into the 
submucosa 253. At least eight different epithelial cell types have been identified 
in the conducting airways of mannnals 32 96118. In addition, inflammatory cells, 
which migrate through the epithelial basement membrane, and terminal pro-
cesses of sensory nerve fibres can be found within the airway epithelium 117 123 
147201240. In the following paragraphs, the ultrastmcture and putative functions 
of the different airway epithelial cells will be described in some detail. 
Ciliated cells 
The ciliated cells are end-stage epithelial cells that presumably originate from 
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Figure 1. Schematic diagram of a medium-sized bronchus. 
basal or secretory cells 4112. The primary function of the ciliated cells is to gen-
erate mucus flow with motile cilia, 200-300 of which cover the luminal surface 
of each cell. Each cilium beats about 1000 times per minute in a cranial direc-
tion 228 237. A cilium is composed of a basal body embedded in the apical cyto-
plasm of the cell and a ciliary shaft (axoneme) that contains a central pair of 
singlet tubules surrounded by nine doublet tubules. The motility of the cilium is 
provided by extensions of the tubules composed of a protein called dynein that 
contains ATPase 153 228 237. The overlying mucous layer is moved by the tips of 
the cilia, facilitated by minute little hooklets 120. Long microvilli interspersed 
between the cilia expand the luminal surface of the cell and may be impoltant in 
ion translocation and fluid exchange. 
SecretOlY cells 
Non-ciliated bronchiolar cells were originally described by Clara in 1937 and 
their morphology has been further documented in later studies 5 118 159222274. 
Five secretory cell types have been identified in the tracheobronchial surface 
and the submucosal glands of the conducting airways. 
Mucolls or goblet cells make up 15-25% of the surface epithelium and can be 
easily recognized by their abundant electron-lucent secretory granules. Produc-
tion and secretion of airway mucus is the most important function of the mu-
20 
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cous (goblet) cell and is controlled by autonomic nerves 96 250, In nOlmal human 
airway epithelium, ten ciliated cells to one goblet cell have been described 240, 
The number of mucous cells may increase in asthma and chronic bronchitis, and 
increases following exposure to ozone and cigarette smoke 119 124 165215, 
Clara cells contain discrete electron-dense granules and produce antiproteases 
and pulmonary surfactant apoproteins 5792192, In addition, Clara cells may have 
ion-absorbing and secreting properties 256, 
The serous cell may also produce antiproteases and is believed to undergo a 
serous to mucous shift 222, The mucous cell, the Clara cell and the serous cell 
may all be stem cells capable of division and differentiation into both ciliated 
and secretory cells 4 128, The mucous cell is the predominant secretory cell in the 
larger airways 118, whereas the Clara cell is predominant in the bronchioles 4 274, 
Recently, serous cells, well-represented in the submucosal glands, were described 
in adult human airway surface epithelium 222, 
Neuroendocrine (NE) cells usually lie in a basal position in the airway epithe-
lium, often with a cytoplasmic projection to the airway surface 53 243, They oc-
cur individually or as clusters (neuroepithelial bodies), preferentially at bifurca-
tions of the bronchi, and their presence increases towards the periphelY 164, The 
small dense granules of NE cells contain amines and peptide hormones which 
may modulate airway smooth muscle tone 152254, Because NE cells are some-
times associated with sensory nerves and degranulate during hypoxia, these cells 
may have a chemoreceptor function regulating shunting of blood to better ven-
tilated zones of the lung 122 152, 
KlIltschitsky cells are common in the fetal lung but their number diminishes 
with lung development. These argyrophilic cells may be a variant of the poly-
peptide hormone-secreting cells of intestinal mucosa (APUD cells), They may 
be involved with secretion of growth and differentiation factors 80, 
Basal cells 
Basal cells are small, flattened cells, containing bundles of tonofilaments, They 
are closely attached to the basement membrane by hemidesmosomes 181, The 
basal cell has been considered as the stem cell of the airway epithelium 4 113, In 
addition, several studies indicate that basal cells anchor columnar cells to the 
basement membrane by hemidesmosomes and basal lamina proteins such as 
laminin, collagen, and proteoglycans 71 84, The number of basal cells, their 
tonofilament content, and the number of desmosomes per basal cell increase 
with epithelial height 72, 
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Figure 2. Schematic representation of the adhesion of the bronchial epithelium. 
2.3 PHYSIOLOGY OF TIIE AiRWAY EPITIIELIUM 
The airway epithelium fonus the interface between the respiratory system and 
the external environment The epithelium acts as a barrier which restricts access 
of inhaled noxious stimuli and is also involved in a variety of other airway 
functions such as ion and fluid transport, enzymatic degradation of neurotrans-
mitters and chemicals, generation of bronchoactive mediators and cytokines, 
and recruitment and activation of inflammatory cells. These epithelial functions, 
except ion and fluid transport, will be discussed in the following sections, 
Epithelium as a diffusion barrier 
Experimental work on human and animal isolated airways and studies in vivo 
have shown that the airway epithelium fonus a barrier against leakage of water 
and solutes into the airways and prevents penetration of inhaled material to the 
airway interstitium 10 83 89 95 126244280, There are two pathways by which sub-
stances can cross the epithelial barrier: the transcellular route, through lipid cell 
membranes with ion channels for transport, and the paracellular pathway through 
which large and hydrophilic molecules pass between epithelial cells 90 275, The 
barrier function of the epithelium is achieved through several mechanisms which 
are shown in figure 2 181 229, The desmosome (macula adherens) and the inter-
mediate junction (zonula adherens) maintain cell-to-cell adhesion. Desmosomes 
are prominent electron-dense plaques consisting of unique proteins called 
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desmoplakins and desmogleins 246, Tonofilaments, made up of filamentous pro-
teins, insert at the cytoplasmic edge of these plaques and extend into the adja-
cent cytoplasm 48, Intermediate junctions form a ring-like adhesive mechanism 
around to which adhesion molecules have been localized 229, Hemidesmosomes 
consist of integrins and anchor the basal cells to the basement membrane 181 184, 
The tight junction (zonula occludens) is a narrow belt-like structure surround-
ing each cell at the apical pole, The composition of the tight junction is un-
known 229, It assists in the maintainance of surface polarity and appears to be 
responsible for paracellular transport 162, Tight junctions are dynamic, regulated 
structures, that depend on intracellular calcium levels and cAMP levels and 
protein kinase C activation in epithelial cells 64 199, 
Enzymatic degradation of neurotransmitters and chemicals 
Autonomic nerves in the airways release acetylcholine, catecholamines, and 
several neuropeptides such as tachykinins and vasoactive intestinal peptide (VIP) 
(see chapter 3), Removal of the airway epithelium or addition of specific peptidase 
inhibitors enhanced the responsiveness of both animal and human airways to 
these neurotransmitters suggesting inactivation of neurotransmitters by peptidases 
present in the epithelium 21 597475 105 140190232, The membrane-bound neutral 
endopeptidase (NEP, CDlO, EC 3.4,24.11), present on human airway epithe-
lium 127 151, inactivates neuropeptides and may modulate the responses to these 
peptides 24, Angiotensin converting enzyme (ACE), also present on human air-
way epithelium 127, may not be important in degrading neuropeptides since the 
enzyme inhibitor captopril did not affect tachykinin-induced responses in man 105, 
Human airway epithelium may also inactivate inflammatory medi-ators: In the 
guinea-pig trachea, histamine and the pro-inflammatory peptide bradykinin are 
metabolized by the enzymes N-methyltransferase and NEP, respectively 3182156 
196, Although there are no functional studies on the role ofN-methyltrans-ferase 
in human aiIways, N-methyltransferase mRNA has been localized to human 
airway epithelium 197, Oxygen free radicals, important molecules that injure 
cells and tissues 40 93270, can be inactivated by intra- and extracellular antioxi-
dant activities of the airway mucosa: Human epithelial lining fluid contains 
molecules with antioxidant capacity 36 and cultured airway epithelial cells have 
potent oxidant-scavenging ability due to the enzymes catalase, superoxide 
dismutase and gluthatione peroxidase 41 98 134 154, Oxidant stress leads to 
upregulation of these antioxidant systems 98, 
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Generation of bronciloactive mediators and cytokines 
Human airway epithelial cells are the source of a variety of biologically active 
compounds which may modulate the function of neighboUling cells and tissues. 
The capacity of epithelial cells to metabolize membrane bound arachidonic acid 
to both cyclooxygenase and lipoxygenase products has been studied extensively 
and is schematically shown in figure 3 39 104 108224. The lip oxygenase product 
l5-hydroxyeicosatetraenoic acid (l5-HETE) and the cyclooxygenase product 
prosta-glandin E2 (POE2) are the major metabolites and their release is stimu-
lated by arachidonic acid, acetylcholine, H20 2 and bradykinin, but not by l:usta-
mine 39 97 211 224. The cyclooxygenase products thromboxane A (TxA2), prosta-
glandin D2 (POD2), and prostaglandin F2a (POF2a) constrict human airways 
both in vivo and in vitro probably through activation of the thromboxane 
prostanoid (TP) receptor 124297. Prostaglandin E2 (POE2) may relax or contract 
airway smooth muscle depending on which receptor subtype is involved 43 44. 
Although prostaglandin 12 (p0I2' prostacyclin) usually relaxes smooth muscle, 
POI2-induced release of tachykinins may result in bronchoconstriction 163. 
Prostaglandins are also involved in the regulation of tracheobronchial blood 
flow 58 268 and mucus and ion secretion 166 167 272. POI2 and POF2a stimulate 
sensory nerve endings and cause reflex bronchoconstriction 163 191. POE2 in-
hibits neuronal acetylcholine release and may playa role in the regulation of 
airway cell growth and differentiation 79104 264. Activation of the lipoxygenase 
pathway leads to the fOimation of 5S-, 12S-, or 15S-hydroxyperoxyeicaso-
tetraenoic acids (HPETE's); instable intelmediates which are further metabolized 
to 5-,12-, and 15-hydroxyeicosatetraenoic acid (HETE's) 104. The physiologi-
cal role of the 12-, and 15-lipoxygenase products is unclear 104. 5-Lipoxygenase 
catalyzes the formation of the unstable leukotriene LTA4 which is further con-
verted to LTC4, LTD4, and LTE4 143 225. Leukotrienes, especially LTC4 and LTD 4' 
are potent constrictors of airway and vascular smooth muscle and increase 
microvascular permeability and mucus secretion 62. LTB4 and LTE4 are potent 
chemoaltractants for inflammatory cells 150 170 but human airway epithelium 
appears unable to produce these leukotrienes in significant amounts 104. 
Human airway epithelial cells not only release prostanoid and eicosanoid 
chemoaltractants but also other chemotactic factors for lymphocytes, monocytes, 
eosinophils and fibroblasts 14 142219236241261. Although the precise identity of 
these chemotactic factors is unclear the airway epithelium has been shown to 
produce the interleukins (IL)-l, IL-6, IL-8, granulocyte/macrophage colony-
stimulating factor (OM-CSF), transfOiming growth factor (TOF)-B, endothelin, 
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Figure 3. Metabolism of arachidonic acid. 
cyclooxygenase 
substance P, and fibronectin 20 50174213223236245, The epithelial cell products 
TGF-B, fibronectin and endothelin may play an important role in the regulation 
of tissue repair: they promote proliferation of epithelial cells and fibroblasts in 
the injured area 216 247, Smooth muscle hyperplasia, a characteristic finding in 
airways of asthmatic subjects, may be a side-effect of this repair mechanism 247, 
The regulation of tissue inflammation and repair not only involves recruitment 
of cells by cytokines but also requires interactions between cells, Specific 
receptors on the surface of epithelial cells called adhesion molecules such as 
intercellular adhesion molecule-l (reAM-I) and HLA-DR molecules partici-
pate in these cell-to-cell interactions 22 259, 
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Airway epithelial cells are also a source of the highly reactive gas nitric oxide 
(NO) 8 85 189. NO is formed as a product of the conversion of L-arginine and 
oxygen to L-cittulline 180. Cultured airway epithelium can produce nitrite and 
immunocytochemical staining has demonstrated the expression of constitutive 
and inducible NO-synthase (cNOS and iNOS) in human airway epithelial cells 
94 139233. cNOS can be stimulated by several mediators such as histamine and 
bradykinin whereas expression and activity of iNOS is increased by certain 
cytokines and oxidants and can be inhibited by glucocorticoids I 8594 138220. NO 
may relax airway smooth muscle in vitro and in vivo through activation of solu-
ble guanylate cyclase either directly or after its reaction with thiol to the more 
stable S-nitrothiol 67 86 187. In addition, endogenous NO may be an important 
modulator of mucociliary clearance by increasing ciliary beat frequency of 
epithelial cells 116. Epithelial NO may not be the so-called 'epithelium-derived 
relaxing factor (EpDRF)' 877 187. In fact, epithelium may metabolize NO or act 
as a diffusion barrier to NO 8. 
2.4 STRUCTURE AND FUNCTION OF THE BASEMENT MEMBRANE 
The airway epithelium is separated from the lamina propria by the basement 
membrane (BM) which is about 10 fUll in thickness. The BM provides elastic 
support to the epithelium, attaches epithelial cells, and constitutes a barrier to 
macromolucules and noninflammatory cells 51. In addition, the BM may influ-
ence cellular behaviour. The BM consists of a electron-dense layer of 50 to 100 
nm called the basal lamina positioned irmnediately above a loose array of colla-
gen fibrils forming the reticular lamina 171. 
The basal lamina contains type IV collagen, laminin, and heparan sulphate 
proteoglycan (HPS) whereas the reticular lamina consists of type III collagen, 
type V collagen, and fibronectin l71 202221249. It is generally believed that the 
components of the BM are synthesized by cells resting on the BM 171. 
The reticular lamina may be produced by a subpopulation of fibroblasts in the 
lamina propria221 . Type IV collagen is found exclusively in BM. Each collagen 
molecule consists of a triple helical sttucture and is linked to three other mol-
ecules via terminal sttuctures 168249. These interactions between type IV mol-
ecules provide a strong flexible three-dimensional framework containing nu-
merous sites where other components of the BM can bind. 
Laminin is the most abundant glycoprotein in BM 169249, and may playa role in 
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attachment, differentiation, and motility of a variety of cells 136 137 249, The 
glycoprotein enactin, unique to EM, may playa role in linking laminin to colla-
gen IV 248, HPS may prevent the passage of negatively charged molecules 129, 
The function of the protein fibronectin is unknown; it may represent plasma 
fibronectin trapped during ftltration 171, 
2,5 STRUCTURE AND FUNCTION OF THE LAMINA PROPRIA 
The lamina propria consists of a dense network of arterioles, capillaries and 
postcapillary venules embedded in collagenous, elastic and reticular fibers 23 107 
145 146, Figure 4 shows a photograph of a vascular cast of this subepithelial 
microvascular plexus, The collagenous, elastic, and reticular fibers provide 
mechanical stability to the lamina propria 23, In bronchioles with a diameter of I 
mm the volume of mucosal blood vessels is about 20% of the total volume of 
the lamina propria suggesting that a considerable part of the total airway blood 
flow is directed to the mucosa 265, Indeed, in sheep as much as 85% of the total 
tracheal bloodflow is directed to the mucosa 200, The arterioles have a diameter 
of 10-50 /.I1ll and have a single layer of smooth muscle that envelopes the 
endothelium 100 145, The capillaries have a diameter of 10 /.I1ll and are orientated 
parallel to the long axis of the airway 107145 176, Their endothelium consists of 
the continuous type although in some species fenestrations have been described 
100 176, The postcapillary venules, 10-50 /.I1ll in diameter, are the most numerous 
of the mucosal blood vessels 107 146 176, Although they have a continuous 
endothelium enveloped by a basement membrane, the tight junction belt be-
tween adjacent endothelial cells is discontinuous which makes the venules vul-
nerable II, Inflammatory mediators like bradykinin, histamine, leukotrienes, and 
platelet-activating factor (PAP) increase vascular permeability by opening of 
these endothelial gaps 73 204 205 208, In addition, vascular permeability can be 
increased by tachykinins released by peptidergic nerves 161, This process called 
'neurogenic inflammation' is described in chapter 3, 
Histochemical studies showed dense i111lervation of atterioles by cholinergic, 
adrenergic and peptidergic nerves whereas no nerve proftles were found near 
the postcapillary venules 60 160 177 201, This suggests that the arterioles are in-
volved in the neural regulation of mucosal blood flow 146 176, Activation of 
adrenergic nerves causes vasoconstriction by release of noradrenaline and 
neuropeptide Y whereas the parasympathetic nerve products acetylcholine and 
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Figure 4. Scanning electron micrograph taken from the luminal side of a vascular cast from 
the wall of the trachea of a dog. A rich vascular network is shown in the tracheal 
mucosa. Small capillaries (C) are draining into deeper veins (V). Bar ~ 100!lll1. 
From reference 145, with permission. 
vasoactive intestinal peptide (VIP) produce vasodilation 53173. 
The main function of the mucosal microcirculation is to provide nutrients to the 
epithelium 273. In addition, the mucosal microvascular plexus may have an im-
pOltant role in the conditioning of inspired air, and the clearance and distribu-
tion of inflammatory mediators 178213 273. Finally, in pathologic conditions such 
as asthma, the mucosal microcirculation is the source of plasma and inflamma-
tory cells, that pass into the lamina propria and the epithelium 205. 
2.6 PATHOPHYSIOLOGY OF THE AIRWAY EPITHELIUM IN ASTHMA 
Histological examination of bronchial tissue of patients who died during an 
asthmatic attack and of bronchial biopsies obtained from patients with asthma 
showed epithelial damage and- shedding, and infiltration of eosinophils and 
lymphocytes 13 66 121 124 141 148 149 193. Because the degree of epithelial damage 
cOlTelated with the presence of eosinophils and their products and with the level 
of bronchial reactivity, eosinophils have been proposed as the major effector 
cells in asthma 9 13 28 121 124 193. Eosinophils produce cationic proteins such as 
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major basic protein (MBP) and eosinophil cationic protein (Eep) and reactive 
oxygen species which are highly toxic to respiratory epithelium 2 9 8187186. Ex-
posure of human and animal airways to cationic proteins and oxidants indeed 
produced epithelial damage and an increase in airway responsiveness 78 91 130198 
255. Recently, it was shown that neutrophils may also contribute to detachment 
of epithelial cells by release of proteases and oxidants 258. It is not clear how 
epithelial damage causes an increase in airway responsiveness. Several mecha-
nisms have been proposed: 
Loss or damage of a diffusion barrier 
In 1979 Boucher et al. described a relationship between airway hyper-reactivity 
and airway permeability to histamine following specific allergen challenge in 
sensitized monkeys 26. In asthmatic patients, increased airway permeability to 
inhaled radiolabeled tracer molecules was found 111 and electronmicroscopic 
studies of the epithelium revealed opening of tight junctions and widening of 
intercellular spaces in these patients 70 193. The opening of tight junctions con-e-
lated with eosinophil infiltration and the degree of bronchial responsiveness, 
suggesting a causal relationship 193. Indeed, in experimental models exposure to 
eosinophils or their products increased both airway permeability and respon-
siveness 99198281. Similarly, increased airway permeability and responsiveness 
have been found following exposure to oxidants 18 19 125 175270. The effects of 
cationic proteins and oxidants on human airway permeability have not been 
studied. 
Loss of a metabolic site 
In paragraph 2.3 the inactivation of neurotransmitters by epithelial neutral 
endopeptidase (NEP) was discussed. NEP-inhibitors like thiorphan and phos-
phoramidon increase bronchial responsiveness to tachykinins and this led to the 
hypothesis that NEP-activity may be decreased in asthmatics. Several studies 
suggested that environmental pollutants and pathogens can decrease airway NEP: 
Inhalation of cigarette smoke or toluene diisocyanate, an agent used in the manu-
facture of plastics, increased airway responsiveness to the tachykinin substance 
P and decreased NEP activity 69235. Similarly, viral infections and chronic air-
way inflammation may decrease NEP activity 68 115 155. Glucocorticoids, used in 
the treatment of asthma, increase NEP expression by airway epithelial cells by 
enhancing transcription and protein synthesis 25 151. In a recent study of mild 
asthmatic subjects, however, no evidence for NEP-dysfunction was found 38. 
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Thus, although NEP activity seems to be decreased during viral infections, air-
way hyperresponsiveness in asthmatic patients cannot be explained by NEP 
dysfunction only, 
Impaired release of relaxing substances 
Following the discovery of a vascular smooth muscle relaxing factor released 
by endothelial cells (endothelium derived relaxing factor, EDRF), much research 
has been spent in order to identify a similar factor released by airway epithelium 
(epithelium derived relaxing factor, EpDRF), It was hypothesized that damaged 
epithelium would not be able to produce the relaxing factor, resulting in broncho-
constriction, Despite the use of various biotechniques including superfusion-
cascade, coaxial bioassays, and perfused airway tubes the existence and the 
putative role of EpDRF remain controversial 76 103 187238244, Recently, EDRF 
has been identified as nitric oxide (NO) 180, Although human airway epithelial 
cells can produce NO 94139 epithelial NO is probably not EpDRF8 77 187, 
Exposure of sensOlY nerves witll release oftacllykinins 
In animal and human airways, superficial tachykinin-containing sensory nerves 
have been identified that terminate in the airway epithelium 45147172 226, In 1986, 
Barnes proposed that epithelial damage might expose these nerve endings to 
inflammatory stimuli, facilitating axon reflexes with local release of tachykinins 7, 
Tachykinins are potent inducers of airway constriction, airway oedema, and 
mucus secretion, all characteristics of asthma 172 242, Evidence that local axon 
reflexes may contribute to bronchoconstriction has thusfar only been found in 
guinea pig isolated airways: Bradykinin-induced bronchoconstriction was re-
duced in airways which were depleted of tachykinin by pretreatment with 
capsaicin 114, The inflammatory peptide bradykinin can stimulate sensory nerve 
fibers, resulting in release of tachykinins 172 227, In asthmatic patients inhalation 
of a tachykinin antagonist protected against bradykinin-induced bronchocon-
striction llO, However, this does not prove local axon reflexes, because a central 
cholinergic reflex could explain these results as well, Until now, the relevance 
of axon reflexes in the pathophysiology of asthma remains to be shown, 
2,7 PATHOPHYSIOLOGY OF TIIE BASEMENT MEMBRANE IN ASTIlMA 
Light-microscopic studies revealed a thickened basement membrane (EM) in 
asthmatic subjects and this abn0I111ality has long been considered pathognomonic 
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for asthma 35 49 66 171 239. The thickening was thought to reflect increased basal 
lamina production by injured epithelial cells 171 207. However,later studies using 
transmission electronmicroscopy and monoclonal antibodies to differentiate 
collagen SUbtypes revealed that the basement membrane has a normal thickness 
in asthmatics 54 221. In these studies, dense collagen fibrils were seen beneath the 
BM which were considered as the BM in the earlier light microscopical studies. 
Immunohistochemistry revealed the presence of collagen IV, fibronectin, and 
laminin in the 'tme BM' of asthmatic patients which is not different from that of 
normal subjects 222. The subepithelial collagen fibrils appeared to consist mainly 
of collagen III and V and fibronectin but not laminin 222. The thickness of the 
subepithelial collagen layer correlated with the number of myofibroblasts be-
neath the epithelium, suggesting that these cells may be responsible for the sur-
plus of collagen fibrils 33 102. Similar pathophysiological changes in the base-
ment membrane zone have been observed in collagenous colitis 109. It seems, 
therefore, that thickening below the basement membrane zone is a nonspecific 
sequel of mucosal inflammation. 
2.8 PATHOPHYSIOLOGY OF THE LAMINA PROPRIA IN ASTHMA 
Inflammation of the mucosa produces hyperemia in the lamina propria 205 273. 
Increased hydrostatic pressure and mediator-induced pelmeability of post-cap-
illary venules cause plasma exudation 204 205. This exudate decreases the colloid 
osmotic pressure gradient, which leads to further plasma leakage. The process 
of vasodilation and plasma leakage may increase airway wall thickness which 
may directly contribute to airway narrowing 55 262 273. In addition, the exudate 
contains inflammatory mediators and peptides that promote migration of 
leukocytes from the venules into the surrounding tissue. This infiltration of leuko-
cytes in the airway mucosa had already been recognized more than 50 years ago 
in patients who died from asthma. Eosinophils, neutrophils, lymphocytes and 
plasma cells were also present in the airways in these fatal cases 35 54 65 66. After 
the introduction of bronchoscopic biopsy techniques it appeared that increased 
numbers of inflammatory cells were present in all asthmatic patients even in 
those with mild or newly diagnosed disease 13 28 121 148. These inflammatory 
cells are not only present in the lamina propria but also in the airway epithelium 
to which they migrate during the inflammatOlY response. 
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Eosillophils 
Eosinophils are the predominant inflammatory cells in the airways in fatal asthma, 
Their presence is less prominent in stable asthma 121 149, Eosinophils in asth-
matic airways are in an activated state, They not only release cationic proteins 
and oxygen metabolites, (described earlier in this chapter) bnt also lipoxygenase 
products, primarily LTC4 131 234, and the interleukins IL-3, IL-5, IL-6, GM-CSF 
and TGF-B I 34 135 158 195, The migration, differentiation, and activation of 
eosinophils is regulated by cytokines mainly produced by lymphocytes of the 
Th2-subtype 27, 
Neutrophils 
The role of the neutrophil in human asthma is controversial. Increased numbers 
of neutrophils have been found in bronchoalveolar lavage (BAL) fluid of asth-
matics and chronic asthma may be associated with mucosal neutrophil in-
flux 56179214, However, neutrophils can also be found in the BAL fluid of normal 
subjects; in a bronchial biopsy study, neutrophils were more numerous in the 
control subjects than in mildly asthmatic patients 13 52 266, Recent evidence sug-
gests, however, that neutrophils may cause detachment of epithelial cells by the 
production of proteases and oxidants 258, 
Mast Cells 
In BAL fluid from asthmatic patients the percentage of mast cells and the amounts 
of mast cell derived mediators such as histamine and tryptase are slightly higher 
than in BAL fluid from non-asthmatics 206 266 271, The epithelium of asthmatics 
also contains more mast cells than the epithelium of normal subjects, No differ-
ences in subepithelial numbers of mast cells were found 206, Most of the mast 
cells in human airways are of the tryptase-containing subtype 230, 
The finding of mast cell mediators in BAL fluid and their degranulated appear-
ance on electronmicroscopy suggests that tissue mast cells are in an activated 
state 206 212, Apart from histamine and tryptase, mast cells may release PGD2, 
LTC4 and small amounts of other arachidonic acid metabolites and the 
interleukins IL-3, IL-4, IL-5, IL-6, GM-CSF and TNF-a 29267 279, Because IL-4 
stimulates differentiation ofT-lymphocytes into the Th2-subtype 203 276 and IL-5 
promotes recruitment and activation of eosinophils 132 158 257 it has been sug-
gested that mast cells may be important in the initial stage of the disease 61 144, 
Macrophages 
Macrophages account for 80-90% of the airway cells in BAL fluid in both asth-
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matic and nonnal subjects 133 266, The macrophages in asthmatic airways, how-
ever, are hypodense and appear more immature, suggesting increased recruit-
ment of circulatory monocytes 209, Macrophages from asthmatic airways have 
enhanced superoxide production and an increased release ofIL-1 37210, In addi-
tion, they are able to release LTB4, PGF2a, TxB2, and TGF-B in response to IgE, 
suggesting their involvement in the early asthmatic response (EAR) 61 188, Fi-
nally, macrophages have been shown to produce the so-called macrophage in-
flammatory proteins (MIPs), members of a superfamily of cytokines called 
chemokines 278, These proteins exhibit proinflammatory and immunoregulatory 
activities; increased MIP expression has been observed in oxidant-induced lung 
injury 63, 
Lymphocytes 
Immunohistochemical analysis of BAL fluid and bronchial biopsies failed to 
show differences in either T-cell numbers or the CD4+/CD8+ ratio between asth-
matic and nonasthmatic patients 30132277, However, the number of epithelial 
lymphocytes is increased in asthma 148, In addition, surface expression of IL-2 
(CD25), HLA-DR, and very late antigen (VLA-l) is enhanced, suggesting acti-
vation of T-cells 46 263 277, CD4+ lymphocytes have been further categorized in 
two distinct subsets, Thl and Th2, because of their different cytokine profrle 185, 
The Th2-subpopulation produces IL-3, IL-4, IL-5, IL-lO, IL-13, and GM-CSF 
and may playa central role in airway inflammation 347218, IL-4 stimulates the 
differentiation of naive T cells into Th2 cells and IL-4 and IL-13 are able to 
induce a B-cell immunoglobulin-isotype switch leading to IgE production 203 
276283, T-lymphocytes in the lavage fluid of asthmatics have increased mRNA 
expression for IL-4 and IL-5 3, The development of selective inhibitors ofTh2 
cells and their products and animal experiments where specific genes are knocked 
out by genetic enginering may give more insight in the precise role of these cells 
in the pathogenesis of airway inflammation, 
Cellular events in allergic ail1vay inflammation 
Local endobronchial challenge techniques have been used to study the processes 
of chemoattraction, adhesion and transendothelial migration of inflammatory 
cells in allergic asthma, Within minutes after challenge, elevations of histamine, 
tryptase, prostaglandins, leukotrienes and B-glucuronidase have been found in 
lavage fluid, suggesting mast cell, macrophage, and endothelial cell acti-
vation 157231 252, Apart from their chemoattractant effects some of these media-
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tors will contribute to airway obstruction. At this stage a reduction in lavage 
CD4+ T-lymphocytes is found, probably because they are more adherent to the 
epithelial cells 88. Endobronchial biopsies six hours after challenge show an 
accumulation of leukocytes expressing B2-integrin and lymphocyte function-
associated antigen (LFA)-l in the epithelium and lantina propria 182. B2 integrin 
and LFA-l are the counter ligands for leukocyte cell adhesion molecule 
(LeuCAM) and intercellular adhesion molecule (ICAM)-l, respectively, which 
are expressed by endothelial cells 183184. LeuCAM's are a group of membrane-
bound proteins of which the selectins P-, E-, and L-selectin and vascular adhe-
sion molecule (VCAM)-l are the best known members. Expression of selectins 
by endothelium is an early event in response to inflannnatory mediators and has 
been demonstrated prior to a spontaneous asthmatic attack followed by expres-
sion ofICAM'l 2 to 4 h later 17194. Up-regulation ofVCAM-l is a slow process 
and is believed to be responsible for eosinophil recruitment 15 282. 
The abovementioned cell-to-cell interactions (cell adhesions) probably enable 
transendothelial and transepithelial migration 269. T-lymphocyte activation is 
apparent 24 h after local endobronchial allergen challenge 16260. Production of 
cytokines by these T-lymphocytes will contribute to further eosinophil accumu-
lation 260. In addition, cytokine production by other leukocytes, tissue fibroblasts 
and epithelium may also contribute to influx of inflammatory cells 106. 
2.9 CONCLUSIONS 
The airway epithelium consists of ciliated and secretory cells that form a diffu-
sion barrier which restricts access of inhaled noxious stimuli and leakage of 
solutes into the airways. In addition, the epithelium has important metabolic 
functions. Epithelial cells degrade neurotransmitters, inflammatory mediators 
and oxygen radicals and produce bronchoactive substances such as cycIo-
oxygenase and lipoxygenase products and nitric oxide. The epithelium also 
releases chemotactic factors for inflammatory cells and growth factors that stimu-
late epithelial repair after damage. In asthma, the epithelium is damaged prob-
ably by cationic proteins and oxidants produced by inflammatory cells. The 
degree of epithelial damage is correlated with the level of bronchial reactivity in 
asthmatic patients. It is not clear how epithelial damage causes airway hyper-
responsiveness. Loss of barrier or metabolic function, exposure of sensory nerves 
with release of tachykinins and a decreased release of relaxing substances have 
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been proposed. Evidence for a contributory role of each of these putative 
pathophysiological mechanisms has been found. 
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Autonomic Innervation of Human Airways: Structure, 
Physiology, and Pathophysiology in Asthma 
3.1 INTRODUCI10N 
The human tracheobronchial tree is innervated via efferent and afferent auto-
nomic nerves. These nerves regulate many aspects of airway function including 
airway smooth muscle tone, airway secretions, bronchial circulation, micro-
vascular permeability and the migration and the release of inflammatory 
cells 162122134174. Apart from the classical adrenergic- and cholinergic nervous 
systems, a third non-adrenergic, non-cholinergic (NANC) component has been 
described in human airways 162425202. This NANC nervous system has inhibi-
tory (iNANC) and excitatory (eNANC) components and neuropeptides and nitric 
oxide (NO) are the neurotransmitters 24 25 27 70 71239. Alexander and Paddock 
were the first to suggest a defect in the autonomic control of the airways in 
asthma 6. Since then, several abnormalities of the autonomic control in airway 
disease have been proposed including enhanced cholinergic-, o:-adrenergic- and 
eNANC mechanisms and, on the other hand, reduced B-adrenergic- or iNANC 
mechanisms. The hypothesis that abnormal neural control of the asthmatic air-
way may be responsible for the airway narrowing in these patients is supported 
by in vitro studies of asthmatic airways. In these studies no correlation was 
found between responsiveness in vivo and in vitro. In addition, no abnormali-
ties of the smooth muscle itself has been found 8 47 57 233. In this chapter the 
autonomic innervation of the human lung is described. In addition, possible 
abnormalities of the autonomic innervation in asthma are discussed. 
3.2 CHOLINERGIC INNERVATION 
The cholinergic or parasympathetic nervous system is the dominant neural path-
way in the control of airway smooth muscle tone and secretion in human 
airways 17 1939203222. Stimulation of cholinergic efferent nerves causes broncho-
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constriction, mucus secretion, and bronchial vasodilatation. These effects are 
mediated via the release of the excitatory neurotransmitter acetylcholine from 
agranular vesicles in cholinergic nerve terminals which rapidly diffuse to 
cholinergic receptors on the target cell. Acetylcholine is broken down by the 
enzyme cholinesterase which can be inhibited by cholinesterase inhibitors, such 
as eserine or pyridostigmine. 
Distribution 
Cholinergic efferent nerves arise in the vagal nuclei" of the brainstem and pass 
down the vagus nerve to synapse in ganglia localized external to smooth muscle 
and cartilage in the airway wall 16 187. These ganglia, which also receive adrenergic 
and NANC innervation, may adjust neural input to airway smooth muscle and 
submucosal glands 162251223. Short postganglionic unmyelinated axons pass to 
airway smooth muscle, vascular endothelium, submucous glands, and probably, 
mast cells 22 53 187. The epithelium and the bronchial vessels are sparsely sup-
plied 16187 although functional studies suggest cholinergic control of bronchial 
blood flow 92 167. Cholinergic innervation is denser in medium-sized bronchi 
(generation 4 to 7) than in the trachea and in the bronchioles and is absent in 
alveolar walls 22 53. Close contacts between nerve endings and individual mus-
cle cells are rare and neuronal excitation may be distributed by myogenic coup-
ling 53 87. 
Cholinergic receptors 
Acetylcholine released from preganglionic vagal fibers activates nicotinic (N)-
receptors on ganglionic nerve cells. Apart from mediating cholinergic trans-
mission, these nicotinic receptors may facilitate the release of neuropeptides 
from sensory nerves 128214. When released from postganglionic nerves, acetyl-
choline stimulates muscarinic (M)-receptors. Receptor binding studies and auto-
radiography demonstrated muscarinic receptors on human airway smooth muscle, 
vascular endothelium, submucosal glands, airway ganglia, peribronchial nerves 
and alveolar walls 161 237. Although muscarinic receptors are only weakly expres-
sed on human airway epithelium, a strong in situ hybridization signal with a 
M3-receptor cDNA probe was found, indicating a rapid turnover of receptors on 
human airway epithelium 162. In animal airways five M-receptor subtypes have 
been cloned 3536131. However, only three sUbtypes of muscarinic receptors have 
been demonstrated pharmacologically and four with specific cDNA probes 1966 
69 109 162 172. In human airways only three muscarinic receptor subtypes have 
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Table 1. Muscarinic receptor subtypes in human airways '* 
Localization 
Parasympathetic ganglia 
Submucosal glands 
Alveolar walls 
Postganglionic cholinergic 
nerves 
Airway smooth muscle 
Sympathetic nerves 
Airway smooth muscle 
Submucosal glands 
Epithelial cells 
Goblet cells 
Endothelial cells 
? 
? 
'based 011 references 19, 109,243, and 245. 
Function 
Facilitation of neurotransmission 
Increased secretion 
? 
Inhibit acetylcholine release 
Antagonism of bronchodilatation? 
Inhibit noradrenaline release 
Contraction 
Increased mucus secretion 
Increased ciliary beating frequency? 
Increased secretion 
Vasodilation via NO~release 
? 
? 
been demonstrated 243. The localization and function of these receptors in the 
lung is shown in table I. The M2-subtype is the predominant muscarinic receptor 
subtype in most smooth muscle types 69. In human airway smooth muscle M2-
receptor mRNA and functional M2-receptors have been detected 162 245 246. Block-
ade of smooth muscle M2-receptors in animal airways augmented isoprenaline-
induced relaxation suggesting a modulatory role of this receptor in airway smooth 
muscle relaxation 76. However, in human airways a functional role of smooth 
muscle M2-receptors in bronchoconstriction remains to be established 207 209. 
Muscarinic receptors of the M3-subtype have been de-monstrated on airway 
smooth muscle of human central and peripheral airways and stimulation of these 
receptors results in bronchoconstriction 161162208. Endothelial cells of the bron-
chial and pnlmonary circulation also express M3-receptors which may mediate 
the vasodilator response to acetylcholine 167 t69. Human submucosal glands have 
both M,- and M3-receptors whereas in alveolar walls M1-receptors are found 161 
162. The muscarinic receptors in human aiJway ganglia are of the M,-subtype 
and may facilitate neuronal conduction 22140. 
Prejunctional M2-autoreceptors have been demonstrated in animal and human 
airways and may play an important role in the regulation of cholinergic neuro-
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Table 2. Modulation of cholinergic neurotransmission by prejullctional receptors 
Receptor/mediator 
(X2-Adrenergic 
B2-Adrenergic 
Muscarinic M2 
Histamine H3 
5-HT2 
PGE2 
Thromboxane 
Opioid 
Tachykinin 
VIP 
Neuropeptide Y 
Nitric oxide 
Diuretics 
- = inhibition, + = stimulation 
Rodent 
+ 
? 
+ 
? 
Human 
? 
+/-
+ 
+ 
? 
References 
7, 14,100 
5, 116,200 
64,171 
110,112 
231 
33 
215 
26,30 
4,34,242 
229 
86,228 
217,241 
74 
transmission by inhibiting the release of acetylcholine from cholinergic nerves 
and noradrenaline from sympathetic nerve terminals 22 84117 171 194. In the rabbit 
lung, M4-receptor mRNA has been localized to alveolar walls and vascular and 
airway smooth muscle 126. No M4-receptors have been found in human air-
ways 162. 
Prejllllctiollaimoduiatioll of cholille/gic Ileurotrallsmissioll 
Acetylcholine release from cholinergic nerve terminals in animal and human 
airways is modulated by many prejunctional mechanisms that may either inhibit 
or facilitate cholinergic neurotransmission. These mechanisms, most of which 
are receptor-mediated, are listed in table 2. 
Abllormalities of the cilOlillelgic illllelvatioll ill asthma 
The benefial effect of anticholinergic dlUgs in acute asthma and COPD indi-
cates that cholinergic mechanisms contribute to bronchoconstriction. Although 
an increase in vagal cholinergic tone may contribute to nocturnal asthma 191, 
there is no direct evidence for an increase in basal cholinergic tone in asthma 
and COPD 21. However, there may be an increase in cholinergic reflex broncho-
constriction due to stimulation of norunyelinated sensory nerve fibers (C-fibers) 
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by inflammatory mediators such as histamine, prostaglandins, and bradykinin 21 
52127 175. Bronchoconstriction may also result from dysfunction of prejunctional 
(inhibitory) M2-receptors resulting in increased postganglionic acetylcholine 
release 9140. Indeed, in virus-infected guinea pigs dysfunction of prejunctional 
M2-receptors has been found resulting in potentiated bronchoconstriction 82. It 
appears that viruses have both a direct and an indirect, leukocyte-dependent 
effect on M2-receptors 83. Loss of M2-receptor function has also been found 
after exposure of guinea pigs to ozone or cyclooxygenase inhibitors 85 216. Ace-
tylcholine release may be facilitated by pre- and post junctional actions of in-
flammatory mediators such as tachykinins and arachidonic acid metabolites 102ll3. 
Finally, inflammatory mediators may directly increase the sensitivity of human 
airway smooth muscle to cholinergic stimulation resulting in an enhanced 
bronchoconstriction l2l. 
3.3 JuJRENERGICINNERVATION 
The adrenergic or sympathetic nervous system may control the airways via sym-
pathetic nerves which release noradrenaline and by circulating catecholamines 
(mainly adrenaline) released from the adrenal medulla 1698. In contrast to the 
dense parasympathetic innervation, the sympathetic innervation to the human 
airways is sparse. Functional studies did not show sympathetic innervation of 
human airway smooth muscle 53 56 205 234. However, sympathetic nerves may 
influence airway tone indirectly by the regulation of airway blood flow 245 and 
by interacting with the cholinergic innervation at the ganglionic or postganglionic 
level 5 1455 100200. Sympathetic nerves supplying blood vessels may have an 
important role in the control of tracheobronchial blood flow and airway secre-
tions 92163183. Finally, adrenergic receptors may have a role in airway smooth 
muscle proliferation: Stimulation of a-adrenergic receptors induced airway 
smooth muscle cell mitogenesis, whereas B-adrenergic receptor agonists inhi-
bited smooth muscle growth 180. 
Distributioll 
Preganglionic sympathetic nerves originating from the upper six thoracic seg-
ments of the spinal cord synapse in the middle and inferior cervical ganglia and 
upper four thoracic prevertebral ganglia. Postganglionic fibers travel to the lung 
where they mix with cholinergic nerves to form a dense plexus around airways 
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and vessels 16203. Morphological studies of human lungs have shown that sym-
pathetic nerves supply bronchial vessels, submucosal glands, and parasympathetic 
ganglia. Airway smooth muscle receives only few sympathetic nerves 53 55 65 136 
186221. Neuropeptide Y (NPY) is a cotransmitter in adrenergic nerves and may 
have a synergistic effect on the actions of sympathetic nerve stimulation 192. 
Adrenergic receptors 
Noradrenaline and adrenaline exert their effects through stimulation of a- and 
B-adrenergic receptors. Adrenergic receptors belong to a large family called the 
G-protein-coupled receptors. The genes for all of the subtypes have been iso-
lated 63144. Radioligand binding studies and autoradiography demonstrated a 
low density of a-adrenergic receptors in the human lung whereas B-adrenergic 
receptors are abundant 15 20 43225226. 
Stimulation of ai-adrenergic receptors causes smooth muscle contraction in pig 
and canine vascular smooth muscle and secretion from submucosal glands 182 
190. After blockade of B-adrenergic receptors in human airways, adrenergic stimu-
lation caused only weak contractions suggesting an insignificant role of 
a-adrenergic receptors in human airway smooth muscle responsiveness 226. 
Prejunctional a 2-receptors (autoreceptors) may inhibit the release of both 
noradrenaline and of neuropeptide Y from adrenergic nerves and the release of 
tachykinins from C-fibers 99133153. Cholinergic neurotransmission may also be 
inhibited via prejunctional a 2-receptors 100. 
On the basis of pharmacological criteria, B-adrenergic receptors have been sub-
divided into BI- and B2-subtypes 141. The B-adrenergic receptor consists of a 
single polypeptide chain containing seven regions of hydrofobic amino acids 
suggesting the forming of seven membrane-spanning helices with the hydro-
phobic segments as extra- and intramembranous loops 64. The gene for the hu-
man B2-adrenergic receptor has been cloned and sequenced 129 and B-receptors 
and mRNA encoding B-adrenergic receptors have been localized by autoradio-
graphy in human airways from trachea to alveolus 43 103226. Expression of mRNA 
encoding B2-adrenergic receptors is increased in subjects with asthma 10. 
B-Adrenergic receptors have also been localized on other cell types including 
epithelium, endothelium, nerve fibers, and inflammatory cells 43 74 75 96 147. Al-
though BI-adrenergic receptors have been demonstrated in the human lung 212 
226, B-adrenergic receptors on human airway smooth muscle are entirely of the 
B2-subtype and their number increases towards the peripheral airways 43 103226 
246. Stimulation of these B2-adrenergic receptors results in relaxation of airway 
52 
AUTONOMIC 1~'ERVATION: PHYSIOLOGY, PHARMACOLOGY Ah'D PATHOPHYSIOLOGY IN ASTHMA 
smooth muscle, The physiological role of these B2-adrenergic receptors is un-
clear, Although circulating adrenaline can dilate normal and asthmatic airways 
16, plasma adrenaline levels in asthmatics are not elevated, not even during an 
attack or bronchoprovocation 143 213, The epithelial and mast cell B-adrenergic 
receptors are also of the B2-subtype whereas in human submucosal glands and 
alveolar walls, receptors of the BI-subtype have also been found 43, Prejunctional 
B2-adrenergic receptors present on postganglionic cholinergic nerves inhibit 
cholinergic output 514 200, They are also present on sympathetic nerve fibers that 
supply human pulmonary arteries 96, Alveolar type 2 cells express both Be and 
B2-adrenergic receptor subtypes 54, B-adrenergic receptor agonists increase 
surfactant production, primarily mediated by the B2-adrenergic receptors 48, 
Recently, evidence for the presence of B-adrenergic receptors of the B3-subtype 
in airways has been found, In canine airway smooth muscle these receptors may 
mediate bronchodilation 232, In guinea pig airways B3-adrenergic receptors may 
exert a prejunctional inhibitory effect on eNANC responses 163 and epithelial 
B3-adrenergic receptors may mediate active transport of albumin across the 
epithelial cell layer 241 , In man, the gene for the B3-adrenergic receptor has been 
isolated and although functional studies have located these receptors in white 
fat cells they were not present in the human lung 130 145 152, 
Abnormalities of the adrellergic illlleivatioll ill asthma 
Szentivanyi postulated a reduced respiratory B-adrenergic receptor function in 
atopic disease and bronchial asthma 229, This would lead to impaired relaxation 
of airway smooth muscle and perhaps also increase cholinergic tone and media-
tor release from mast cells, Investigations of B-adrenergic receptor function in 
asthmatics, however, have shown conflicting results, Several investigators 
reported decreased B-adrenergic receptor function in isolated aiIways from asth-
matic patients 124793, whereas others found nOlmal relaxations of airway smooth 
muscle from asthmatics 58, 
After cloning and sequencing of the gene encoding the human B2-adrenergic 
receptor, it appeared that experimentally induced mutations, involving small 
regions of the B2-adrenergic receptor, markedly altered the functional properties 
of the receptor 148, This led to the hypothesis that mutations might be present in 
the B2-adrenergic receptor of asthmatic patients, Indeed, the Gly16 (glycine at 
position 16) polymorphism, which causes enhanced downregulation of B2-
adrenergic receptors, is overrepresented in patients with nocturnal asthma 236, 
However, the frequency of most polymorphisms of the B2-adrenergic receptor 
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gene is not different between asthmatic patients and control subjects 193199. Thus, 
there seems to be no genetic defect in the 132-adrenergic receptor. This was, 
however, unlikely because l3-agonists have excellent bronchodilatory effects in 
asthmatic patients. 
3.4 EXCITATORY NON-ADRENERGIC, NON-CHOLINERGIC (ENANC) 
INNERVATION 
Excitatory NANC (eNANC) bronchoconstrictor responses are believed to be 
mediated via the release of sensory neuropeptides from a subpopulation of non-
myelinated sensory C-fibers in the airways. Six sensory neuropeptides have been 
identified in matmnalian sensory nerves: calcitonin gene-related peptide (CORP) 
and the tachykinins substance P (SP), neurokinin A (NKA) neurokinin B (NKB), 
neuropeptide K (NPK), and neuropeptide Y (NPY) 25 105. The peptides may be 
colocalized in the same secretory granules 170 and can be released from sensory 
nerve endings by a range of chemical and physical stimuli 22 224. 
Sensory neuropeptides have been shown to induce airway smooth muscle con-
traction in vitro 2 158 177 and in vivo 50 122, mucus secretion 195 210, vascular 
hyperpermeability40 189219, and tracheobronchial vasodilatation 244. In addition, 
SP modulates chemotaxis of inflammatory cells and the production of immuno-
globulines and cytokines by these cells 38 42181. 
The effects of neuropeptides are limited because they are rapidly degraded by 
neutral endopeptidase (NEP, CD 10, EC 3.4.24.11), a membrane-bound enzyme 
present in human airways 120 142, angiotensin-converting enzyme (ACE, kininase 
II, EC 3.4.15.1), mast cell tryptase and chymase 48, and other peptidases 3137. 
Distribution 
Tachykinin-containing, nonmyelinated C-fibers have been localized in human 
airways by immunohistochemistty. Terminal varicosities are located within the 
epithelium, airway smooth muscle, submucosal bronchial glands, bronchial blood 
vessels, and intramural tracheobronchial ganglion cells 91 155 156157159165166. In 
the rat lung an association between peptidergic nerves and mast cells has been 
found and this may also be the case in the human lung 179. Sensory C-fibers 
from the airways travel up the vagal nerves to neuronal bodies in the jugular and 
nodose ganglia. In addition, SP-containing nerves pass with sympathetic nerve 
fibers via the stellate ganglion to terminate in thoracic spinal dorsal root gan-
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glion cells 16224, Both SP, NKA and NPK but not NKB have been demonstrated 
by radioimmunoassay in human bronchi 156 165, 
Tachykinin receptors 
Tachykinins exert their action through activation of specific receptors in the 
target tissue, In human airways, radiolabeled binding studies with 125I-labeled 
SP have shown a high density of tachykinin receptors in vascular endothelium 
of microvessels of the lamina propria, whereas airway smooth muscle, puhno-
nary vascular smooth muscle, submucosal glands and the epithelium were 
scarcely labeled 45 94238, In contrast, recently a high density of SP-receptors was 
reported in airway smooth muscle, submucosal glands and airway epithelium of 
the human lung, which is in accordance with the pharmacological action of 
SP 78, Three classes of tachykinin receptors have been demonstrated pharmaco-
logically in mammalian airways: the neurokinin I (NKI-), N~- and NK3-
receptors 160 196 197 198, In addition, a species-dependent heterogeneity has been 
described for the NKI- and NK2-receptor based on differences in affinity for 
specific nonpeptide antagonists 123 160196, The tachykinin receptors differ in their 
affinity for natural tachykinins: NKI-receptors are activated preferentially by 
SP, NK2-receptors by NKA, and NK3-receptors by NKB 101 198, 
In animal airways the N~-receptors and in some species the NK1-receptors 
have been shown to be involved in bronchoconstriction, whereas the NK1-
receptor is involved in mucus secretion, microvascular leakage, vasodilation, 
and mucociliary activity 81 124 151 160, In human airways the N~-receptor medi-
ates bronchoconstriction 3 72 177, The functions of NKI- and NK3-receptors in 
human airways have not been elucidated, 
The three tachykinin receptors from animals and humans have been cloned and 
sequenced 9097176, The receptors belong to the superfamily of G-protein-coupled 
receptors characterized by seven transmembrane regions and the homology 
among species is high 176, mRNA for the NK1- and the NK2-receptor has been 
detected in central and peripheral human lung and is predominantly localized in 
airway epithelium and vascular endothelium I 13, 
Specific binding studies with radiolabeled CGRP have shown that CGRP-
receptors are widely distributed in human lung, Bronchial and pulmonary blood 
vessels and alveolar walls were densely labeled whereas smooth muscle, epi-
thelium and submucosal glands were sparsely labeled 224, There are two receptors 
for CGRP which are probably coupled to G-regulatOly proteins 25, 
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Table 3. Factors modulating tachykinin release" 
Factors promoting release 
Capsaicin 
Bradykinin (B,-receptor) 
Histamine (HI-receptor) 
Leukotriene D 4 
Hydrochloric acid 
PGI, (IP receptor) 
PAF 
Cholinergic agonists (N-receptor) 
Ammonia vapor 
Electrical field stimulation 
Mechanical probing 
Hypertonic aerosol 
Cationic proteins 
* based on references 22 and 224. 
Prejllnctionalmodlliation of tachykinin release 
Factors inhibiting release 
Capsaicin (systemic dose) 
Opioids (11 receptor) 
Histamine (H3 receptor) 
Neuropeptide Y 
Vasoactive intestinal peptide 
PGE, (EP receptor) 
Adenosine (PI receptor) 
(1.2-' fi2-adrenergic agonists 
Ruthenium red 
Sodium cromoglycate 
Lidocaine 
co-Conotoxin 
Tetrodotoxin 
A variety of chemical and mechanical factors can modulate C-fiber conductivity 
and neuropeptide release (table 3), Capsaicin, the pungent agent in chili pep-
pers, is commonly used as a pharmacologic tool to stimulate sensOlY nerves 106158, 
It acts on a nonselective cation channel resulting in release of tachykinins from 
C-fibers 32, Addition of this agent to the perfusate of isolated, perfused guinea 
pig lungs increases SP-immunoreactivity in the effluent 214, Chronic systemic 
administration of capsaicin partially depletes the lung from tachykinins 24 119, 
a characteristic that is often used in studies of laboratory animals in vivo, 
Abnormalities of the eNANC innervation in asthma 
Because the effects of tachykinins in the airways resemble the pathophysiology 
of asthma, Bames postulated his 'axon reflex hypothesis' in 1986 23, This states 
that in the damaged epithelium of asthmatic patients, epithelial C-fibers will be 
exposed, Excitation of these fibers will produce a retrograde local axon reflex 
that results in release of tachykinins, This local release of tachykinins causes 
smooth muscle constriction, microvascular leakage and tracheobronchial vaso-
dilatation, a process called 'neurogenic inflammation', Until now evidence for 
this mechanism has only been found in experimental animals 115 153247: 
Bradykinin-induced contractions of the guinea pig trachea were reduced by 
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tetrodotoxin or pretreatment with capsaicin, suggesting that bradykinin-induced 
contraction was potentiated by the release of tachykinins 115, In asthmatic patients, 
inhalation of the tachykinin antagonist FK-224 partly prevented bradykinin-
induced bronchocontriction Ill, Although the authors speculated that local axon 
reflexes were involved, their findings can also be explained by a reduced 
cholinergic reflex bronchoconstriction after blockade of tachykinin receptors 
on cholinergic nerve terminals, 
In 1991, Ollerenshaw reported a greater number of SP-containing nerve fibers 
in lung tissue of patients who died from asthma 185, Later studies reported in-
creased SP-immunoreactivity in bronchoalveolar fluid and sputum of asthmatic 
patients 178235, Although these studies favour a role of neuropeptides in the 
pathophysiology of asthma there are some controversies: In bronchial biopsies 
of asthmatic patients no difference in substance P contents was found between 
asthmatic and control subjects 108, Moreover, in a recent study, resected lung 
tissue from asthmatics contained less SP-immunoreactivity than tissue from 
nonasthmatic patients 150, 
Neurogenic inflammation may also result from an increased production or re-
lease of neuropeptides or from a reduced degradation of neuropeptides, Envi-
ronmental pollutants such as sigarette smoke or toluene diisocyanate decrease 
airway NEP activity and increase airway responsiveness to SP 68 221, Similarly, 
viral infections and chronic airway inflammation may decrease NEP activity 
and increase the effects of (endogenous) neuropeptides 67118149, In a recent study 
of mild asthmatic subjects, however, no evidence for NEP dysfunction was found 
49, Despite all the evidence that neuropeptides are involved in asthmatic airway 
inflammation, the precise role of neuropeptides in the pathophysiology of asthma 
remains to be elucidated, 
3,5 INHIBITORY NON-ADRENERGIC, NON-CHOLINERGIC (INANC) 
INNERVATION 
Because functional studies did not show important sympathetic innervation of 
human airway smooth muscle 53 56 205 233, the inhibitory NANC (iNANC) nerv-
ous system is believed to be the only neural bronchodilator pathway in human 
airways 24138204, iNANC nerves have been demonstrated in vitro in human air-
ways by electrical field stimulation 204 233 and in vivo by laryngeal stimulation 139, 
Stimulation of iNANC nerves results not only in bronchodilation but also in 
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increased mucus secretion 188 and tracheobronchial vasodilation 59 21l 244. Al-
though vasoactive intestinal peptide (VIP) has long been considered to be the 
neuro-transmitter of the iNANC nerves 71168, evidence is accumulating that nitric 
oxide (NO) is the major iNANC neurotransmitter in human airways 1l 282971. 
Although exogenous VIP can be degraded by neutral endopeptidase (NEP, CD 10, 
EC 3.4.24.11) and angiotensin-converting enzyme (ACE, kininase II, EC 
3.4.15.1), the NEP inhibitor phosphoramidon did not affect iNAN C responses 201. 
It is likely, therefore, that mast cell tryptase and chymase may be mainly re-
sponsible for the breakdown of VIP 46 80 231. 
The neurotransmitter NO is formed during the conversion of L-arginine and 
oxygen to L-citrulline by the enzyme nitric oxide synthase (NOS). After pro-
duction NO is released by simple diffusion. NO is a highly reactive, unstable 
molecule with a half-life in tissue of less than 5 sec, and may behave in a paracrine 
fashion 88. 
Distribution 
Immunohistochemical procedures have been used to localize VIP-containing 
nerves in human airways 60 135. VIP appeared to be present in nerve fibers sup-
plying airway smooth muscle, blood vessels and submucosal glands. The VIP-
containing nerves were more abundant in larger airways 135. In addition, a dense 
network of VIP-immunoreactive nerve fibers is present around nerve cell bodies 
in local microganglia 135. VIP-immunoreactivity was also found in the vagus 
nerve 154 and appeared to coexist with acetylcholine-containing granules 135, 
suggesting a functional relationship between VIP and classic cholinergic neural 
control. Indeed, studies in rodent tracheas showed that endogenous VIP modu-
lates cholinergic neurotransmission and airway smooth muscle contraction 27 218. 
In human airways, however, these mechanisms could not be confirmed 239. Other 
peptides with the same immunohistochemical distribution and similar charac-
teristics as VIP have been identified in mammalian nervous tissue such as peptide 
histidine isoleucine (PHI) and peptide histidine methionine (PHM), encoded by 
the same gene as VIP, peptide histidine valine (PHV), and helodermine 24. 
The NO producing enzyme NO synthase (NOS) has been demonstrated in the 
human lung by immunohistochemical staining and is present in epithelial cells, 
endothelial cells, vascular smooth muscle cells, iNANC-neurons, and inflam-
matory cells 4177 88104. cNOS in NANC-nerves is colocalized with VIp61 and is 
present in airway smooth muscle, blood vessels, submucosal glands and 
symphatic and sensory ganglia 77. It has been suggested that NO may be co-
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released with acetylcholine from parasympathetic nerves. However, iNANe 
responses are absent in heart-lung transplant recipients whereas choliner-
gic responses are preserved 18. 
VIP receptors 
VIP receptors have been localized in human airways by binding studies using 
1251_ VIP. In two studies a high density of labeling over airway smooth muscle in 
the human bronchus was found and blood vessels were very densely labeled 44 
206. These fmdings are in contrast, however, with another study in which lack of 
specific binding over airway smooth muscle and a high density of binding in 
pulmonmy artery smooth muscle was found 146. In all studies dense labeling 
was also found over submucosal glands, the epithelium and alveolar walls 44 95 
146206 
Nitric oxide does not act through binding with a specific receptor but simply 
diffuses through the cell membrane to react with intracellular cyclic guanosine 
3',5'-monophosphate (cGMP) 1988173. Alternatively, NO may react with thiol to 
form S-nitrothiols which are potent smooth muscle relaxants 89. 
Abnormalities o/the iNANe innervation in asthma 
In 1990 Ollerenshaw and colleagues described absence of VIP-immunoreactive 
nerves in patients with asthma 184. Their observations suggested that bronchial 
hyperresponsiveness in asthma might be due to a loss of bronchial relaxation 
mediated by the release of VIP by iNANe nerves. However, normal VIP-
immunoreactive nerves were found in biopsies from asthmatics 107, suggesting 
that the results of Ollerenshaw and coworkers may have been influenced by 
degradation of VIP when sections of lung tissue were cut 21. Alternatively, the 
VIP-degrading enzyme lIyptase 46, elevated in asthmatic airways 242, may degrade 
VIP before it exerts its bronchodilatory and antiinflammatory actions. 
The importance of these observations can be questioned because NO is now 
regarded as the principle neurotransmitter of iNANe nerves. Therefore, a defect 
in airway iNANe responses seems possible. This could result from breakdown 
of NO by superoxide anions produced by inflammatory cells 88 or, alternatively, 
from dysfunction or reduced expression of NOS. Evidence for a NOS dysfunc-
tion was found in tracheas from virus-infected guinea pigs: In vitro the tracheas 
were hyperresponsive to histamine and this was accompanied by a decrease in 
NO release 89. Functional studies in vivo and in vitro, however, showed no dif-
ferences in iNANe responses between asthmatic and nOlmal subjects 12 137. 
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3.6 CONCLUSIONS 
It is clear that the cholinergic (parasympathetic) nervous system is the dominant 
neuronal pathway in the control of airway smooth muscle tone in human air-
ways. Stimulation of cholinergic nerves causes bronchoconstriction, mucus 
secretion and bronchial vasodilation. Although abnormalities of the cholinergic 
innervation have been suggested in asthma, thusfar the evidence for cholinergic 
dysfunction in asthmatic subjects is not convincing. 
Adrenergic (sympathetic) nerves have been demonstrated by immunohisto-
chemistry in human airways. Although the adrenergic nervous system may con-
trol tracheobronchial blood vessels, functional studies could not demonstrate 
sympathetic innervation of human airway smooth muscle. B-adrenergic receptors, 
however, are abundant on human airway smooth muscle and activation of these 
receptors causes bronchodilatation. The physiological role of B-adrenergic 
receptors is unclear and their function seems normal in asthmatic patients. 
Recently, non-adrenergic, non-cholinergic (NANC) nerves with inhibitory 
(iNANC) and excitatory (eNANC) components have been described in human 
airways. iNANC nerves may be the only bronchodilatory nerves in human air-
ways. Although a dysfunction of iNANC nerves has been proposed in asthma, 
thusfar no differences in iNANC responses were found between asthmatic and 
normal subjects. In animal airways, eNANC activation causes bronchocon-
striction, mucus secretion, vasodilation, vascular hyperpermeability and chemo-
taxis of inflammatory cells, a process called 'neurogenic inflanunation'. Al-
though eNANC nerves and their neurotransmitters have been demonstrated in 
human airways, their functional relevance and their role in the pathophysiology 
of asthma remains to be elucidated. 
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Methods 

Chapter 4 
Studies of Human Airways in Vitro: 
A Review of the Methodology 
4.1 INTRODUCTION 
The pathophysiology of human airway narrowing that characterizes asthma and 
chronic obstructive pulmonary disease (COPD) is only partly understood. In-
flammation of the lung, especially of the airways, is found both in asthma 32 and 
in COPD 20 and may playa pivotal role in the development of bronchial hyper-
responsiveness in asthma 17 75 and COPD 5 152. 
In order to gain more insight into the underlying processes of human lung dis-
eases, animal models have been developed. In most of these animal models, the 
immediate (IAR) and the late asthmatic reaction (LAR) can be induced by aller-
gen challenge 61 6295 129 142. However, important differences between species 
exist 129. Therefore, it is important to study pathophysiological and pharmaco-
logical aspects of human airway disease in human isolated aitways. Most in 
vitro studies of human airways have been performed on tissue derived from 
smokers with or without COPD who were operated on because of bronchial 
malignancy. These studies have shown that the sensitivity of isolated aitways is 
not related to the sensitivity to inhaled histamine or methacholine in nonasthmatic 
subjects indicating that airway hyperresponsiveness may not result from an 
intrinsic abnormality of airway smooth muscle 1523135140. In the rarely available 
airways of asthmatic patients increased 6 24 125 as well as decreased 52 147 respon-
ses to contractile agonists have been reported. These apparently contradictory 
results, that may well be due to methodological factors, and the lack of correla-
tion between in vitro and in vivo measurements illustrate that itl vitro data should 
be interpreted with caution 28. 
Nevertheless, the study of phatmacology of human airways in vitro may pro-
vide insight into the pathogenesis of human airway disease. For instance, the 
role of the aitways epithelium 3 40 45 and the non-adrenergic, non-cholinergic 
Based all: Hulsmann AR, De Jongste Ie. Studies of human airways in vitro: A review of 
the methodology. J Phal1l1aeo/ Toxieol Methods 1993; 30:117-32. 
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(NANC) nervous system 2536118 in airway responsiveness have been studied in 
detail in isolated airways. Furthermore, studies in vitro offer the opportunity to 
test the effects or side effects of novel pharmacological compounds potentially 
acting on lung tissue. The relaxant effects of the potassium channel opener 
cromokalirn 19, originally developed for the treatment of hypertension, and of 
the phosphodiesterase inhibitors rolipram and SK&F 94120 8 on human isolated 
airways are examples of such in vitro studies. 
A variety of models for animal and human isolated airways in vitro has been 
described since Williams 149 demonstration of the contractile mechanisms in 
isolated lungs. This review wiII briefly discuss these models, their historical 
backgrounds, their applications, and their restrictions. Furthermore, methodo-
logical aspects such as preparation and overnight preservation, epithelium 
removal, and electrical field stimulation are discussed, emphasizing human air-
ways. 
4.2 ISOLATED AIRWAY PREPARATIONS 
Ainvay strip and ring preparations 
In 1912 an isolated large airway preparation was described by Trendelenburg 138. 
Isotonic recordings were made in bovine tracheal rings with or without carti-
lage, and the bronchodilator effects of caffeine, adrenaline, and atropine were 
demonstrated 138. In order to measure the responses of tracheal muscle of small 
animals in vitro, Castillo and De Beer 14 used a chain of 10 to 12 tracheal rings. 
By means of the additive responses of the rings in the chain preparation, they 
were able to demonstrate bronchoactive effects of various drugs. The same prin-
ciple was applied to human central bronchi 60120. However, the tracheal chain is 
a laborious preparation that requires a lot of airway tissue, and each connecting 
knot is a potential source of tissue damage and mechanical instability. Several 
years later, spirally cut airway strips from animals 18 112 114 and humans 1250 114 
were described. These were easier to prepare, but the preparation also caused 
tissue damage. The development of sensitive transducers made it possible to 
record isotonic shortening or isometric force development in strips or rings of 
dissected animal I 63 114 and human 22 43 73 114 small airways. In figure 1 the 
different airway strip and ring preparations are shown schematically. Theoreti-
cally, airway ring preparations have advantages over airway strips: the contrac-
tion of a ring is directly related to airway narrowing and, furthermore, the con-
74 
STUDIES OF HUMAN AIRWAYS IN VITRO: A REVIEW OF TilE METHODOLOGY 
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Figure 1. Schematic representation ofthe airway strip (A), airway ring (B), spiralized airway 
strip (C), and airway chain preparation (D). 
figuration of the smooth muscle bundles is largely preserved. A practical advan-
tage is that only a small piece of tissue is needed. A disadvantage of the aitway 
strips and ring preparations is the inability to stimulate the mucosal or the serosal 
side selectively. Figure 2 displays an airway ring preparation in a conventional 
double-jacketed organ bath. 
LUllg parellchymal strips 
The lung parenchymal strip was developed by Lulich and colleagues 88 as an in 
vitro preparation to evaluate the actions of dmgs on peripheral airways. Thin 
strips (approximate dimensions 20 x 3 x 3 mm) were dissected from a lung lobe 
and studied in a conventional organ bath. The preparation has been widely used 
in studies of both laboratory animal 16 33 77!O8 and human 4249123 lungs. Marked 
differences in responsiveness to various agents of the smooth muscle of central 
airway strips, and lung parenchymal strips were found, and it was assumed that 
the dmg-induced effects in parenchymal strips reflected the responses of smooth 
muscle of small aitways present in the bronchioles and alveolar ducts 1633424988. 
However, since the responses of parenchymal strip preparations to sympatho-
mimetic dmgs were not consistent between species and even within a single 
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Figure 2. Schematic representation of an airway ring preparation mounted in a double-
jacketed, glass organ bath. A = airway preparation; B = buffer supply; C = carbogen 
supply; E = platinum electrodes; H = stainless steel hooks; T = isotonic transducer; 
W = warm (37"C) water supply. 
animal, the involvement of non-airway components snch as vascular smooth 
muscle 50 96 and, probably, interstitial contractile cells 76 was suggested. Indeed, 
Bertram and coworkers 10 showed that the type and size of responses of human 
parenchymal strips to the sympathicomimetic drugs serotonin and noradrenaline 
depended on the relative amounts of blood vessels and larger airways present in 
the airway preparation. Thus, noradrenaline will induce a contractile response 
in parenchymal strips containing more than twice as much vascular smooth 
muscle as airway smooth muscle, and noradrenaline will induce a relaxation 
when this ratio is lower than twofold (figure 3). These relative amounts of the 
contractile components were determined with stereological analysis, a method 
that enables estimates of different parameters in a 3-dimensional body t43, and a 
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Figure 3. Relationship between the ratio of the volume densities of blood vessel wall to 
airway wall in tissue, V, (BVwallff)N, (AWYwallff), and responses of human 
isolated lung parenchyma slrips 10 noradrenaline (r;0.65, p<0.05). From reference 
10, with permission. 
large variability in composition was shown between strips obtained from the 
same lung lO. Similarly, the disparity of responses in different species can be 
explained by differences in composition; a slice of rat lung will comprise larger 
airways and blood vessels than would a similarly sized slice of human lung 38 51. 
lt appears, therefore, that the anatomical complexity of the parenchymal strip 
restricts its value as a method to study small airway pharmacology. 
Isolated pelillsed ail1vays 
The airway epithelium may modulate airway responsiveness through the release 
of relaxing factors 39, the breakdown of agonists 2 31, and by acting as a physical 
barrier lO3. In human airway strips and rings, however, only a 1.5- to 2.5-fold 
increase in sensitivity to contracting agonists is found after mechanical removal 
of the epithelium 3 74 I 16, probably because the stimulus reaches the smooth muscle 
not only via the mucosal side but also via the serosal side and the cut surface. 
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Therefore, models have been developed that allow independent stimulation of 
rodent intact tracheas and pig and human bronchial segments from the serosal 
and the mucosal side selectively. These airway 'tube preparations' were perfused 
under conditions of constant flow 40 97 102 154 or constant pressure 97 107 130, and 
responsiveness was measured as a change in perfusion pressure or flow, respec-
tively. In these intact perfused airway preparations, the sensitivity to luminally 
applied contractile and relaxing agonists was much lower (over 30-fold) than 
that to serosally applied agonists. These differences were abolished after 
mechanical rubbing of the epithelium, indicating that the effect was caused by 
the presence of epithelium. We developed a similar model to investigate the 
modulatory role of the epithelium in human peripheral airways 64. Human isolated 
peripheral airway tubes were perfused with Krebs-Henseleit (K-H) solution at a 
constant pressure of 6 cm H20 (figure 4), and responsiveness was measured as 
a change in flow. Accurate and reproducible measurements of sensitivity to 
methacholine were obtained. With this method we demonstrated a much greater 
modulatory role of the epithelium in human perfused peripheral airways than in 
peripheral airway strips 65. 
Apart from studying the modulatory role of the epithelium, airway tube prepa-
rations have been used to study other factors that determine airway narrowing 
such as preload and airway compliance. The effect of preload on airway narrowing 
has been studied in rabbit, pig, and human isolated airways. The transmural 
pressure in closed airway segments was varied between -10 and +30 cm H20, 
and the pressure change to field stimulation was recorded. It appeared that both 
the presence of cartilage and the transmural pressure determine the preload (and 
hence force) of the smooth muscle (figure 5) 100 132. 
Gunst and Stropp 57 determined pressure-volume relationships in canine bronchi 
by measuring bronchial transmural pressure changes during inflation and defla-
tion of the airway preparation with K-H solution. The compliance of contracted 
airways was lower than that of relaxed airways. Large airways contracted with 
acetylcholine (l0·3M) developed pressures >30 cm H20 only near their maxi-
mal volumes, whereas small airways developed similar pressures at a much wider 
volume range (figure 6). Fmthermore, small airways were able to constrict to 
closure but large airways constricted only to 30% of maximal volume. These 
differences are probably due largely to differences in orientation of the smooth 
muscle tissue and in the amount of cartilage between large and small airways 57. 
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Figure 4. Schematic presentation of the human perfused airway preparation. The transmural 
pressure is maintained at 6 em H,o. B = buffer supply; C = stainless steel cannula; 
a = organ bath; A = airway segment; T = electromagnetic transducer. 
From reference 64, with pennission. 
Isolated pelfllsed llings 
The lung is supplied by both the pulmonary circulation and the tracheobronchial 
circulation. The tracheobronchial circulation may be important in the patho-
genesis of asthma because of its involvement in the influx of inflammatory cells 
into the airways, in the development of airway wall edema, and in the clearance 
ofbronchoactive mediators and inhaled dtugs 2930 115148. In addition, hyperemia 
and hyperpermeability of bronchial vessels may increase airflow resistance and 
airway responsiveness to bronchoconstricting agents 87 ll5. These aspects can 
not be studied in isolated aiIway preparations. In isolated whole-lung prepara-
tions, however, relationships between airways and the vascular systems are pre-
served. Models of dog, rat, rabbit, and guinea pig perfused and ventilated lungs 
have been described 37 59 84 90104 122 146. After anesthesia, animals are tracheo-
tomized, and a cannula is inserted into their trachea and connected to a ventila-
tor. Then the thorax is opened, and heparin sodium is injected into either the 
right ventricle or intravenously. The pulmonmy artery and pulmonary vein or 
the left atrium are cannulated, and the blood is flushed from the pulmonmy 
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Figure 5. Relationship between transmural pressure and response to EFS of bronchial 
segments from pig (3 nnm i.d.) and human (4 nnm i.d.) lung. Closed segments 
were activated by electrical field stimulation (20 Hz, 0.5 IllS, 60 V) and the increase 
in pressure was recorded via a transducer attached to a T-piece at one end of the 
preparation. The transmural pressure was changed by introducing different 
volumes of Krebs-Henseleit solution into the segment. Means ± SEM, n=3-4 
animals. From reference 131, with permission. 
circulation with K-H solution at 3TC. The lungs are either left in situ 141 or 
removed from the thorax and placed in a water vapor-saturated glass or perspex 
chamber warmed to 37'C. During the experiment the lungs are perfused via the 
pulmonary artery with oxygenated K-H buffer (3TC) containing 4%-5 % bovine 
albumin or with whole blood under either constant pressure or constant flow 
conditions. In most studies the preparation is ventilated with preheated and hu-
midified gas by creating a rythmically varying negative pressure (-3 to -12 
cm H20) in the thorax chamber. Alternatively, positive pressure ventilation has 
been used 59 71 8492. Weight gain during the experiment, indicating extravasation 
of the perfusate, is continuously monitored or measured before and after the 
experiment. In figure 7 the experimental set-up of an isolated perfused and 
ventilated guinea pig lung is displayed. 
The absence of perfusion of the bronchial circulation and lymphatic drainage 
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circles represent passive pressure obtained 1 min after inflation. Open circles 
represent pressures obtained after contraction with acetylcholine (10-3 M). From 
reference 57, with pennission. 
are considered as major drawbacks in these preparations. However, after pelfusion 
ofthe pulmonary artery with fluorescein isothiocyanate (FITC-D, MW 150,000) 
Kroll and coworkers found abundant presence of FITC-D in tracheobronchial 
tissue S2. This indicates functioning anastomoses between the pulmonary and 
the bronchial circulation, and this increases the validity of this model. In order 
to ensure oxygenation of medium-sized and large airways, Kroll and colleagues 
ventilated the isolated lung with supraoOlmal 02 tension SI. The nonfunctioning 
lymphatic system, fluid extravasation, and the use of an artificial perfusion me-
dium may lead to a weight gain during perfusion 44 81. Nevertheless, prepara-
tions can be used for several hours during which the lung function remains 
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stable 81. The model can be used for the measurement of lung resistance (RL ) 
and dynamic compliance (Coyn) and for metabolic and phmmacological studies 
81. Furthe1more, Wang and coworkers 141 showed that it is possible to measure 
capillary transit time in isolated rabbit lungs by fluorescence video microscopy. 
No studies in perfused ventilated human lungs have been described, probably 
because a fresh whole-lung preparation is rarely available. 
It might be possible to develop a model for the perfusion and ventilation of 
human lung lobes or segments. However, the fact that the blood supply of a 
given ventilatory unit comes from several vascular units 144 may provide a major 
problem in preparations of human lung segments. 
4.3 PREPARATION AND OVERNIGHT STORAGE 
Animal airways tissue can usually be studied innnediately after removal. Human 
airway tissue, however, is often obtained with some delay because pathological 
examinations have to be performed. In case of autopsy there may be even many 
hours of delay. In a study by Ferguson and Richardson 41, lung tissue was obtained 
at autopsy within five hours of death. Electronmicroscopy of epithelium and 
smooth muscle cells showed swelling of mitochondria and endoplasmatic 
reticulum, condensation of cell nuclei and blebs in the cell membrane. In addi-
tion, in the smooth musle cells disorganization and clumping of the contractile 
filaments was seen 41. These changes were largely reversible after incubation of 
the tissue in organ baths containing carbogenated K-H buffer solution. Although 
this may indicate recovery of the preparation from the anoxic period, only brief 
functional studies were performed by the authors. Bronchial tissue obtained at 
thoracotomies seems preferable because the anoxic damage and autolysis can 
be largely avoided when the tissue is submerged in cooled (0 to 4°C) K -H buffer 
solution immediately after surgical resection. De Jongste and colleagues described 
a technique for preparation and storage of human lung tissue 22. After washing 
to remove blood, bronchi are identified on the cut surface of the excised lung 
tissue and cannulated with polyethylene tubes. Air is gently inflated to ascertain 
that an airway and not a blood vessel is cannulated. The airway is carefully 
separated from the surrounding tissue guided by the cannula. Thereafter, blood 
vessels, lymphatic tissue, and parenchyma are removed from the airway with 
iris scissors under a binocular preparation microscope 22. The airway tubes can 
be cut into helical or transversal SHips or lings. 
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Figure 7. Experimental set-up for studies in isolated perfused lungs. 
Tissue preparations can be stored ovemight in cooled (4 'C) Ringer's solution 60 
or, preferably, cooled, and carbogenated K-H solution t2 22 117. With K-H buffer, 
the response to methacholine remains unchanged until up to 55 hours after re-
section 22. To prevent bacterial overgrowth, antibiotics, e.g. penicillin (3x 10.5 gil) 
and tobramycin (5xlO·3 gil) should be added. 
4.4 PHYSIOLOGICAL SALT SOLUTIONS 
In vitro studies are performed in glass or plexiglass organ baths filled with a 
physiological salt solution. Plexiglass organ baths can be a problem because 
interaction of several drugs with synthetics has been described 80. 
A physiological salt solution is a solution of inorganic salts in which an isolated 
organ or tissue survives for some time and displays most of its normal func-
tions. The critical ions in any salt solution are sodium, potassium, calcium, and 
bicarbonate. Sodium and chloride are the main osmotic ions, potassium, cal-
cium, sodium, and magnesium are important for contractility. Bicarbonate is 
patt of a bicarbonate - carbon dioxide buffer system. Ringer was the first to use 
a physiological salt solution in his studies on the frog heart t 19. The first salt 
solution for mammalian tissues was devised for the heart by Locke 86. He 
increased the salt concentration of Ringer's solution to increase the osmotic 
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Figure 8. Recording oftension and length changes of smooth muscle obtained under isotonic 
(A), isometric (Bl and auxotonic (C) conditions. 
pressure and he added glucose (0.1 %) to improve the survival time of the heart. 
Tyrode added phosphate to improve buffering and magnesium to maintain 
contractility of the smooth muscle preparation 139. The disadvantage of Tyro de's 
solution is its tendency to become alkaline and to precipitate calcium carbonate. 
In the solution of Krebs and Henseleit, a higher concentration of bicarbonate is 
used, similar to that found in plasma 78. The solution should be gassed with 
carbogen (95% 02' 5% CO2) to achieve a pH of7.4. For studies on tissue respira-
tion, Krebs replaced part of the sodium chloride with sodium salts of fumaric, 
pyruvic, lactic, or glutaric acid as additional substrates apart from glucose 79. 
The K-H solution is most commonly used. 
In studies of isolated perfused organs, a colloid should be added to the physio-
logical salt solution in order to prevent edema. Several colloids have been used 
including dextrans 55, polyvinylpyrrolidone (PVP) 121 and bovine serum albu-
min 126. Most investigators use albumin, however, disadvantages of albumin are 
its tendency to lower the pH, to bind calcium ions, and to froth when aerated 13. 
Although most physiological salt solutions are gassed with carbogen (95% 02' 
5% CO2), perfused mammalian organs may need more oxygen than can be pro-
vided in this way. Oxygen transport can be increased by using erythrocytes or 
fluorocarbons 53 58128. Fluorocarbons are inert organic substances in which the 
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Figure 9. Lengthwtension relationships of airway smooth muscle. The active tension curve 
is obtained by subtracting passive tension from total tension. The isometric curve 
is also shown. The arrows indicate isotonic smooth muscle shortening at different 
lengths. Modified after reference 132. 
hydrogen atoms are replaced by fluorine. They have the capacity to carry more 
oxygen than can be carried in human whole blood 13. In the perfused ventilated 
lung, however, addition of an oxygen carrier may not be necessaty because 
during ventilation of the preparation with supranormal 02 tension, tissue hypoxia 
does not seem to be a problem 81. 
4.5 REcORDING OF RESPONSES 
Isometric, isotonic and auxotonic recording 
Mechanical muscle activity can be measured under isotonic, isometric and 
auxotonic conditions. Under isotonic conditions, changes in length are recorded 
in a muscle to which a constant predetermined load is applied (figure 8a). Iso-
metric recordings can be made by measuring changes in force of contraction in 
a muscle preparation which has a constant predetermined length (figure 8b). 
When changes in length and changes in force are measured simultaneously in a 
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muscle preparation where the applied load increases while the muscle shortens, 
this is called auxotonic (auxanein (Gr.) = to increase; figure 8c). In the early 
days of research of smooth muscle contractility in vitro, isotonic recording tech-
niques were standard: The preparation was connected to the short mm of a lever, 
the long arm of which recorded changes in muscle length on a slowly moving 
kymograph. When isometric transducers became available length-tension rela-
tionships in canine tracheal smooth muscle were examined (figure 9) 132. The 
preparations were stepwise stretched, and the resulting passive load and the 
total contractile force after electrical field stimulation (EFS) were recorded. The 
active load causing isotonic shortening can be derived by subtraction of resting 
load from total force generated. The active force development in airway prepa-
rations increases with length until an optimal length (La or Lmax) is reached. The 
passive tension at Lmax is only 5% to 10% of the active tension. The horizontal 
difference between the active and the total tension (arrows in figure 9) repre-
sents the smooth muscle shortening under isotonic conditions. When the muscle 
is stretched beyond Lmax, the maximum active tension will decrease. At all muscle 
lengths, force development in isometric experiments is higher, indicating that in 
isotonic contraction the smooth muscle does not contract fully 132. This incom-
plete contraction may be due to thickening of the muscle hindering diffusion of 
the neurotranslnitter and folding of contractile elements impairing optimal func-
tioning 94 132. At functional residual capacity (FRC) in vivo, the tracheal smooth 
muscle may be stretched to around Lmax 99. The experiments of Stephens and 
Van Niekerk imply that, for optimal results, isolated airway preparations should 
be stretched to approximately Lmax by applying a weight (isotonic measure-
ments) or increasing baseline length (isometric measurements) 132. 
In the rabbit bronchus, Atmour and coworkers found a correlation between the 
maximal isometric force generation in response to carbachol and the amount of 
airway smooth muscle present in the airway preparation 4. In contrast, the maxi-
mal isotonic shortening was not related to the smooth muscle content of the 
preparation, and it was concluded that isometric measurements are preferable 
because they represent changes in smooth muscle contraction in response to an 
agonist more accurate 4. In human small airways, however, only small differ-
ences were found between both methods, perhaps because the experiments were 
performed under near optimal tension and length conditions 26. Although both 
recording techniques allow accurate and reproducible measurements of force 
generation, airway smooth muscle contraction in vivo is neither isometric nor 
isotonic, but auxotonic: during narrowing the load against which the smooth 
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muscle shortens increases due to an elastic load provided by the surrounding 
structures 99 131. This situation has been simulated in a study performed by Ishida 
and colleagues who measured the effect of elastic loads on smooth muscle short-
ening in pig isolated airways 68. It was shown that, at small loads, contractile 
responses were more or less isotonic, whereas, at large loads, minimal shorten-
ing was found indicating a isometric response 68. Thus the size of the elastic 
load on the airway provided by the airway wall and the surrounding tissue de-
termines the degree to which a contraction is isometric or isotonic. 
Pressure orflow recording 
The responses of perfused airway tube preparations are measured by recording 
changes in flow rate or perfusion pressure, depending on whether experiments 
are done under constant pressure or constant flow conditions, respectively. The 
configuration of the airway is left intact and the mode of contraction is more 
physiological than that in an airway strip preparation. However, in the constant 
flow model, the transmural pressure increases during contraction and this will 
influence the load on the muscle in an elastic (auxotonic) way. In the constant 
pressure model, airway closure may occur at higher doses of a contracting 
agonist 97, and this precludes accurate determination of the pharmacological 
sensitivity (ECso) of the preparation. In human peripheral ahways perfused at a 
constant pressure, we were able to avoid airway closure by stretching the air-
way preparations to 140% of their initial length 64. 
Other methods to record ainvay responses 
Other techniques to record airway responses have been developed and are briefly 
described below. These methods, however, are not commonly used, and their 
value remains to be established. 
High-resolution ultrasonic imaging. In order to visualize airways smooth muscle 
contraction in vitro, Iizuka and colleagues introduced an ultrasonic catheter in 
porcine and human isolated bronchi 67. The ultrasound technique produced a 
three-layer image of the bronchial wall corresponding to the mucosa, cartilage, 
and adventitia. The muscle could not be distinguished from the mucosa. Dose-
dependent responses to acetylcholine could be obtained and it was found that 
human bronchus contracts elliptically, not circularly 67. Because the diameter of 
the transducer is 1.7 mm, the technique can be only used in airways of at least 
this size. 
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SOllomicrometl)'. Okazawa and coworkers measured length changes of canine 
trachealis muscles in vivo with sonomicrometry 106. This technique uses the 
transit time of ultrasound traveling between two piezoelectric crystals as a 
measure for the linear distance between these crystals. Small (I mm) piezoelectric 
transducers were placed in the postetior tracheal wall in parallel with the muscle 
fibers. Length changes during mechanical ventilation and pressure-volume curves 
could be obtained. This method may be applicable in isolated large airways as 
well. 
High-resolutioll computed tomography. With this technique, airways of 1-2 mm 
diameter can be visualized 137, and this method has been used to study carbachol-
induced changes in airway dimensions in excised canine lung lobes 93. The de-
gree of airway narrowing could be accurately quantified, and it was shown that 
airway narrowing after carbachol is greatest in intermediate-sized airways 
(internal diameter: 2-6 nnn). 
Photoelectric recording. Schabert and colleagues developed a photoelectric 
method to record changes in blood vessel diameter 124. A beam of parallel infra-
red light is directed at right angles to the blood vessel. The light passing the side 
of the vessel is a measure of the outer vessel diameter and is detected by a 
photocell. A decrease in vessel diameter causes an increase in photocell current. 
In isolated airways, photoelectric methods have been only used to study respira-
tory ciliary activity 133 151. 
4.6 BETWEEN-PATIENT AND WITHIN-PATIENT VARIABILITY 
With the above-mentioned recording techniques, accurate and reproducible 
measurement of parameters such as tissue sensitivity (EC50), maximal contrac-
tion, or relaxation and intrinsic (baseline) tone is possible in human airway strips, 
rings, and tubes 226473. However, for some purposes an in vitro model should be 
able to detect between-patient differences. De Jongste and coworkers showed 
that in airway strips despite large within-patient variability, significant between-
patient differences could be shown for EC50 and maximal response 22. In airway 
tubes, between-patient differences in EC50 and intrinsic tone accounted for more 
than 90% of the total variability 64. 
The finding of smaller within-patients variability in airway tubes compared to 
airway strips may indicate that within-patient variability in airway strips are 
largely due to disturbance of the airway structure during the cutting of the strips. 
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4.7 lNTIuNSIC TONE 
Isolated airway preparations may exhibit an intrinsic muscle tone. In guinea pig 
airways this tone appears to be dependent on prostanoids and not on intrinsic 
innervation 109. In human airways, however, the role of prostanoids is unclear 
since both enhancement 69 and reduction 70 of intrinsic tone have been described 
after inhibition of cyclooxygenase. In addition, peptidoleukotrienes may be 
involved because inhibition of 5-lipoxygenase decreased intrinsic tone 70. 
Mansour and Daniel expressed the responses of guinea pig tracheas on a scale 
between maximal relaxation and maximal tension in response to carbachol 91. It 
appeared that the responses to exogenous arachidonate were dependent on the 
intrinsic tone of the airway preparation; when this intdnsic tone was low, con-
traction was found; when it was high, relaxation was found 91. Their findings 
emphasize the importance of the expression of responses on a scale that dis-
plays the maximal active contractile range (MACR) in order to be able to com-
pare responses of different airway preparations. Monitoring intrinsic tone is also 
relevant when BFS is used. With high intrinsic tone, BFS may predominantly 
give relaxations, whereas with low tone, contraction will result. 
We routinely determine maximal contraction to exogenous cholinergic stimula-
tion at the beginning of experiments, and maximal relaxation to B-adrenoceptor 
stimulation and calcium free buffer after completion of the experiments. Alter-
natively, a supramaximal dose of theophylline, sodium nitroptusside, or papa-
verine can be used to obtain maximal relaxation. 
4.8 REMOVAL OF THE EPITHELIUM 
Classically, the modulatory role of the airway epithelium is evaluated in paired 
observations of intact and epithelium-denuded isolated airway preparations. The 
epithelium is commonly removed by 'gentle tubbing' with a wet cotton gauze, 
and its effectiveness is verified histologically 3 45 74. In guinea pig tracheas the 
effectiveness of epithelium removal can be also verified functionally by adding 
arachidonic acid which causes smooth muscle contraction in epithelium-denuded 
tracheas, whereas intact tracheas respond with relaxation 105. This procedure 
has not been tested in human airways. With mechanical tubbing, it is possible to 
remove over 95% of the epithelium leaving the basal membrane and the smooth 
muscle histologically intact. However, Franconi and colleagues showed that 
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Figure 10. Effect of change in pulse voltage, -frequency and -width on the contraction and 
relaxation responses of human bronchial strips. (A) effect of voltage (0 to 50 V) 
with constant frequency (30 Hz) and pulse width (0.3 msec). (B) effect offrequency 
(0 to 50 Hz) with constant voltage (30 V) and pulse width (0.3 msec). (C) effect 
of pulse width (0.2 to 0.75 msec) with constant voltage (30 V) and frequency (30 
Hz). Pulse trains of 30 sec. Contractions and relaxations are expressed as a 
percentage of the maximal response in a given strip. Mean values ± SEM of 4-5 
experiments are shown. From reference 27, with permission. 
mechanical rubbing of the epithelium may lead to release of granules contain-
ing tryptase from mast cells present in the lamina propria 47. In dog airways, 
tryptase causes hyperresponsiveness, probably due to an effect on Ca2+-chan-
nels t27. This mechanism may explain at least part of the hyperresponsiveness 
reported in epithelium-denuded airways. Furthermore, epithelial damage and 
denudation in asthma is not caused by mechanical rubbing but, probably, by the 
release of basic proteins such major basic ,protein (MBP) and eosinophil 
peroxidase (EPO) and oxygen radicals released from inflammatory cells present 
in the inflamed aitway 7 48 98. Deposits of EPO were found in areas of mucosal 
injury in asthmatics 11. Human MBP causes epithelial damage lOt and hyper-
responsiveness in vitro 46 and in vivo 56. Oxygen radicals increase the permea-
bility of cultured epithelium t45 as well as epithelium in the guinea pig trachea 
72, and the responsiveness of human airways is enhanced after damaging the 
epithelium with hydrogen peroxide 65. In a model of asthma it may be more 
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appropriate to use these agressive substances rather than mechanical mbbing to 
induce epithelial damage. Apart from basic proteins and oxygen radicals, several 
other methods for damaging and removal of epithelium in vitro have been 
described. Franconi and cowokers removed epithelium from animal and human 
airways by perfusing the preparations during 0.5 to 2 hours with pronase (protease 
type XIV; I mglmI) 47. Whereas the epithelium was effectively removed, the 
integrity of mast cells in the lamina propria and the smooth muscle was not 
affected. 
Interferon-y, produced by intra-epithelial T-Iymphocytes 35 enhances tight junc-
tion permeability in a human intestinal epithelial cell line 88 but has not been 
examined in airway epithelium. Perfusion of rat arteries with a hypotonic Tyrode 
solution 113 or the nonionic, nondenaturing detergent CHAPS (3-[(3-cholami-
dopropyl)-dimethyl-anmlOnio]-l-propanesulfonate) 136 153 resulted in a dismp-
tion of endothelial cells, and this method may be applicable for epithelial cell 
removal in airways as well. It appears, therefore, that there are altematives for 
the mechanical removal of airway epithelium. These altematives have the 
advantage that they mimic the damage that is found in asthma (basic proteins 
and oxygen radicals) or that they produce less artifacts (pronase). 
4.9 ELECTRICAL STIMULATION 
Basically, there are two methods of electrical stimulation of isolated organ prepa-
rations: contact stimulation using electrodes that are attached to the tissue and 
field stimulation via electrodes that are not in direct contact with the tissue. 
Also, one electrode may be in contact with the tissue while the other, often a 
ring, is not (hybrid stimulation). EFS is most commonly used to study neural 
responses in smooth muscle preparations including isolated airways. The tech-
nique is relatively simple; platinum- or silver-silver chloride sheet electrodes 
are suspended close to, but not in contact with, the tissue, in an organ bath 
containing K-H solution (figure 2). A stimulator generates rectangular pulses of 
short duration (0.1 to 1 msec) at a constant current. Voltage- and frequency-
response curves can be obtained and the interval between stimuli and pulse 
width can be varied (figure 10). 
EFS was introduced by Paton in 1955 who demonstrated that single electrical 
pulses (1 to 25 V, 0.5 msec) elicited brief twitches (I sec) in the guinea pig 
isolated ileum III. Since the twitch was abolished by atropine, prolonged by 
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eserine, and was insensitive to hexamethonium, he concluded that postganglionic 
nerve fibers were excited by EFS. In later studies it was confinued that with 
appropriate stimulation parameters, nerve fibers can be activated selectively 
without stimulating the smooth muscle directly 34 110. 
In human airways, EFS causes a fast, nerve-mediated cholinergic contraction 
followed by a slow non-adrenergic, non-cholinergic inhibitory nerve-mediated 
(iNANC) relaxation 21 ll8 134. In addition, De Jongste and coworkers found a 
rapid non-neural contraction and a sustained non-neural contraction resulting 
from synthesis of cyclooxygenase metabolites and leukotriene-like substances 
by fresh human airway tissue, respectively (figure 11) 25. These nonneural con-
tractions may interfere with neural responses and should be taken into account 
as a confounding factor. In guinea pig airways vasoactive intestinal peptide (VIP) 
and nitric oxide (NO) may be the neurotransmitters of the non-adrenergic 
inhibitory nerves 83 85, whereas in human bronchi the response may be due mainly 
to N0936. 
Although EFS is a useful tool to evoke neural responses in isolated airway tis-
sues, the technique has an important side effect. During EFS with commonly 
used stimulation parameters activated oxygen molecules may be generated in 
carbogenated K-H buffer. These activated oxygen molecules have been shown 
to relax smooth muscle preparations directly 54 and may oxidize contractile drugs 
66 150. The inactivation of histamine by EFS may even occur at a frequency of 2 
Hz (50 V, pulse duration 0.3 msec) 66. 
4.10 CONCLUSIONS AND DIRECTIONS FOR FUTURE RESEARCH 
In the present overview, we discussed models that have been developed over the 
years to study the effects of drugs, inflammatory mediators, autonomic nerves, 
and epithelial cells on the responsiveness of airway smooth muscle in vitro. 
These models range from the simple bronchial strip preparation to the complex 
ventilated and perfused lung preparation. Although these models have substan-
tially contributed to the progress in our understanding of the pathophysiology of 
asthma and COPD, the precise relationships between airway inflammation, bron-
chial hyperresponsiveness, and airway narrowing is still not clear. The relative 
contributions of inflammatory cells and their products, of autonomic nerves and 
of the tracheobronchial circulation to airway disease should be further investi-
gated. With the currently available in vitro models, however, the role of the 
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Figllre 11. Schematic representation of time course, peak latency and amplitudes of the 4 
phases that constitute the response of fresh human bronchus to electrical field 
stimulation (EFS) in vitro. Phases are numbered according to peak latency after 
EFS; 1: cholinergic nerve-mediated, rapid contraction. 3: non-adrenergic inhibitory 
nerve-mediated relaxation. 2 and 4: non-neural contraction due to the release of 
cydo-oxygenase and lipoxygenase metabolites, respectively. From reference 25, 
with permission. 
bronchial circulation in airway disease cannot be elucidated. Efforts should now 
be made to develop models in which the normal relationships between the 
ventilatory and the circulatory unit is preserved in vitro. The study of isolated 
perfused and ventilated lung tissue may be an important step in this direction, 
and it might be possible to develop such a model for the human lung. 
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Chapter 5 
The Perfused Human Bronchiolar Thbe: 
Characteristics of a New Model 
5.1 INTRODUCTION 
Airway reactivity in vitro is usually assessed using strips or rings of airway 
tissue immersed in organ baths. Due to spiralization and cutting in such prepa-
rations the airway has lost its normal structure and the agonist reaches both the 
mucosal and the serosal side of the preparation. Hence, the specific modulatory 
role of the epithelium on airway smooth muscle responsiveness cannot be 
assessed accurately. Furthermore, the magnitude of the contractile response of 
strips is dependent on the orientation of the smooth muscle, and this is an impor-
tant confounder when absolute responses are measured. 
Recently, in vitro methods that allow for independent stimulation from either 
the mucosal or the serosal surface have been described for animal airways. These 
airways were pelfused with Krebs-Henseleit (K-H) buffer under conditions of 
constant flow 7 9 10 or constant pressure 6 II, and airway reactivity was measured 
as a change in pressure or flow respectively. Results obtained in perfused tube 
models in presence and absence of epithelium were significantly different from 
those with conventional preparations 7-11. Perfused tube models have been 
described for pig and rodent airways 7-1113. 
In human asthma, the relative contribution of the different levels of the bron-
chial tree to bronchoconstriction is not known and it has recently been sug-
gested that small airways contribute to airflow regulation to an important 
degree 4 12. Hence, it is interesting to develop an in vitro model of human 
peripheral airways which offers the possibility to study the modulatory effects 
of human airway epithelium and to study small airway mechanics. This paper 
describes the characteristics of the isolated, perfused human bronchial segment. 
Based all: Hulsmann AR, Raatgeep HR. Bonta IL, Stijnen T, Kerrebijn KF, De Jongste Je. 
The perfused human bronchiolar tube: characteristics of a new model. J Pha17t1aco/ To:ricol 
Methods 1992; 28:29-34. 
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5.2 MATERIALS AND METHODS 
Tissue preparatioll 
Human lung tissue was obtained from 17 patients (3 females), with a mean age 
of 62 y (range 39 to 79 y) who underwent a thoracotomy for bronchial carci-
noma. None of the patients had asthma. Immediately after surgical resection, a 
macroscopically normal part of the resected tissue was immersed in K -H buffer 
at room temperature (composition in mM: 118 NaC!, 4.7 KCl, 2.5 CaCl2, 1.2 
MgS04, 1.2 ~P04' 25 NaHC03, 5.55 glucose), carbogenated (95% °2-5% 
CO2) to produce a pH of 7.35, a PC02 of 4.7 kPa, and a P02 of 71.8 kPa. The 
tissue remained in fresh carbo gena ted buffer throughout the dissection proce-
dure and during the experiments. Tubular segments of peripheral airways (gene-
ration 9-11; internal diameter 1.0-1.4 mm; length 5-8 mm) were carefully dis-
sected free from parenchyma and blood vessels under a 20x stereo microscope 
with iris scissors and forceps 3. The side branches were ligated with thin surgical 
silk threads (6/0). Each end of the segment was cannulated with stainless-steel 
cannulas (external diameter 1.6 mm; internal diameter 1.2 mm). The resistance 
of the cannulas was low compared with the bronchial segment. The preparation 
was placed horizontally in a double jacketed 4 ml organ bath that contained 
carbogenated Krebs buffer at 3TC. The bronchial lumen was perfused with 
carbogenated K-H solution (inner perfusate) from a seperate reservoir (figure I). 
The temperature, 02 tension, and CO2 tension in this reservoir were maintained 
at the same level as in the tissue bath. 
The transmural pressure of the airway was maintained at 6 cm ~O, which is 
similar to the normal transpulmonary pressure in vivo. The distal cannula was 
connected to an electromagnetic flowmeter (Nihon Kohden, model MFV-1200, 
Tokyo, Japan) after which the perfusate was calTied to waste. The flow rate 
(ml/min) through the bronchial segment was displayed on a pen recorder (Kipp 
BD 40, The Netherlands). The use of human lung tissue for in vitro experiments 
was approved by the Ethical Committee of the Rotterdam University Hospital. 
Drugs 
Methacholine hydrobromide (Janssen PhalTI1aceuticals, Beerse, Belgium) and 
EDTA (Sigma Chemicals, St. Louis, MO, USA) were dissolved in 0.9% NaC!. 
L-Isoproterenol sulfate (Janssen) was dissolved in distilled water containing 
ascorbic acid (88 mgll). Fresh drug solutions were prepared daily and kept on 
ice during the experiments. 
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Figure 1. Schematic presentation of the measurement system. The bronchiolar segment (8) 
is cannulated with stainless steel cannulas (C) and mounted in a double jacketed 
organ bath (0) that contains carbogenated Krebs-Henseleit (K-H) solution at 37'C. 
The bronchial lumen is perfused with carbogenated K-H buffer (B). The transmural 
pressure is maintained at 6 em H,O. The transducer (T) of the electromagnetic 
flowmeter is connected to the distal cannula (C). 
5.3 EXPERIMENTAL PROTOCOLS 
Before the experiments, the preparations were allowed to equilibrate for 1 h. 
During that time, the organ bath fluid was replaced evelY 15 min and the prepa-
ration was continuously perfused with fresh K-H buffer. To assess contractile 
functions before each protocol, the preparations were contracted maximally with 
two consecutive doses of methacholine (10-5 and 1O-4M) added to the organ 
bath, followed by wash-out. The cholinergic sensitivity was measured as the 
-log EC50 of methacholine: the negative logarithm of the methacholine concen-
tration that produces 50% of the maximal effect. 
Pressure-flow relationship 
To evaluate whether laminar flow was present at the pressures used, we exami-
nated the pressure dependency of flow rates by perfusing 4 segments with a 
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stepwise increasing pressure (l to 10 cm HP). The airways were studied at 
100%, 140% and 180% of their initial length respectively. 
Length-dependency oj responses 
Excised lung tissue is collapsed because of lack of the negative intrathoracic 
pressure, which, in vivo, counteracts the elastic recoil of the lung tissue. To 
mimic the in vivo situation stretching of the excised airway is necessary. We 
stepwise stretched seven segments of six patients from their initial length (i.e., 
excision length) to 180% of this length by 20% increments with a microscrew. 
Perfusion pressure was 6 cm H20. After each step the preparation was allowed 
to equilibrate and then stimulated from the serosal side with methacholine 
(1O-sM) once, followed by wash-out. After reaching 180%, the length of the 
preparation was returned to 100% and a final methacholine stimulation was 
given. For each length, baseline flow rate and maximal flowreduction after 
methacholine stimulation were measured. 
Reproducibility ojresponses lVithin preparations 
Airway preparations (n=1O) of 10 patients were stretched to 140% of their ini-
tiallength which in the above-mentioned experiments had been established as 
the optimal length. 1\vo consecutive cumulative concentration responce curves 
(CCRC) were made with an interval of 2 h by adding methacholine (l0-8 to 
1O-3M) to the organ bath, followed by wash-out. After both CCRCs were com-
pleted, full relaxation of the preparations was obtained by adding L-isoproterenol 
(l0-4M) and EDTA (4x1O-3M) to the organ bath. From each CCRC, the -log 
ECso was determined. 
Between-patients and lVithin-patientsibeflVeen segments variability 
Lung tissue was obtained from seven patients. From each patient three different 
segments were used. Airway preparations were stretched to 140% of their initial 
length. A CCRC to methacholine administered to the serosal side of the prepa-
ration (l0-8 to 1O-3M) was made, followed by washout. Next, preparations were 
fully relaxed by adding L-isoproterenol (l0-4M) and EDTA (4x1O-3M) to the 
organ bath. For each segment the -log ECso and the spontaneous intrinsic con-
tractile activity (SICA; baseline flow as a percentage of maximal flow in the 
presence of L-isoprenaline and EDTA) were obtained. 
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Figure 2. Mean pressure-flow relationship of 4 airway preparations. Horizontal axis displays 
transmural pressure, vertical axis represents the resulting flow rate at 100% (open 
circles), 140% (closed circles) and 180% (open triangles) of the initial length. 
For reasons of clarity, SEM bars were omitted. The SEM was <20% (n=4). 
Data analysis 
The -log EC50 was calculated using a BMDP software module for non-linear 
curve fitting t. The curves were fitted to a four parameter logistic function 2. The 
-log EC50 of the two consecutive CCRCs were compared by Student's t tests for 
paired data (two-tailed, a=0.05). The contribution of the between-patients and 
within-patientslbetween segments variation to the total variation for -log EC50 
and SICA was computed using a one-way analysis of variance (ANOVA). AIl 
data are expressed as means ± SEM. 
5.4 RESULTS 
Pressure-flolV relationship 
The flow rate proved to be pressure dependent at all airway lengths; however, 
only at 100% and 140% of the initial length there was a linear relationship 
between pressure and flow rate indicating laminar flow (figure 2). At 180% of 
the initial length, flow rate tended to level off at high pressures indicating turbu-
lent flow. 
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Figure 3. Baseline flow (closed symbols) and flow rate in the presence of 10,5 M metha-
choline (MCh) added to the organ bath (open symbols. n = 8 segments of 8 
patients). The horizontal axis depicts stretching the preparation in 20% increments. 
The vertical axis represents changes in baseline flow and flowreduction after 
MCh. Vertical bars represent SEM. 
Length-dependency of responses 
Stepwise stretching the airway preparation to 180% of theirinitiallength resulted 
in an increase of baseline flow by 356 ± 53% (figure 3). Serosal stimulation 
with methacholine (lO-sM) caused a length-dependent reduction of flow rate 
ranging from complete closure in 4 out of 7 unstretched preparations to only a 
minor flow reduction of 16 ± 9% after stretching to 180% (figure 3). After re-
turning the length of the airways to their initial value (100%). flow reduction to 
methacholine returned to values that were not different from those initially ob-
tained at that length (paired t test). 
Reproducibility of responses within preparations 
The initial buffer flow before stimulation with methacholine with a perfusion 
pressure of 6 cm 140 and the preparations stretched to 140% of the initial length 
was approximately 7 mlImin. Serosal stimulation with methacholine (10,8 to 
1O,3M) consistently reduced the flow in a concentration dependent way (figure 4). 
The maximal reduction of flow by methacholine was 74 ± 6% of the initial flow. 
A small but significant increase in flowrate was observed at the onset of the 
second CCRe. No significant difference in -log ECso was found between the 
two consecutive CeRCs (figure 4). 
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Figure 4. Consecutive CCRCs to methacholine (MCh) of human bronchiolar tubes (n = 10 
segments of 10 patients), measured with an interval of 2 h. (Open circles: first 
CCRC; closed circles: second CCRC). The horizontal axis depicts the negative 
log of the Mch concentration in the organ bath, the vertical axis represents the 
contractile response to Mch as a reduction in flow. Vertical bars represent SEM. 
Between-patients and between-segments/within-patients variability. The values 
of -log ECso and SICA for each patient are summarised in table 1. It can be seen 
that the between-patients component for both -log ECso and SICA is responsible 
for the major part of the total variation. The estimates of the between-patients 
and within-patients/between-segments variability for -log ECso were 0.256 and 
0.026, respectively. Thus the differences between the patients accounted for 91 % 
of the total variability. For SICA these values were 113.6 and 520.9, respec-
tively, thus 82% of the total variance in SICA was due to between-patients 
differences. 
5.5 DISCUSSION 
The purpose of the present study was to develop an in vitro model that allows 
for independent stimulation of the mucosal and serosal sides of intact, human 
peripheral airways. Our results show that human peripheral airways can be 
perfused under a constant pressure, and that the resulting flow is laminar. The 
flow rate and reduction of flow rate by methacholine administered to the serosal 
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Table 1. Methacholine responses of 7 patients 
-Log EC" SICA (%) 
SI S2 S3 51 52 S3 
Patient I 6.73 6.30 6.50 20.1 21.0 22.4 
Patient 2 5.32 5.75 5.76 49.4 54.4 46.0 
Patient 3 6.15 6.16 6.17 0.0 12.6 5.2 
Patient 4 5.39 5.78 5.62 46.4 30.4 68.8 
Patient 5 6.25 6.51 6.34 64.3 48.1 26.3 
Patient 6 5.28 5.11 5.08 ND ND ND 
Patient 7 6.37 6.39 6.33 ND ND ND 
S = segment; ND = not determined 
side of the preparation depend on the initial degree of stretching of the airway 
tubes. Repetitive serosal stimulation of the same airway preparation with metha-
choline (l0·8 to 1O-3M) provides accurate and highly reproducible responses. 
Finally, a significant between-patients variability and a small nonsignificant 
between-preparations/within-patients vadability for both -log ECso and SICA 
was found. 
The model is a more realistic approach to the in vivo situation than is the 
bronchiolar strip or ring preparation for the following reasons. First, the 
bronchoactive drug can be selectively applied to the mucosal side of the airway, 
thus mimicking the situation in bronchial provocation studies in vivo. TIus makes 
it possible to compare serosal and mucosal stimulation, and thereby investigate 
the modulatory role of the airway epithelium; exploring this aspect was beyond 
the scope of the present study. Second, the configuration of the smooth muscle 
bundles in the airways is preserved. This is important, because it removes an 
important source of variation. Indeed, the present results indicate a much smaller 
within-patient variation of airway responses than previous studies that used air-
way strips or segments 3 s. Third, airway contraction is directly related to airway 
narrowing and not like in strips or rings of airway tissue measured as an isotonic 
shortening or isometric force development. Finally, in our model, preload is 
applied by keeping the luminal pressure at 6 em H20, which is similar to the 
transpulmonary pressure at functional residual capacity (FRC). 
At 100% and 140% of the initial length, flow rate was directly related to pres-
sure. This indicates that there was a laminar flow, and Poiseuille's equation for 
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laminar flow, which states that resistance is proportional to the inverse of the 
fourth power of the radius, can be used at these lengths. At 180% the relation-
ship between pressure and flow was not entirely linear. This can be explained by 
a tendency for turbulent flow which increases in direct proportion of the flow 
rate. Our observation that stepwise stretching of the airway preparation results 
in an increase of baseline flow (i.e., a decrease in resistance) is surprising because 
according to the Poiseuille equation for laminar flow, increasing the length of 
the preparation should result in an increase in resistance. The most probable 
explanation of this finding is that stretching the airway preparation removes 
mucosal folds and thereby decreases the resistance. Stepwise stretching the air-
way preparation decreased the flowreduction by methacholine 1O-5M (figure 3). 
To explain this finding, it is important to remember that in the smaller human 
airways, smooth muscle is oriented spirally and makes an angle of±30· with the 
cross-sectional plane 4. Stretching the airway preparation, increases the pitch of 
the helix of the smooth muscle bundles and thereby diminishes the constrictive 
forces which act to narrow the airway. Mitchell observed near-complete closure 
in pig bronchial cylinders perfused at constant pressure when stimulated with 
10-5 M carbachol, that is, airway closure occurred before the pharmacological 
end point of the CCRC was reached 6. We also observed near-complete closure 
in 4 out of 7 preparations by 1O-5M methacholine but only in the unstretched 
situation. Mitchell's results may be caused by the use of insufficiently stretched 
airway segments, or species differences may be present. 
Because excised lung tissue is collapsed, we chose to do further experiments at 
140% of the initial length because this assured a stable, reproducible signal and 
avoided airway closure at high agonist concentrations. Repetitive stimulation of 
the same airway preparation showed that reproducible measurements of -log 
EC50 could be obtained. However, an increase in flow was observed during the 
second CCRC for all concentrations of methacholine (figure 4). This difference 
may be explained by an increase in airway diameter in time due to the stretching 
of elastic components in the airway wall while smooth muscle contractility 
remained stable. Alternatively, it may be explained by the washout of mucus. 
Clearly, the sensitivity of the airways is not affected by repetitive stimulation. 
Analysis of variance revealed significant between-patients variation and a small 
non-significant between-segments/within-patients variation for both -log EC50 
and SICA. In bronchiolar strips, de Jongste and coworkers found a relatively 
large within-patients variability for both -log EC50 and the maximal tension, 
and it was assumed that tlus was due to the mechanical forces applied to the 
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airway tissue during the preparation procedure 3. A somewhat better reproducibi-
lity was found in ailway segments, where spiral cutting is avoided 5. The use of 
bronchiolar tubes requires still less preparation and less disturbance of airway 
wall structure. This may explain the smaller within-patient variability that we 
observed. 
We conclude that this in vitro model offers interesting possibilities for evaluating 
the modulatory effects of the ailway mucosa on luminally applied stimuli. Meas-
urements of the sensibility of perfused intact human peripheral airway tubes are 
both accurate and reproducible. In addition, the model provides the oPP011unity 
to study human small airway mechanical properties. 
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Chapter 6 
Oxidative Epithelial Damage produces Hyperresponsiveness 
of Human Peripheral Airways 
6.1 INTRODUCTION 
Epithelial damage or loss is a characteristic finding in biopsies obtained from 
patients with asthma and is related to airway hyperresponsiveness 1620. The 
epithelium may modulate airway responsiveness because it releases relaxing 
factors 2 8, inactivates agonists 1 5, and, finally, acts as a physical barrier to in-
haled stimuli 1231. In human airway strips, however, only a small 1.5- to 2.5-
fold increase in sensitivity to contracting agonists was found after mechanical 
removal of the epithelium 227. This may be due to shortcomings of the airway 
strip preparation since in rodent perfused tracheas where the stimulus could be 
selectively applied to the mucosal or the serosal side, a much larger modulatory 
role of the epithelium has been found 24 26 31. Furthermore, epithelial cell injury 
in vivo is not caused by mechanical rubbing but, probably, by the release of 
basic proteins and oxygen radicals by inflammatory cells present in the lumen 
and mucosa of the airways 3 21. 
Previously, we developed a perfusion model for human peripheral airway tubes 
13 and in the present study we assessed the modulatory role of the epithelium on 
the responsiveness of tubes and strips of human peripheral airways by compar-
ing responses of intact preparations with those of preparations with epithelial 
damage. In strips, the epithelium was damaged mechanically and in tubes the 
oxidant hydrogen peroxide (H20 2) was used to damage the epithelium. Finally, 
we investigated whether the effect of oxidative epithelial damage on histamine 
responses could be explained by a change in barrier function to luminally ap-
plied histamine. 
Based 01/: Hulsmann AR, Raatgeep HR, Den Hollander Ie, Stijnen T, Saxena PR, Kerrebijn 
KF. De Jongste Ie. Oxidative epithelial damage produces hyperresponsiveness of human 
peripheral airways. Alii J Respir Crit Care Med 1994; 149:519-25. 
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6.2 MATERIALS AND METIIODS 
Tissue preparatioll 
Human lung tissue was obtained from 24 male and 3 female patients (mean age 
64.1 y; range 31 to 75 y) who underwent thoracotomy for bronchial carcinoma. 
Their mean preoperative forced expiratory volume in 1 sec as a percentage of 
the inspiratory vital capacity was 63.4 ± 4.1 %. None of the patients had charac-
teristics of asthma. The premedication was the same for all patients: atropine, 
thiopentone, fentanyl, 0/N20, halothane, and pancuronium. Immediately after 
surgical resection, a macroscopically normal palt of the lung tissue was im-
mersed in carbogenated (95% 02' 5% CO2) Krebs-Henseleit (K-H) buffer at 
room temperature (composition in roM: NaC1118, KCI4.7, CaCI2 2.5, MgS04 
1.2, KH2P04 1.2, NaHC03 25, glucose 8.3). The tissue remained in fresh 
carbogenated buffer throughout the dissection procedure and during the experi-
ments. The use of human lung tissue for these in vitro experiments was approved 
by the Ethical COHunittee of the Rotterdam University Hospital. 
Ai/way strips 
Airways with a diameter of I to 2.5 mm (generation 7 to 12) 33 were carefully 
dissected free from parenchyma and blood vessels. As described previously 18, 
segments were cut open to obtain bronchial strips and thin surgical silk threads 
(6/0) were tied to the ends of the strips. The tissues were studied at 3TC in 
double-jacketed 10 ml organ baths containing carbogenated K-H buffer. One 
thread was attached to a glass hook at the bottom of the bath and the other to the 
arm of a high precision isotonic angular position transducer (Penny and Giles 
type 3810/60, Christchurch, Dorset, UK) which was connected to a digital volt-
meter (Fluke 73 multimeter, Everett, WA, USA) and a pen recorder (Kipp BD 
40, Delft, The Netherlands). 
Pelf used ai/way tubes 
For these studies we used a modification of a model that was recently developed 
at our laboratory 13. In short, tubular segments of peripheral airways (generation 
7 to 12; internal diameter I to 2.5 mm; length 5 to 8 mm) were carefully dis-
sected and side branches were ligated with oculists silk threads (6/0). Each end 
of the segment was cannulated with a stainless steel cannula (external diameter 
1.6 mm; internal diameter 1.2 mm). The preparation was placed horizontally in 
a double-jacketed 4 ml organ bath that contained carbogenated K-H buffer at 
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Figure 1. Schematic representation of the measurement system. The ainvay segment {S) is 
cannulated with stainless steel cannulas (C) and mounted in a double-jacketed 
organ bath (0) that contains carbogenated Krebs solution at 37'C. The bronchial 
lumen is perfused with carbogenated Krebs-Henseleit buffer (B) from a separate 
reservoir at a constant flow rate of 1 mVmin. Responsiveness is measured by 
recording changes in transmural pressure with a pressure transducer (T) that is 
connected to the inlet port of the airway. H = heat exchange. 
3TC. The bronchial lumen was perfused at a constant flow rate of 1 mlImin 
with carbogenated K-H solution from a separate reservoir (inner perfusate, 
figure I). The temperature, 02 tension, and CO2 tension in this reservoir were 
maintained at the same values as in the tissue bath. The responsiveness of the 
airway preparation was measured as a change in perfusion pressure with a 
piezoresistive type pressure transducer (Microswitch 176 PC14HG2; Honeywell, 
Freeport, IL, USA) connected to the inlet of the airway and was displayed on a 
pen recorder (Kipp BD 40, Delft, The Netherlands). 
Pretreatment with hydrogen peroxide 
Organ baths containing perfused airway tubes were cooled to lOT (Frigomix 
1496; Braun, Melsungen, Germany) to inactivate the endogenous radical scaven-
ger catalase which degrades H20 2 11. Then the tubes were perfused at I ml/min 
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with K-H solution containing 100 mmol/l H20 2 for 10 min. This concentration 
was chosen because in guinea-pig tracheas exposure to this concentration of 
Hz02 for 20 min caused selective damage to the epithelium 17, and because we 
found in preliminary experiments that 100 mM, but not 10 mM or 1 mM, pro-
duced selective epithelial damage in human airways. Control tissues were 
perfused with K-H solution without H20 2 under the same experimental condi-
tions. After treatment, the lumen was flushed with fresh K -H solution to remove 
Hz02• Finally, the preparations were rewarmed to 3TC and stabilized for 1 h 
before phatmacologic stimulation. 
Assessment of barrier properties to histamine 
Paired airway preparations from seven patients were used. One airway was 
pretreated with Hz02' the other served as a control. The airways were perfused 
with histamine (10.5 M, 1100 !1g/I) and samples (0.5 ml) of the organ bath were 
taken at 0, 5, 15, 25, 35, and 45 minutes and stored at -70°C. Each sample was 
replaced by 0.5 ml of fresh K-H solution. The histamine concentration in these 
samples was measured with an automated fluorometric assay (Technicon, 
Tarrytown, NY, USA). 
Ainvay histology and mOlpllOmetl), 
After the experiments, the preparations were fixed in 10% buffered formalde-
hyde solution and embedded in paraffin wax. Transverse sections of 6-!1n1 thick-
ness were cut and stained with hematoxylin and eosin. The sections were exam-
ined under a light microscope to assess the presence or absence of epithelium 
and the extent and nature of oxidative damage to the epithelium of airways 
strips and perfused airways, respectively. To assess whether the modulation by 
the epithelium was dependent on airway size, additional experiments were per-
formed. Airway tubes (17 tubes from 4 patients) were stimulated with histamine 
or methacholine from the serosal and the mucosal side in random order. After 
fixation, airway size was determined by measuring the intemal perimeter (Pi) 
which is independent of the degree of bronchoconstriction and can therefore be 
used as a marker of airway size 15. The intemal perimeter was measured with a 
light microscope (Zeiss Axioplan; Carl Zeiss Gmbh, Jena, Germany) connected 
to an automated image analysis system (rbas 2000; Kontron Bildanalyse, 
Mtinchen, Germany). 
Drugs 
Methacholine hydrobromide (Janssen Phatmaceutica, Beerse, Belgium), hista-
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ntine dihydrochloride (Janssen), EDTA (Sigma Chemicals, St. Louis, MO, USA), 
and salbutamol hemisulphate (Sigma) were dissolved in 0.9% NaCI. L-Isopro-
terenol sulfate (Janssen) was dissolved in distilled water containing ascorbic 
acid (88 mg/l). Fresh dmg solutions were prepared daily and kept on ice during 
the experiments. 
6.3 EXPERIMENTAL PROTOCOLS 
Ainvay strips 
To assess contractile functions, the airway strips were stimulated once with 
methacholine (lO,5 and 1O.4M) against an isotonic load of 250 mg. From each 
patient one pair of airways was used for each agonist. From one of each pair, the 
epithelium was removed by gentle mbbing with a wet gauze. Cumulative con-
centration response curves (CCRCs) to methacholine and histamine were made 
by adding the dmgs to the organ bath (l0·8 to 1O.4M, by log increments). CCRCs 
to salbutamol (l0·9 to 1OA M, by log increments) were made after precontraction 
with methacholine (3x1O·6M). The B2,adrenoceptor agonist salbutamol was 
chosen since this dmg, unlike isoproterenol, is not metabolized by epithelial 
enzymes 28. After washout, full relaxation of the preparations was obtained by 
adding L-isoproterenol (lOAM) and EDTA (4x1O·3M). 
Pe/fused ai/way tubes 
From each patient two pairs of airways were studied for each agonist; one pair 
was treated with hydrogen peroxide, the other pair served as a control. Of each 
pair, one airway was stimulated from the mucosal side and the other from the 
serosal side. First, all preparations were stimulated once from the serosal side 
with methacholine (l0·5M and 1OAM) to assess contractile function. Thereafter, 
CCRCs were made by adding the agOlusts either to the organ bath (serosal stimu-
lation) or to the inner perfusate (mucosal stimulation). Finally, the preparations 
were maximally relaxed by isoproterenol and EDTA. 
Data analysis 
From each CCRC the following parameters were derived: -log EC50: The nega-
tive logarithm of the agonist concentration that caused 50% of the maximal 
effect. Smax: Maximal contractile response of a preparation expressed as shor-
tening (mm), or increase in perfusion pressure (cm HzO), for the airway strips 
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and the perfused airways, respectively. Rmax: Maximal relaxation to salbutamol 
expressed as a percentage of the difference between methacholine (3xlO·6M) 
induced precontraction level and maximal relaxation by EDTA and isoproterenol 
at the end of an experiment. Precontraction level: Precontraction induced with 
methacholine (3xlO-6M) expressed as shortening (mrn) or increase in perfusion 
pressure (em Hz0) from maximal relaxation. Baseline contractile state (BeS) 
was expressed as a percentage of the difference between Smax (100% contrac-
tion to the methacholine or histamine) and maximal relaxation with EDTA and 
isoproterenol. The -log EC50 was calculated using the SPSS software module 
for nonlinear curve fitting. The curves were fitted to a four parameter logistic 
function 4. Means of -log EC50, BCS, Precontraction level, Smax and Rmax of 
the CCRCs were compared with paired Student's t tests (two-sided, a=0.05). 
The relationship between the differences in sensitivity between mucosal and 
serosal application of histmnine and methacholine (Le., modulation, expressed 
as ,1-log EC50) and airway size (expressed as the internal perimeter in mrn) was 
examined using analysis of covariance. Analysis of variance (ANOVA) was 
used to test the differences between the histamine concentration in organ baths 
of H20 2-treated tissues and their paired controls. Values of p <0.05 were con-
sidered significant. All data are expressed as mean ± SEM. 
6.4 RESULTS 
Ainvay strips 
All airway preparations responded dose-dependently to the agonists. Mean values 
for BCS, -log EC50, Precontraction level, Smax, and Rmax for intact and epithe-
lium-denuded airway strips (n=8) are given in table I. There was a significantly 
higher BCS in epithelium-denuded preparations. Removal of the epithelium 
produced a small, nonsignificant lA-fold and 1.3-fold increase in mean sensi-
tivity to histamine and methacholine, respectively. No difference in Smax was 
found between intact and epithelium-denuded airways for both histamine and 
methacholine. The precontraction level to methacholine (3x10-6M) and the sen-
sitivity to salbutamol were also not different in intact and epithelium-denuded 
airways. However, maximal relaxation to salbutamol was significantly smaller 
in epithelium-denuded airways (table I). 
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Table 1. Baseline contractile state (BCS), sensitivity (-log EC,,), precontraction level 
(Precon) and maximal effect (Smax and Rmax) of agonists on human airway strips. 
Intact Strips (n=8) Denuded Strips (n=8) 
• Histamine 
BCS (%) 21.7 ± 5.8 40.3 ± 7.3' 
-log EC,o 5.96±0.16 6.12 ± 0.13 
Smax(mm) 2.77 ±0.52 2.43 ± 0.35 
• Methacholine 
BCS (%) 22.5 ±5.6 39.0± 8.6" 
-log EC,o 5.69 ± 0.04 5.82± 0.08 
Smax(mm) 2.53 ±0.31 2.72± 0.29 
• Salbutamol 
Precon (mm) 1.80 ± 0.21 1.82±0.14 
-log EC,o 6.57±0.11 6.48 ± 0.10 
Rmax (%) 62.5 ±5.6 62.5 ± 5.6 
.. p<O.Ol and ++ p<O.05 compared to intact airways. 
Perfused Ai/way Tubes 
The mean values for BCS, -logECso' precontraction level, Smax, and Rmax for 
perfused airways are given in table 2. In intact airways no differences in BCS, 
Smax, or Rmax were found between serosal and mucosal stimulation for all 
agonists (n=8). Neither were there differences in BCS, sensitivity, precontraction 
level, Smax, and Rmax between the H20 2-treated preparations stimulated either 
from the serosal or the mucosal side and the untreated preparations stimulated 
from the serosal side, although the mean Smax and the precontraction level with 
methacholine (3xlO·6M) tended to be lower in H20 2-treated preparations (non-
significant). The sensitivity to histalnine and methacholine of airway tubes when 
they were stimulated from the mucosal side was 10.0- and 3.4-fold lower than 
when they were stimulated from the serosal side (p<O.OO I). In contrast, no dif-
ference in sensitivity to salbutamol was found between serosally and mucosally 
stimulated intact airways. After treatment with H20 2, the differences in -log 
ECso between mucosal stimulation and serosal stimulation were abolished for 
the contractile agonists and similar for salbutamol. 
The time required to reach a response plateau (steady-state contraction or 
-relaxation) after mucosal stimulation was similar to that after serosal stimula-
tion for all agonists and did not change after H20 2 treatment (data not shown). 
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Table 2. Baseline contractile state (BCS), sensitivity (-log EC50), precontraction level 
(preeon) and maximal effect (Smax or Rmax) of agonists applied to serosal or 
mucosal side of perfused human airways. 
Mucosal stimulation Serosal stimulation 
Intact tubes Treated tubes Intact tubes Treated tubes 
(n=8) (n=6) (11=8) (11=6) 
• Histamine 
BCS (%) 25.9± 8.2 16.8 ±4.7 21.9±4.4 21.9±8.7 
-log EC50 4.87 ± 0.19' 5.64 ± 0.20 5.87±0.23 5.60 ± 0.36 
Smax (cmH,o) 17.6 ± 2.2 14.4 ± 2.6 21.5± 2.4 15.0 ± 5.2 
• Methacholine 
BCS (%) 11.6±4.3 17.2 ± 4.3 18.9 ± 5.5 10.4 ± 3.6 
-log EC50 4.92± 0.14' 5.45 ± 0.17 5.45 ± 0.09 5.38 ± 0.08 
Smax (cmH,O) 19.8 ± 3.7 16.2± 2.6 21.9 ± 3.6 15.8 ± 4.2 
• Salbutamol 
Precon (cmH,O) 22.3 ± 3.1 15.2 ± 2.1 16.4 ± 2.6 12.9 ± 1.9 
-log EC50 6.19 ± 0.16 6.20 ± 0.21 6.29 ± 0.10 6.29 ± 0.17 
Rmax (%) 72.5 ± 9.0 65.7 ± 9.2 69.6± 10.2 68.9± 10.0 
*p<O.OOl, compared to stimulation from the serosal side of intact airways. 
This suggests that the intact epithelium does not limit the rate at which the agonists 
reach the smooth muscle receptors. 
Ai/way histology and mOlphomelly 
In mechanically rubbed strips the epithelium was effectively removed and the 
basement membrane and smooth muscle were intact. The epithelium of intact 
perfused airways was also largely undamaged (figure 2a), whereas in airway 
tubes treated with Hz02 the superficial epithelial cell layer was damaged or lost, 
leaving the basement membrane covered with basal cells (figure 2b). 
In figure 3 the internal perimeter of 17 ahway preparations from four patients is 
expressed against the difference in sensitivity (t.-log BC5o' in log-units) between 
mucosal and serosal stimulation of these preparations. Covariance analysis 
showed significant positive correlations between the modulatory effect by the 
ahways epithelium and airway size (p<0.007) for histamine and methacholine. 
Measurements of histamine concentration 
Measurements of the histamine concentrations in organ baths of seven intact 
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Figure 2a. Section of human airway showing an intact epithelium. Hematoxylin-eosin (H&E) 
stain; magnification: x400). 
Figure 2b. Section of a H,O,-treated airway showing patchy loss of the superficial celllayefs 
whereas the basal cell layer largely remains. Hematoxylin-eosin (H&E) stain; 
magnification: x400). 
and seven H20 2-treated airways perfused with a histamine concentration of 
10.5 M (l100 ~g!l) are shown in figure 4. During 45 min of perfusion there was 
an increase in the histamine concentration in the organ baths of both intact and 
H20 2-treated airways but no plateau was reached. No difference was found in 
the histamine concentration from organ baths containing intact and H20 2-treated 
airways (p=0.98, ANOVA). 
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Figure 3. Correlation between the modulatory effect of the epithelium to the contractile 
agonists histamine (closed circles) and methacholine (open circles) and airway 
size (n=17). Horizontal axis depicts airway perimeter (mm). vertical axis represents 
the difference in sensitivity (A-log EC50, in log-units) between serosal and luminal 
stimulation of an airway preparation. 
6.5 DISCUSSION 
Our results show that intact bronchial epithelium modulates the sensitivity of 
human perfused peripheral airways to the contracting agonists histamine and 
methacholine but not to the relaxing agonist salbutamol. The extent of the modu-
latory effect on contractile agonists increases with airway size and is completely 
abolished after oxidative damage to the epithelium. The barrier properties of the 
airways to the agonist histamine were unchanged after oxidative epithelial 
damage. 
In earlier studies of human central airway strips, only a small modulatory role 
of airway epithelium to contractile reponses was found 2 t8 27; mechanical removal 
of the epithelium increased the sensitivity to histamine by 1.6-fold 2 and the 
sensitivity to acetylcholine by 2.6-fold 2 or 2.2-fold 27. Our study of peripheral 
airway strips shows even smaller nonsignificant differences in sensitivity be-
tween intact and epithelium-denuded airways (table 1). Several mechanisms 
have been proposed to explain the modulatory role of the bronchial epithelium. 
The epithelium may release an epithelium-derived relaxing factor (EpDRF) 278, 
it may act as a diffusion banier to pharmacologic agents 1231, or it may inactivate 
them as has been shown not only for adenosine 1, and tachykinins 5 but also for 
histamine 19 and acetylcholine 25. Inhibition of cholinesterase and of histamine 
N-methyltransferase increased the sensitivity of intact- but not of epithelium-
denuded guinea-pig trachea rings to acetylcholine and histamine, respectively, 
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Figure 4. Histamine concentration in the organ baths of intact (closed circles) and hydrogen 
peroxide-treated (open circles) airways (n=7) during a 45-min period of perfusion 
with histamine 10-5 M (1100 ~g1I). The horizontal axis depicts time (min), the 
vertical axis represents histamine concentration in the organ baths (~g/l). 
suggesting a significant role of the epithelium in inactivation of these agonists 19 
25. It seems, therefore, that removal of these epithelial enzymes during treat-
ment with HP2 explains the finding of a modulatory role of the epithelium in 
the present study. However, this is unlikely for several reasons: Firstly, we did 
not find a modulatory effect of the epithelium in intact airway strips. Secondly, 
a modulatory role of the epithelium has also been found in airways perfused 
with the carbamic ester carbachol which is very resistant to cholinesterase 7 31. 
Finally, it has been shown that after inhibition of cholinesterase with ecothiopate 
or physostigmine, epithelium removal still augments responses to acetyl-
choline 7831. 
In airway strips, the stimulus reaches the smooth muscle not only via the mncosal 
side but also via the serosal side and the cut snrface. Therefore, the role of the 
epithelium as a barrier cannot be assessed, and this may be the reason why only 
small sensitivity shifts are fonnd between intact and epithelium-denuded air-
way strips. Indeed, after sealing of the nomnucosal snrfaces of airway strips 
with vaseline, Iriarte and coworkers 14 observed a 27 -fold decrease in sensitivity 
to acetylcholine applied to the organ bath. Recently, in vitro models have been 
developed that enable independent stimnlation of rodent isolated tracheas from 
either the serosal or the mucosal side 242631. Large differences in sensitivity 
(30-fold or more) between serosal and mucosal stimulation with contractile 
agonists were found in guinea-pig 24 31 and rat tracheas 26, which were abolished 
after mechanical rubbing of the epithelinm. In the present study of hnman 
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perfused airways, we found a smaller difference in sensitivity between serosal 
and mucosal stimulation with contractile agonists: 10- and 3.4-fold for hista-
mine and methacholine, respectively (tabel 2). However, these differences are 
much larger than the differences in sensitivity between intact and epithelium-
denuded central airway strips reported in earlier studies 218 27. 
In canine airway strips (generation 2 to 4) the potentiating effect of epithelium 
removal on the response to contractile agonists diminished with decreasing air-
way diameter and was absent in fOUl1h order aiJways 32. These investigators 
concluded that in canine airways there is a release of a relaxing factor that reduces 
the sensitivity to constricting agents in larger aiJways but not in smaller bronchi 32. 
The present study confIrms a positive correlation between airway size or gen-
eration and modulatory role of epithelium in human peripheral airways. Fur-
thelmore, our results suggest that in peripheral human airways there may be a 
release of a relaxing factor as well. 
Considering the limitations of the airway strip preparation and our finding of a 
positive correlation between airway size and modulation to contractile agonists, 
it can be hypothesized that the actual modulatory role of the epithelium in human 
central airways is much larger than previously reported 218 27 and may be similar 
to that in rodent tracheas. We were not able, however, to examine human central 
airways since these are rarely available. 
In most in vitro studies, the epithelium is damaged by mechanical rubbing. This 
may induce an artifact, since it has been shown that in isolated dog airways the 
mechanical stimulus of rubbing increases the release of tryptase from mast cells 
in the submucosa 9 and tlus may cause hyperresponsiveness of the smooth muscle 
preparation via an effect on Ca2+ channels 30. This may explain the increased 
sensitivity in epithelium-denuded airway strips noted in our report and in other 
studies. In addition, it may explain the increase in BCS that we found in epithe-
lium-denuded airway strips. It is not clear why, in epithelium-denuded airway 
strips, we found a smaller relaxation to salbutamol than in intact strips and in 
airway tubes. The smaller relaxation in epithelium-denuded strips may be related 
to the rubbing procedure resulting in loss of relaxing properties of the smooth 
muscle, although histologically no evidence for damage to the smooth muscle 
was found. Our fInding that salbutamol-induced relaxation in airway tubes is 
not modulated by the epithelium contrasts with a study of Yang and coworkers 
36, who found a lower sensitivity to salbutamol when it was applied to the mucosal 
side of isolated guinea-pig tracheas. However, central airways were studied and 
differences between species may exist. 
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Epithelial cell injury in vivo is probably mainly due to the release of basic peptides 
from eosinophils and to the release of oxygen radicals from various inflamma-
tory cells 3 21 but not by mechanicalmbbing. Therefore, perfusing the prepara-
tion with HP2 is likely to produce a more physiologic damage to the epithe-
lium. The concentration of HP2 that we used produces visible epithelial damage 
in guinea-pig trachea 17 and the studies iu human airways at our laboratory have 
shown that this is also the case for human airways. After treatment with H20 2, 
BCS, sensitivity, precontraction level, Smax, and Rmax of treated tissues stimu-
lated from the serosal side or from the luminal side were not significantly differ-
ent from serosally stimulated intact tissues, although precontraction level and 
maximal contraction were consistently lower in H20 2-treated preparations. In 
guinea-pig tracheas exposed to similar concentrations of H20 2, maximal con-
tractions after a single dose of methacholine were also decreased 23. AIthough it 
is likely that HP2 is reduced to H20 and 02 during its passage through the 
epithelium, the decrease in maximal contraction may be due to some H20 2-
iuduced smooth muscle damage. The sensitivity (-log EC50) to the serosally 
applied agonists, however, remains unchanged in both H20 2-pretreated guinea-
pig tracheas 29 and human airways (this study) and this suggests intact receptor 
function. Therefore, the hyperresponsiveness to luminally applied histamine and 
methacholine that we observed after H20 2 treatment is likely to be due to 
oxidative damage to the airways epithelium and not to a direct effect of H20 2 on 
smooth muscle responsiveness. 
In cultured (monolayer) epithelium, exposure to H20 2 increased the paracellular 
permeability 34. At physiologic pH, histamine is in a monovalent cation fOIm 10 
and will therefore cross the epithelium primarily via the paracellular route. On 
the basis of the experiments by Welsh and coworkers 34, one might expect an 
increase in permeability of the epithelium in airways treated with HP2' How-
ever, the epithelium in situ is not a monolayer and the basal membrane of airway 
epithelium may also form an important additional barrier to large and hydrophilic 
molecules 35. 
In H20 2-treated airways we found loss of superficial cells (columnar cells) leaviug 
basal cell rows intact. These basal cell rows are connected to the basal mem-
brane and neighboring cells through junctional (desmosomes, hemi-desmosomes) 
and non-junctional adhesive mechanisms 6 21. Because columnar cells do not 
have hemidesmosomes, they call1lot fmm junctional attachments with the basal 
lamina 6 and tlus may explain why only superficial cell layers are lost after ~02 
treatment in our model. In patients with asthma, disruption of the epithelium 
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also occurs in a suprabasal plane 22. Therefore, the H20 2-induced epithelial 
damage in our model is a realistic approach of epithelial damage in asthma. 
After 45 min of perfusion of intact and Hp2-treated airways with histamine 
10.5 M (1100 ~I), the histamine concentration in the organ baths was only 
0.42% and 0.44% of the concentration of the perfusate for intact and treated 
airways, respectively, and there was no difference between histamine concen-
tration in organ baths of intact and H20 2-treated airways. Thus, althongh the 
epithelium fmms a barrier to histamine, the abolition of the modulatory role of 
the epithelium after oxidative damage cannot be explained by a change in barrier 
properties. Another argument against a barrier function as the single explana-
tion of the modulatory role of the epithelium is our finding that the titne to 
steady-state contraction or steady-state relaxation was similar in luminal and 
serosal application and, moreover, did not change after H20 2 treatment. Our 
results contrast with the findings of Jeppsson and associates 17 who found an 
increased efflux of 3H-terbutaline in H20 2-treated guinea-pig trachea. However, 
differences in pharmacologic and physical properties between histamine and 
terbutaline may be involved. Mitzner measured the transfer of histamine in 
guinea-pig airways with and without epithelium (W. Mitzner, personal commu-
nication). 'Diffusivity' (D) to histamine was defined as: D = (F/i'l.c)T/A; where F 
is the rate of transfer, i'l.c is the concentration difference between airway lumen 
and the organ bath, T is the estimated airway wall thickness, and A is the surface 
area of the perfused airway. He found a diffusivity for histamine of 3x I 0-8 cm2/s 
and 7x1O-6 cm2/s for intact and epithelium-denuded tracheas, respectively 
(W. Mitzner, personal communication). Assuming a surface area of 0.3 cm2 and 
an airway wall thickness of 0.01 cm, we estimated a diffusivity of approxi-
mately 3x I 0-7 cm2/s in both intact and H20 2-treated airways. Thus, intact human 
peripheral airways may be more permeable to histamine than intact guinea-pig 
tracheas. Since the pelmeability of human intact peripheral airways seems high 
already, an increase in diffusivity after Hp2-induced epithelial damage may be 
difficult to detect. Alternatively, the basal cell layer that remains after treatment 
with H20 2 may still form an impmtant batrier to histamine. 
We conclude that the epithelium modulates the sensitivity of human isolated 
peripheral airways to the contractile agonists histamine and methacholine but 
not to the relaxing agonist salbutamol. The modulatmy effect to the contractile 
agonists increases with airway size and is abolished after oxidative damage to 
the epithelium. It Calmot be assessed accurately in airway strips because of short-
comings of this preparation. Although the epithelium forms a physical barrier 
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to agonists, the modulatory role of the epithelium calUlot be explained by a 
change in barrier function of the epithelium because the responsiveness of 
salbutamol did not change and because the permeability to histamine did not 
increase after damage to the epithelium. Our results show that oxidative epithelial 
damage, similar to that found in asthma, may contribute to the enhanced 
responsiveness to histamine and methacholine that characterizes this disease. 
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Permeability of Human Isolated Airways increases after 
Hydrogen Peroxide and Poly-L-arginine 
7,1 INTRODUCTION 
The airway epithelium forms the interface between the respiratory system and 
the external environment and consists of ciliated and nonciliated cells tightly 
attached to each other 31, In bronchial asthma, areas of airway epithelium be-
come denuded of columnar epithelial cells and the degree of epithelial damage 
correlates with the level of bronchial responsiveness both in vivo 25 32 and in 
vitro 33, Eosinophils may contribute to the epithelial damage by producing reac-
tive oxygen species and cationic proteins such as major basic protein (MBP) 
and eosinophil cationic protein (ECP) 1 7 15 1735, In addition, the bronchial epi-
thelium of asthmatic patients may be more fragile than that of normal subjects 31, 
Several mechanisms have been proposed to explain the relationship between 
the loss of epithelial integrity and airway hyperresponsiveness, These include 
reduced production of epithelium-derived relaxing factor 213, exposure of intra-
epithelial peptidergic nerves with reflex bronchoconstriction 3 and decreased 
metabolization of contractile agonists 10, Alternatively, airway permeability to 
bronchoactive agonists may be increased after epithelial damage 20 37, Indeed, 
airway permeability to hydrophilic drugs is increased in asthmatic subjects in 
vivo 23 and this may explain why inhaled but not infused histamine causes 
increased bronchoconstriction in these patients 4, 
Because of the supposed key role of eosinophil products in· the pathogenesis of 
airway hyperresponsiveness, we investigated the effect of the oxidant hydrogen 
peroxide (HP2) and the cationic protein poly-L-arginine, a synthetic analogue 
similar in charge and molecular weight to MBP 9 38, on the permeability and 
Based 011: Hulsmann AR, Raatgeep HR, Den Hollander Ie, Bakker WH, Saxena PR, De 
Jongste Ie. Penneability of human isolated airways increases after hydrogen peroxide and 
poly-L-arginine, Alii J Respir Crit Care Med 1992; 152: in press, 
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morphology of nonasthmatic, human peripheral airways. We also examined the 
relationship between aitway penneability and airway size, since airway perme-
ability in vivo increases with decreasing airway size 5. 
7.2 MATERIALS AND METHODS 
Tissue preparation 
Human lung tissue was obtained from 24 male and 3 female patients (mean age 
64.1 y; range 31 to 75 y) who underwent thoracotomy for bronchial carcinoma. 
None of the patients had characteristics of asthma. The medication was the same 
for all patients: atropine, thiopentone, fentanyl, 0/N20, halothane, and 
pancuronium. Immediately after surgical resection, a macroscopically normal 
part of the lung tissue was immersed in carbogenated (95% 02' 5% CO) Krebs-
Henseleit (K-H) buffer at room temperature (composition in mM: NaCI 118, 
KCI4.7, CaCI2 2.5, MgS04 1.2, ~P04 1.2, NaHC03 25, glucose 8.3). The 
tissue remained in fresh carbogenated buffer throughout the dissection proce-
dure and during the experiments. For these studies we used a modification of a 
model that was recently developed at our laboratory 22. In shOlt, tubular segments 
of peripheral airways (generation 7 to 12; internal diameter 1.0 to 3.0 mm; length 
10 to 20 mm) were carefully dissected and side branches were ligated with oculists 
silk threads. Each end of the segment was calmulated with a stainless steel cannula 
(external diameter 1.6 mm; internal diameter 1.2 mri1). Airways with an internal 
diameter that was smaller than the external diameter of the cannula could be 
easily stretched to fit around the cannula without causing any damage to the 
preparation. The airway was placed horizontally in a double-jacketed 4 ml organ 
bath that contained carbogenated K-H buffer at 3T C. The length of the aitway 
preparation was measured with Vernier calipers. The bronchial lumen was 
perfused at a constant flow rate of 10 m1Jh with carbogenated K-H solution 
from a separate reservoir (inner perfusate). The temperature, 02 tension, and 
CO2 tension in this reservoir were maintained at the same values as in the organ 
bath. The use of human lung tissue for these in vitro experiments was approved 
by the Ethical Committee of the Rotterdam University Hospital. 
Assessment of ail1vay permeability 
After equilibration of the aitway tube preparation, the luminal K-H buffer was 
replaced with K-H buffer containing either IIIIndium-Iabelled diethylene triamine 
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pentaacetic acid (llIIn-DTPA; 1O-6M), a hydrophilic tracer that crosses the epi-
thelium via paracellular pathways 27, or 14C-antipyrine ct4C-AP; 1O-6M), a 
lipophilic molecule that passes through the epithelial cells 18. The organ bath 
fluid was changed every 15 min and the radioactivity was measured in 4 ml 
samples of luminal perfusate and organ bath fluid. llIIn-DTPA radioactivity 
was measured in cpm using a gamma counter (Packard Minaxi Autogamma 
5000, Packard Instrument Company, Downers Grove, IL, USA). 14C_AP radio-
activity was measured in dpm with a beta counter (Packard Tri-Carb liquid 
scintillation analyzer 1500). Because of the shOlt half life of III In-DTPA (2.8 d) 
samples containing llIIn-DTPA were measured in the same order and with the 
same time interval (15 min) as they were obtained. Therefore, no correction for 
rate of decay was required. 
The permeability (P; cm/s) of the airways to the radiolabeled tracer molecules 
during each 15 min period was calculated as described by Hanafi and 
coworkers 18: 
p=- (dQ/dt)/S.1c 
where dQ/dt is the rate of uptake of llIIn-DTPA or 14C-AP by the organ bath 
fluid in cpm/s, S is the luminal surface of the airway (in cm2) calculated from 
the airway perimeter (measured after fixation) and length (recorded at base-
line), and .1C is the concentration difference of tracer (in cpm/ml) between 
perfusate and organ-bath fluid. 
Airway histology alld mOlphometl), 
After the experiments, the preparations were fixed in 10% buffered formalde-
hyde solution and embedded in paraffin. Three transverse sections of 5 J1lll thick-
ness were cut from the middle part of each airway preparation and stained with 
hematoxylin and eosin (H&E). The sections were examined with a light 
microscope (Zeiss Axioplan; Carl Zeiss Gmbh, Jena, Germany) connected to an 
automated image analysis system (Ibas 2000; Kontron Bildanalyse, Miinchen, 
Germany). Airway size was determined by measuring the internal perimeter 
(Pi), which is independent of the degree of bronchoconstriction and can there-
fore be used as a marker of airway size 24. In addition, the percentage of the 
basement membrane covered with intact epithelium was measured. The meas-
urements were made by an experienced pathologist who was unaware of the 
previous treatment (H20 2, poly-L-arginine, or none) of the airway preparation. 
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The mean values of the Pi and the percentage of the basement membrane covered 
with epithelium of the three sections of each airway preparation were deter-
mined and used in further calculations. 
Three airways (from three different patients) treated with hydrogen peroxide 
(100 mmolll) were examined by transmission electron microscopy. After fixa-
tion in 2.5% glutaraldehyde and 0.8% paraformaldehyde in 0.1 M phosphate 
buffer (pH 7.3), tissues were postfixed in cacodylate-buffered 1% osmium 
tetroxide (OS04)' dehydrated in ethyl alcohol and embedded in epoxy resin. 
Thin sections (40 nm) were stained with lead citrate and examined with a Zeiss 
EM902 electron microscope. 
Dl'lIgs 
I II In-DTPA was purchased from Merck-Frost Radiopharmaceuticals (Quebec, 
Canada); 14C_AP and poly-L-arginine were obtained from Sigma Chemical Co. 
(St. Louis, MO, USA). 
7.3 EXPERIMENTAL PROTOCOLS 
Effect of lumillal exposure of the ail1vays to hydrogell peroxide 
From each patient (n=lO), five airways were studied in parallel. Three of these 
airways were perfused with K-H solution containing 1IIIn-DTPA (l0·6M), the 
other two airways were perfused with K-H solution containing 14C_AP (l0·6M). 
Baseline permeability to the tracer molecules was measured every 15 min for 
75 min by sampling the organ bath fluid. At t=75 min, HP2 (10 or 100 mmolll) 
or vehicle (control airway) was added to the II 1 In-DTPA-containing perfusate 
and HP2 (100 mmolfl) or vehicle (control airway) to the 14C-AP-containing 
perfusate over a period of IS min. These concentrations of H20 2 were chosen 
because in previous studies, 100 mmol!l but not 10 mmolll HP2 produced 
selective damage to the epithelium and an increase in airway responsiveness in 
both guinea pig and human airways 21 26. Thereafter, permeability to the tracer 
molecules was measured by sampling the organ bath fluid every 15 min for 
another 2.5 h. 
Effect of lumillal exposure to poly-L-argillille 
From each patient (n=8), four airways were studied in parallel. From t=O to t=2 
h, the perfusate of the airways contained IIIIn-DTPA (l0·6M). Baseline permea-
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Figure 1. Time courses of the effect of luminal H20 2 on permeability of human isolated 
airways to Illjn_DTPA (n=lO) exposed to 10 mmol!1 H,o, at T=75 min for 15 
min (gray bars); exposed to 100 mmolll H,o, at T=75 min for 15 min (open 
• bars). Closed bars represent controls not exposed to H,o,. p< 0.05 compared 
with controls. 
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Figure 2. Time courses of the effect of luminal H20z on permeability of human isolated 
airways to 14C-antipyrine (n=lO) exposed to 100 nnllolll H20, at T=75 min for 
15 min (open bars). Closed bars represent controls not exposed to H20 2· 
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bility to the tracer molecule was measured every 15 min for 2 h, and the mean 
permeability during the second hour was calculated. After these 2 h, the perfusate 
of two airways was changed to K-H buffer containing poly-L-arginine (100 
Ilillolll), the other two airways were perfused with K-H buffer withont poly-L-
arginine (controls). The concentration of 100 Ilillol/l poly-L-arginine was used 
because this concentration increased transmucosal flux of albumin in bovine 
bronchial mucosa 19. From t=5 to 7 h, the permeability of one airway exposed to 
poly-L-arginine (for 3 h) and a control airway was measured by changing the 
perfusate to K-H buffer containing III In-DTPA . The mean permeability of these 
airways between t=6 hand t=7 h was calculated and compared, and the airways 
were fixed in buffered formaldehyde. From t=18 to 20 h, the permeability of the 
other airway exposed to poly-L-arginine (for 16 h) and of the remaining control 
airway was measured by changing the perfusate to K-H buffer containing 
11 I In-DTPA. The mean permeability between t=19 hand t=20 h was calculated 
and compared, and the airways were fixed in buffered formaldehyde. 
Relationship between aillvay perl/leability alld aillvay size 
Thirty-two airway preparations from three patients were perfused for 2 h with 
K-H buffer containing II1In-DTPA. Permeability was measured evelY 15 min. 
The mean permeability during the second hour was related to airway size, as 
determined by the intemal perimeter (Pi) of the airway, and the correlation coef-
ficient was calculated. 
Data analysis 
All data are expressed as mean ± SEM. Means of airway permeability in differ-
ently treated preparations at corresponding 15 min periods (in the experiments 
with ~02) and the mean permeability during the second hour (in the experi-
ments with poly-L-arginine) were compared with paired Student's t tests (two-
sided, =0.05). The correlation between baseline permeability and airway size 
(expressed as the internal perimeter in mm) was examined by calculating 
Spearman's rank correlation coefficient (r,). Values of p <0.05 were considered 
significant. 
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Figure 3. Time courses of the effect of luminal poly-L-arginille 011 permeability of human 
isolated airways to lllIn_DTPA (n~8) after exposure to poly-L-arginine 100 !-UlloVl 
(open bars). Closed bars represent controls not exposed to poly-L-arginine. 
, p<0.02 compared with controls. 
7.4 RESULTS 
Effect of luminal exposure to hydrogen peroxide all ail1vay permeability 
The results of the studies are shown in figures 1 and 2. Within 30 min of perfusion 
a stable baseline penneability was obtained to both lIIIn_DTPA and 14C_AP. 
Baseline permeability (at t=l to 2 h) of the airways to 14C_AP was about five 
times greater than baseline penneability to lllIn-DTPA. Fifteen minutes of 
luminal exposure of the airways to 10 mmolJl HP2 or vehicle did not change 
permeability to lIIIn_DTPA. Luminal exposure of the airways to 100 mmolJl 
H20 2 produced a significant six-fold increase in permeability to llIIn-DTPA, 
whereas no increase in permeability to 14C_AP was found. After removal of 
H20 2> airway penneability decreased and remained at a 2.5-fold greater level 
than in controls which was statistically significant. 
Effect of lumillal exposure to poly-L-argillille all ail1vay permeability 
Luminal exposure of the airways to poly-L-arginine for 3 hand 16 h produced a 
significant 4.5- and 7-fold increases in permeability to lllIn-DTPA, respectively, 
as compared with controls (figure 3). 
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Figure 4. Correlation between IIIIn_DTPA permeability and airway size of human isolated 
airways (n:::32 airways from 3 patients). Horizontal axis depicts airway internal 
perimeter (mm); vertical axis represents airway permeability to 111In_DTPA (x 10-6 
cmis). Different symbols represent airways obtained from three different patients. 
Spearman's rank correlation coefficient [s=-O.75, p<O.Ol. 
Relationship between ail1vay permeability and ail1vay size 
In figure 4 the Pi of 32 airway preparations from three patients is expressed 
against the pemieability of these airways to I I I In-DTPA. The logarithm of the 
permeability to IIIIn-DTPA correlated negatively with the Pi of the airways 
(1',=-0.75, p<O.OI). 
Histopathologic effects of IUlllinal e.lposure to hydrogen peroxide 
Light-microscopic examination showed that 87.9 ± 2.6% of the basement mem-
brane of the control airways was covered with intact epithelium. In airways 
exposed to 10 nunolJl HP2' 86.9 ± 3.0% of the epithelium was intact (ns). After 
exposure to 100 mmolll H20 2, 72.5 ± 6.1 % of the basement membrane was 
covered with intact epithelium (p<0.05 compared to controls). In the damaged 
regions of the airways, focal preservation of the basal cells was seen. Elec-
tromnicroscopic exatnination of 3 airways exposed to 100 nm101l1 H20 2 revealed 
opening of the tight junctions and widening of the intercellular space in areas 
that seemed intact on light-microscopic examination (figures Sa and 5b). 
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A 
B 
Figure 5. Electronmicroscopic photomicrographs of human bronchial epithelium (n;;;;3) after 
exposure to 100 mmolll H20 2 during 15 min. (A) widening of intercellular spaces 
(arrows), tight junctions intact (B) opened tight junction (arrow) and a widened 
intercellular space, bar = I f.U11. 
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Histopathologic effects of lumillal exposure to poly-L-argillille 
In the light-microscopic examinations, 78.8 ± 7.4% of the basement membrane 
of control airways (perfused for 18 h) was covered with intact epithelium 
(figure 6a). After 3 hand 16 h of exposure to poly-L-arginine, 45.8 ± 13.3 and 
23.1 ± 6.4% of the basement membrane was covered with intact epithelium, 
respectively. In the damaged areas, focal preservation of basal cells was found 
in airways exposed to poly-L-arginine for 3 h (figure 6b), whereas in airways 
exposed to poly-L-arginine for 16 h basal cells were partly lost (figure 6c). 
7.5 DISCUSSION 
Our results show that both HP2 and the synthetic cationic protein poly-L-arginine 
increased the permeability of human peripheral airways to the hydrophilic tracer 
molecule 11IIn-DTPA. Pelmeability to the lipophilic tracer molecule 14C_AP 
was not increased after exposure to H20 2, indicating that the increase in permea-
bility is caused by opening of paracellular pathways. Light- and electronmicro-
scopic examination of airway epithelium exposed to hydrogen peroxide and 
poly-L-arginine showed epithelial damage with loss of ciliated cells and rela-
tive preservation of basal cells. Finally, we demonstrated that permeability of 
human peripheral airways increases with decreasing airway size. 
Increased transfer of hydrophilic tracer molecules during and after exposure to 
oxidants has also been described in epithelialmonolayers, isolated airways, and 
in vivo in experimental animals 6 26 34 39. In most studies, oxidant-induced 
increases in permeability were accompanied by histopathologic changes in the 
epithelium. Welsh and coworkers demonstrated widening of intercellular spaces 
in cultured kidney epithelial cells 39, and Bhalla and colleagues found destabi-
lisation of the cytoskeleton in rat airway epithelium following exposure to the 
oxidant gas ozone (03)6. In the present study of human airway epithelium exposed 
to HP2' we observed focal loss of ciliated epithelial cells, opening of tight 
junctions, and widening of intercellular spaces. Similar histopathologic findings 
were described for bronchial biopsies from astlnnatic subjects 12 32. Bhalla and 
coworkers could not demonstrate opening of tight junctions after exposure to 
°3, and suggested that disruptions of tight junctions may occur in a disconti-
nuous, patchy manner and may not be included in the thin sections taken for 
electromnicroscopy 6. 
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The mechanism of action of oxidants is unknown. Extracellular H20 2 penetrates 
cell membranes and may deplete cellular adenosine triphosphate (ATP) levels 
which may lead to alteration of the cytoskeleton and the opening of tight junc-
tions 30. However, an oxidant-induced increase in epithelial permeability has 
also been observed without cytotoxicity supporting the hypothesis that oxidative 
stress increases paracellular permeability by activating intracellular signaling 
systems 34 36. In the present study, the increase in aitway permeability was partly 
reversible after removal of H20 2. This was also found in epithelial monolayers 
after discontinuation of the oxidative stress 634 39. Welsh and coworkers showed 
that both H20 2-induced functional and structural changes were reversible 39. 
Cells that separated during exposure to H20 2 fused again after removal of Hz02' 
These observations suggest that cell-to-cell adhesion is a dynamic process with 
a high capacity for repair, even after exposure to high concentrations of oxidants. 
Previously, we reported that exposure of airway epithelium to HP2 (100 mm01l1) 
for 15 min increased the responsiveness of human peripheral aitways to luminally 
applied histamine 21. The epithelial permeability to histamine of aitways exposed 
to H20 2, however, was not different from controls. In the present study, performed 
under similar experimental conditions, airway permeability to the radioactive 
tracer molecule. IIIIn-DTPA increased after exposure of the epithelium to H20 2. 
In our previous study, however, we measured cumulative concentrations of his-
tamine in the organ baths, which may be less sensitive than measuring permea-
bility to a radioactive tracer at 15 min intervals. 
Eosinophils release cationic proteins such as MEP and eosinophil cationic protein 
(ECP), which may play important roles in the pathophysiology of asthma 17151731. 
Numbers of eosinophils and levels of ECP were increased in broncho-alveolar 
lavage fluid (BALF) from asthmatic subjects and were con'elated with the severity 
of the disease 7. Exposure of animal ahways to cationic proteins causes increased 
airway responsiveness to histamine and methacholine in vivo 1738 and in vitro 9. 
In the present study, we demonstrated that luminal exposure of human airways 
to the synthetic cationic protein poly-L-argitline for 3 h caused extensive epithelial 
damage. Superficial columnar epithelial cells were damaged or lost, whereas 
basal cells, which are tightly anchored to the basement membrane through 
hemidesmosomes 31 , were still present. After 16 h of exposure to poly-L-arginine, 
most of the basal cells were also lost, leaving large parts of the basement mem-
brane uncovered. Similar patterns of mucosal injury were found in previous 
studies of the effects of cationic proteins on guinea-pig, bovine, and human 
airway epithelium 11419. We found that luminal exposure of the airways to poly-
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Figure 6. Light-microscopic photomicrographs of human bronchial epithelium (n=3) 
exposed to poly-L-arginine. (A) control airway after 18 h of exposure. The 
epithelium and cilia appear intact; (B) airway exposed to 100 !1Inolll poly-L-
arginine for 3 h. Destruction and exfoliation of epithelial cells; (C) airway exposed 
to 100 Itl11oll1 poly-L-arginine for 16 hours. Ciliated epithelial cells are lost, only 
a few basal cells (arrow) are left. Hematoxylin-eosin (H&E) staining; bar = 10 JlI11. 
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L-arginine for 3 hand 16 h produced a 4.5- and 7-fold increase in permeability 
to ll1In-DTPA, respectively. Herbert and colleagues showed that a similar con-
centration of poly-L-arginine produced a doubling of the paracellular flux of 
albumin in bovine bronchial mucosa 19. The concentration of poly-L-arginine 
used in their and our study was much higher than the concentration of MBP 
found in the sputum and BALF of patients with asthma 71114. Concentrations in 
sputum and BAL F, however, are influenced by unknown dilutional factors. It is 
possible, therefore, that local concentrations of cationic proteins in asthmatic 
airways are much higher than in sputum and BALE In addition, the in vivo 
duration of exposure to such substances may be much longer. Furthermore, the 
airway epithelium in vivo may be exposed to a combination of cationic proteins 
and H20 2 and other oxidants which may produce more epithelial damage than 
HP2 or cationic proteins alone 1. Finally, the epithelium of asthmatic patients 
may be more susceptible to injury than the airways of nonasthmatic patient used 
for our studies 31. Thus, even low concentrations of oxidants and cationic proteins 
may be responsible for epithelial damage in asthmatic patients. 
The epithelial damage after exposure to poly-L-arginine in our study closely 
resembles the histopathologic findings reported by many investigators in asth-
matic patients. Although epithelial damage is often regarded as a hallmark of 
asthma, several authors have reported the absence of such damage in asthmatic 
patients 28 29. These observations, however, do not exclude a role of oxidants 
and cationic proteins in the pathophysiology of asthma: In laboratory animals, 
both oxidants and cationic proteins produce airway hyperresponsiveness without 
evidence of epithelial damage 34 36 38. 
It is not clear how cationic proteins cause airway hyperresponsiveness and 
epithelial damage. Charge interactions between cationic proteins and airway 
epithelium have been suggested. This hypothesis is supported by the observa-
tion that the effects of poly-L-arginine in isolated guinea pig trachea were 
inhibited when albumin or heparin was added to the organ bath 9. In a recent 
study in rats, Coyle and coworkers showed that cationic protein-induced a{rway 
hyper-responsiveness could be inhibited by the bradykinin receptor antagonist 
NPC 17713 8. Because bradykinin itself did not increase airway responsiveness, 
Coyle and colleagues suggested that an additional factor is involved, for instance 
an increase of epithelial permeability 8. 
Lung permeability has been studied in vivo with aerosols of99mTc-DTPA. After 
inhalation of the tracer molecule, the clearance of radioactivity from the lung 
can be measured with a gamma camera 5 23. With this technique, a reduced 
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clearance of 99mTc_ OTPA from central airways has been described in both animal 
and human lung, probably reflecting a low permeability of central airways 5 16. 
However, these in vivo studies are confounded because the exposed surface is 
not known, and because of mucociliary clearance of 99mTc_DTPA 1623. 
Permeability to 99mTc_OTPA of the ferret trachea was about 10 times lower 
(5xlO·7 cmls) than the pe1meability of the largest airways we studied 18. In the 
present study, we found that airway permeability increased with decreasing 
airway size. This observation and the findings by Hanafi and coworkers 18, sup-
port the in vivo observation that central human airways have a lower pe1mea-
bility than peripheral airways. 
In conclusion, we showed that human peripheral airways are more permeable to 
lipophilic than to hydrophilic molecules. The permeability to the hydrophilic 
III In-DTPA increased after exposure to the oxidant H20 2 or the cationic protein 
poly-L-arginine, which suggests the opening of paracellular pathways. In con-
trast, Hz02 did not change the permeability to the lipophilic 14C_AP. Micro-
scopic examination after exposure to H20 2 and poly-L-arginine l·evealed 
epithelial damage that resembled histopathologic findings in asthma and showed 
opening of tight junctions. Finally, we found that human airway permeability 
and airway size are negatively correlated. A more penneable epithelium no longer 
maintains a barrier to inhaled water-soluble antigens or spasmogens, such as 
histamine and methacholine, and this may at least partly explain the increased 
airway responsiveness to these agents in astlnna. Enhanced entry of inhaled 
hydrophilic agents into the airway tissue after epithelial damage should be con-
sidered as a therapeutic target when new antiasthmatic drugs are designed. 
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Epithelium Removal and Peptidase Inhibition enhance 
Relaxation to Vasoactive Intestinal Peptide 
8.1 INTRODUCTIoN 
In human airways, vasoactive intestinal peptide (VIP), a 28 amino acid peptide, 
is mainly colocalized to cholinergic fibers near the airway smooth muscle and 
submucosal glands II . VIP may mediate the non-adrenergic inbibitOlY response 14, 
which is considered as the only neuronal bronchodilator mechanism in human 
airways 1823. 
Early studies on human isolated central bronchi showed a small 2 17, or a large 1619 
bronchodilating effect of VIP. In contrast, VIP did not relax human isolated 
bronchioles 16. Later studies suggested that the action of VIP on human airway 
tissue was limited by the enzymatic degradation of VIP by mast cell chymase 
and tryptase 6 22 or by epithelial neutral endopeptidase (NEP) 5. 
Indeed, Tam and colleagues showed that a cocktail of inhibitors of chymase, 
tryptase, and NEP potentiates the effect of VIP on isolated central human 
airways 21. This study, however, gives no insight in the role of the airway epithe-
lium in the modulation of VIP responses. In addition, it remains unclear whether 
or not peripheral airways are less responsive to VIP than central airways. 
Therefore, in the present study the responsiveness to VIP of isolated central and 
peripheral human airways, with or without epithelium, was directly compared 
in the absence or presence of peptidase inhibitors. 
8.2 MATERIALS AND METHODS 
Tissue preparation 
Human lung tissue was obtained from 6 male and 2 female patients (mean age 
58.6 y; range 33 to 75 y) who underwent thoracotomy for bronchial carcinoma. 
Based all: Hulsmann AR, longejan Re, Raatgeep HR, Stijnen T, Bonta IL, Kerrebijn KF, De 
JOllgste Ie. Epithelium removal and peptidase inhibition enhance relaxation to vasoactive 
intestinal peptide. Alii Rev Respir Dis 1993; 147:1483-6. 
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Their mean preoperative forced expiratory volume in 1 sec as a percentage of 
the inspiratOlY vital capacity was 63.7 ± 2.8%. None of the patients had charac-
teristics of asthma, 7 were current smokers. Immediately after surgical resection, 
a macroscopically nOlmal part of the lung tissue was immersed in carbogenated 
(95% O2-5% CO2) Krebs-Henseleit (K-H) buffer at room temperature (compo-
sitionin mM: NaC1118, KCI4.7, CaCl2 2.5, MgS04 1.2, ~P04 1.2, NaHC03 
25, glucose 5.55). The tissue remained in fresh carbogenated buffer throughout 
the dissection procedure and during the experiments. Tubular segments of 
cartilaginous bronchi (generation 3 to 5) and bronchioles with a diameter of 0.8 
to 1.0 mm (generation 11 to 13) were carefully dissected free from parenchyma 
and blood vessels 3. As described previously 10, the segments were cut trans-
versely to obtain bronchial strips, and thin surgical silk threads (6/0) were tied 
to the ends of the strips. The tissues were studied at 3TC in double-jacketed 10 
ml organ baths containing carbogenated K-H buffer. The baths were siliconized 
regularly to prevent adhesion of the peptides to the glass wall. One thread was 
attached to a glass hook at the bottom of the bath and the other to the mTIl of a 
high precision isotonic angular position transducer (Type 3810/60; Penny and 
Giles Ltd., Christchurch, UK) which was connected to a digital voltmeter (Fluke 
73 multimeter, Everett, WA, USA) and a pen recorder (BD 40; Kipp, Delft, The 
Netherlands). The epithelium was removed by gentle mbbing of the luminal 
surface with a wet gauze. The efficacy of the epithelial removal was verified 
histologically. The use of human lung tissue for in vitro experiments was approved 
by the Ethical Committee of the Rotterdam University Hospital. 
Drugs 
Methacholine hydrobromide (Janssen Pharmaceutica, Beerse, Belgium), hista-
mine hydrochloride (Janssen), VIP (Cambridge Research Biochemicals Inc., 
Wilmington, DE, USA), timolol maleate (Merck, Sharp & Dhome Research 
Laboratories, Rahway, NJ, USA) and EDTA (Sigma Chemical Company, St. 
Louis, MO, USA) were dissolved in 0.9% NaCI solution. The peptidase inhibi-
tors phosphoramidon (Peninsula Laboratories, Inc., Belmont, CA, USA), 
leupeptin (Sigma), aprotinin (Sigma), soybean trypsin inhibitor (Sigma), captopril 
(Sigma), and bestatin (CRB) were prepared in 0.9% NaCI solution. Indomethacin 
(Bufa, Uitgeest, The Netherlands) and FPL 55712 (Fisons pic, Loughborough, 
Leicestershire, UK) were prepared in methanol. L-!soproterenol sulfate (Janssen) 
was dissolved in distilled water containing ascorbic acid (88 mg/l). Fresh dmg 
solutions were prepared daily and kept on ice during the experiments. 
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8.3 EXPERIMENTAL PROTOCOLS 
To assess contractile functions and to ensure a stable function for the rest of the 
day, the preparations were contracted twice with methacholine (10-5 and 10-4M) 
against an isotonic load of 500 mg for central airways and 250 mg for peripheral 
airways 3. Following washout, all airway preparations were incubated with the 
following drugs: the B-receptor antagonist timolol (1O-6M), the muscarinic 
receptor antagonist atropine (1.2xlO-6M), the cyc100xygenase inhibitor indo-
methacin (6xlO-6M) and the leukotriene C/D4 receptor antagonist FPL 55712 
(11.5xlO-6M). From each patient 2 pairs of central airways and 2 pairs of 
peripheral airways were used. From one of each pair, the epithelium was removed. 
After 10 minutes the peptidase inhibitors phosphoramidon (2.5I-lg/ml), leupeptin 
(20 I-lg/ml), aprotinin (20 I-lg/ml), captopril (20 I-lg/ml), soybean trypsin inhibitor 
(20 I-lg/ml), and bestatin (2.8 I-lg/ml) were added to one pair of central airways 
and to one pair of peripheral airways. Another 10 minutes later, all preparations 
were precontracted to a submaximallevel with histamine (5xlO-6M). After ob-
taining a stable contraction plateau, a cumulative concentration response curve 
(CCRC) to VIP (10-10 to 1O-7M, by half-log increments) was constlUcted. After 
washout, full relaxation of the preparations was obtained by adding L-iso-
proterenol (10-4M) and EDTA (4xlO-3M). This parameter was calculated by linear 
interpolation between the two concentrations on either side of tlus 10% threshold. 
To minimize bias in the results, the calculations were based on the signal of the 
transducers as recorded by a digital voltmeter rather than on measurement of the 
response on the recording paper. The values of the level of precontraction and 
the net response were analyzed with a repeated-measurement analysis of variance 
(MANOVA), using the BMDP 5V program (BMDP statistical software, Inc., 
Los Angeles, CA, USA). The addition of a cocktail of peptidase inhibitors, the 
removal of the epithelium, and the airway size (central or peripheral) were taken 
as factors and the different patients were taken as random factors. The values of 
-log TC were compared by Student's two-tailed t tests for paired observations. 
Values p <0.05 were considered significant. All data are expressed as means 
± standard error of the mean (SEM). 
Data analysis 
The contractile state of the preparations was expressed on a scale which defines 
the maximal active contractile range (MACR) 13. The second response to 
methacholine 10-4M, obtained at the beginning of each experiment, was defined 
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Figure 1. Mean CCRC to VIP of human central (A) and peripheral (B) airway strips 
precontracted with histamine (n=8). Closed symbols represent intact airways, 
open symbols depict epithelium-denuded airways. Triangles indicate that 
peptidase inhibitors are added. The horizontal axis depicts the negative log of the 
VIP concentration in the organ bath; the vertical axis represents the contractile 
state of the airway preparation as a percentage of the maximal active contractile 
range (%MACR). P ~ precontraction level. Vertical bars represent SEM. 
as 100% shortening. Maximal relaxation after lO-4M isoproterenol and 4x 10-3M 
EDTA, determined at the end of each experiment, was defined as 0% shortening. 
The difference between the level of precontraction by 5xlO-6M histamine and 
the contractile state after lO-7M VIP is the net response (% MACR, table 1). 
Because of the high cost of VIP, it was not possible to construct complete CCRe's. 
In addition, minor responses to VIP in control preparations precluded accurate 
calculation of the negative logarithm of the effective concentration (-log ECso) 
values. Therefore, the sensitivity to VIP was expressed as the negative loga-
rithm of the VIP concentration that elicited a 10% reversal of the histamine-
induced tone, and this was called the threshold concentration (TC). 
8.4 RESULTS 
PreCOllfracfioll level 
Removal of the epithelium significantly reduced the histamine induced 
precontraction level in central airways (89.4 ± 3.6% versus 71.6 ± 4.9% MACR, 
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Table 1. Net responses to VIP 1O·7M (%MACR) 
Intact 
Without epithelium 
With peptidase inhibitors 
Without epithelium 
with peptidase inhibitors 
Central airways 
(n~S) 
7.1±7.S 
IS.7 ± 3.4' 
24.0 ± 7.S' 
39.0± 6.4*,t 
Peripheral airways 
(n~S) 
17.1 ± 6.4 
32.6 ± 11.6 
42.7 ± 4.3' 
45.5 ± 4.3*,t 
Net responses to VIP IO-7M of human central and peripheral airways precontracted with 
histamine with and without epithelium in the presence or absence of peptidase inhibitors. 
Data represent the reduction of histamine (5xlO-6M)-induced precontraction expressed as a 
percentage of the maximal active contractile range (% MACR). *' p<O.05 compared to intact 
preparations. t p>O.05 for interaction meaning that an additive effect of epithelium removal 
and peptidase inhibitors is present 
figure la) but not in peripheral airways (figure I b). In intact central and peripheral 
airways, the presence of the peptidase inhibitors also significantly reduced the 
precontraction level (89.3 ± 3.6% versus 74,3 ± 3.6% and 88.9 ± 3.6% versus 
74,8 ± 3,8% MACR, respectively). The combination of epithelium removal and 
peptidase inhibitors caused a further decrease in precontraction, resulting in a 
similar precontraction level for central and peripheral airways (60,6 ± 8.0% and 
60.9 ± 4,8% MACR, respectively), 
Nef response fo VIP j(t7M 
VIP (10-10 to 1O-7M) induced a concentration-dependent relaxation in all prepa-
rations, except for the preparations with intact epithelium and without the 
peptidase inhibitors, in which only the highest VIP concentrations produced 
minor relaxations (figures la and Ib). Both removal of the epithelium and the 
presence of peptidase inhibitors increased the net response to VIP (table I), 
although in peripheral airways the effect of removal of the epithelium did not 
reach statistical significance (p=O.II), MANOVA showed no interaction between 
the effects of epithelium removal and peptidase inhibitors on the net response in 
both central and pelipheral airways. Thus, removal of the epithelium in the 
presence of peptidase inhibitors produced a significant additive increase of the 
net response to VIP in both central and peripheral airways. 
149 
CHAPTER 8 
Table 2. Threshold concentration (TC) values (-log M) of VIP-induced relaxations. 
Central airways Peripheral airways 
(n=8) (n=8) 
Intact airways 6.96±0.22 7.27 ± 0.08 
Without epithelium 8.00± 0.28' 7.73 ± 0.29t 
With peptidase inhibitors 7.58 ± 0.16" 7.98 ± 0.22'," 
Without epithelium, 
8.27 ± 0.29' 8.6l ± 0.20'," with peptidase inhibitors 
Threshold concentration (TC) values (-log M) of VIP-induced relaxations of human central 
and peripheral airways precontracted with histamine (5xlO-6M) with and without epithelium 
in the presence or absence of peptidase inhibitors (means ± SEM). " p<0.05, t p=0.07, COffi-
pared with intact airways. H p<O.05 compared with central airways. 
Sensitivity to VIP 
The -log TC values of central and peripheral airways with and without epithe-
lium and in the absence or presence of peptidase inhibitors are listed in table 2. 
Removal of the epithelium or the presence of peptidase inhibitors increased the 
sensitivity to VIP in both central and peripheral airways, although in peripheral 
airways the effect of removing the epithelium only approached statistical sig-
nificance (p=0.07, table 2). The addition of peptidase inhibitors to epithelium-
denuded airways produced an additional increase in sensitivity, resulting in a 
more than 20-fold increase in sensitivity compared to intact airways without 
peptidase inhibitors. Compared with central airways, the -log TC for VIP was 
significantly higher in peripheral airways with and without epithelium, but only 
when the peptidase inhibitors were present (table 2). 
Effect of precol/lractioll level on the responsiveness to VIP 
Since there were significant differences in precontraction level between intact 
preparations (controls) and peptidase-treated airways with or without epithe-
lium, we investigated whether the responsiveness to VIP varied with the 
precontraction level. In seperate experiments intact peripheral airways were 
precontracted with 5xlO-8M (n=5) or 5xlO-6M (n=5) histamine (precontraction 
levels of 52.9 ± 2.6% and 81.2 ± 2.9% MACR, respectively). The net responses 
were 7.6 ± 2.7% and 8.5 ± 3.9% (p=0.55), the -log TC's were 7.31 ± 0.33 and 
7.28 ± 0.27 (p=O.92) for airways precontracted with 5xlO-8M and 5xlO-6M 
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histamine, respectively. These results indicate that, between 52.9% and 81.2% 
on the MACR scale, precontraction levels have no effect on the sensitivity and 
net responses to VIP. 
8.5 DISCUSSION 
Our results show that exogenous VIP causes only minor relaxations of human 
isolated precontracted central and peripheral airways irrespective of the 
precontraction level. When the epithelium is removed or peptidase inhibitors 
are added, VIP effectively relaxes both central and peripheral airways. Removal 
of the epithelium and presence of the peptidase inhibitors had additive effects 
on the net response to 1O·7M VIP. The sensitivity, expressed as the -log TC, 
increased in both central and peripheral airways more than 20-fold when the 
epithelium was removed and peptidase inhibitors were added. Finally, we found 
that in the presence of peptidase inhibitors peripheral airways were slightly more 
sensitive to exogenous VIP than central airways. 
The precontraction level in epithelium-denuded central airways was significantly 
lower than in intact airways (figure la). This difference may represent an arti-
fact due to damage of the bronchial smooth muscle by the tubbing procedure. 
This seems unlikely, however, because in peripheral airways, which are much 
more vulnerable, no difference between precontraction level in rubbed and 
umubbed preparations was seen. In our study, the presence of peptidase inhibi-
tors resulted in a decreased precontraction response to histamine in both central 
and peripheral airways (figure la and Ib). In dog bronchi, exogenous tryptase 
enhances histamine-induced contraction by an effect on Ca2+ channels 20. In 
contrast, inhibition of endogenous tryptase by peptidase inhibitors may explain 
the reduced contractile response to histamine in our experiments as a result of 
the impaired influx of extracellular Ca2+. That in a previous study by Tam and 
colleagues 21 precontraction to carbamylcholine was not affected by the presence 
of peptidase inhibitors may be due to the fact that acetylcholine contracts air-
way smooth muscle by mobilizing intracellular Ca2+ stores 8. 
Our results concerning the net responses to VIP confn'l11 those of others 1721, 
who found that exogenous VIP causes only minor relaxations of isolated human 
bronchi after precontraction with histamine or carbamylcholine. In the study of 
Tam and coworkers 21, peptidase inhibitors significantly potentiated the broncho-
dilator responses of central human airways to VIP, which is similar to our 
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findings. Our results contrast with those of Palmer and colleagues, however, 
who found a potent VIP-induced relaxation of intact human bronchi 16. They 
reported a -log ECso of?77 for VIP and a -log ECso of 6.11 for isoproterenol in 
central aiIways, indicating that VIP was 50 times more potent than isoproterenol. 
The values of -log ECso for isoproterenol in their study were considerabely lower 
than in other studies 417, however, and incomplete CCRC's to VIP were made, 
which precludes accurate ECso detelminations. Therefore, in intact central air-
ways, VIP may not be as potent as has been suggested. In the study of Palmer 
and colleagues 16, intact bronchioles showed no response to exogenous VIP. 
They support theiI· findings by referring to binding studies using 1251_ VIP in 
which density of labeling over smooth muscle in the bronchus was three times 
higher than in bronchioles I. Labeling with 12sI_VIP is merely a measure of 
uptake, however, and does not predict the physiological events that follow 
receptor binding. Furthermore, iiI a study of Leys and coworkers 12, no specific 
binding of 12sI_ VIP to bronchial smooth muscle was seen in airways of all sizes, 
including extrapulmonary bronchus. These authors argue that VIP receptor 
density on airway smooth muscle may be too low for autoradiographic visuali-
zation 12. Therefore, a relaxing effect of VIP on peripheral airways cannot be 
excluded on the basis ofbmding studies. The present study shows that VIP relaxes 
bronchioles, but only in the presence of peptidase inhibitors. Thus, it seems that 
VIP-receptor density on smooth muscle of peripheral airways is not too low to 
mediate relaxations but that the lack of relaxing effect on peripheral airways in 
previous studies may have been due to the breakdown of VIP by endogenous 
peptidases before it could act on the smooth muscle cell. 
We found that both removal of the epithelium and the addition of peptidase 
inhibitors augment the sensitivity to VIP of both central and peripheral human 
airways. This is in accordance with previous studies in guinea-pig trachea, in 
which epithelium removalS or peptidase inhibitors s 24 produced a leftward shift 
of the CCRC to exogenous VIP. In the study of Farmer and Togo s, a similar 
increase in sensitivity to VIP was seen with phosphoramidon or thiorphan (NEP 
inhibitors) and epithelium removal, indicating that epithelial NEP is the princi-
pal source of degradation of VIP in the guinea-pig trachea s. In the present study, 
we found an additive effect of removal of epithelium and the presence of peptidase 
inhibitors in both central and peripheral airways. T\yo possible mechanisms may 
contribute to this additive effect. The most obvious explanation is that in human 
airways VIP is inactivated not only at epithelial sites where NEP is localized 9 
but also by peptidases derived from subepithelial sources. Subepithelial pepti-
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dases may be produced by mast cells (chymase and tryptase), macrophages (acid 
proteases and endopeptidases), or endothelium, which generates angiotensin 
converting enzyme, or they may be situated on the airway smooth muscle itself 
(NEP), as was suggested previously 15. In addition, the epithelium in human 
airways may act as a diffusion barrier for VIP, and removal of this barrier could 
increase the sensitivity to VIP. It should be noted that the influence of epithelial 
peptidases in the present experimental setting may be underestimated since 
mechanical removal of epithelium may lead to peptidase release from subepi-
thelial mast cells 7. 
Under physiological conditions, the VIP-degrading properties of epithelial NEP 
may not be important since endogenous VIP will not reach the epithelial surface 
where NEP is situated. Peptidases derived from the lamina propria, however, 
may be able to degrade endogenous VIP produced by non-adrenergic, non-
cholinergic (NANC) nerves in the vicinity of airway smooth muscle. Therefore, 
these peptidases may modulate NANC neural control of airway tone in both 
central and peripheral airways. In an inflammatory disease like asthma, an 
increase in VIP-degrading peptidases released by inflammatory cells in the 
airways may lead to increased bronchial obstruction and, perhaps, contribute to 
bronchial hyperresponsiveness. It can be questioned, however, whether VIP plays 
an important modulatory role in peripheral airways in vivo since in small airways 
few VIP-like immunoreactive nerves were found II. 
We conclude that exogenous VIP relaxes human precontracted central and peri-
pheral airways only to a minor degree unless the epithelium is removed or 
peptidase inllibitors are present. Peptidase inllibitors and removal of the epithe-
lium have additive effects on VIP-induced relaxation, indicating that in human 
airways epithelial and subepithelial peptidases are both important in the inacti-
vation of VIP. 
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Bradykinin-induced Contraction of Human Peripheral 
Airways mediated by both Bradykinin B2 and 
Thromboxane Prostanoid Receptors 
9,1 INTRODUCTION 
Bradykinin (Bk), a nine amino acid peptide formed from the plasma precursor 
kininogen, may be an important mediator in inflammatory diseases such as 
asthma 2, Elevated kinin concentrations have been found in the bronchoalveolar 
fluid of asthmatic subjects after allergen challenge 5, and inhaled Bk induces 
bronchoconstriction in asthmatic but not in normal individuals 152733, In iso-
lated central airways, however, only small contractile or potent relaxant effects 
ofBk were found 34141533, After removal of the epithelium, Bk-induced smooth 
muscle relaxation changed to contraction, indicating a protective role of the 
epithelium, TIns may involve the production of relaxant prostanoids or degra-
dation of Bk by epithelial neutral endopeptidase (NEP) 3 4 14, 
Because epithelial damage is found in biopsies of astlunatic subjects, it is tempting 
to hypothesize that the loss of epithelium in asthma makes the airways prone to 
Bk-induced bronchoconstriction, Studies in asthmatic patients, however, show 
that inhalation of ipratropium bromide 15, sodium cromoglycate 12 15, and the 
tachykinin receptor antagonist FK-224 18 protects against Bk-induced broncho-
constriction, This suggests activation of cholinergic and peptidergic nerves by Bk. 
The involvement of prostanoids in Bk-induced bronchoconstriction in the human 
is controversial. In one study, an oral dose of the cyclooxygenase inhibitor 
flurbiprofen significantly inhibited Bk-induced bronchoconstriction 26, whereas 
other investigators did not observe a protective effect of an oral dose of aspirin 15, 
The aim of the present study was, therefore, to investigate the effects of epithe-
lium removal, inhibition of the enzymes NEP and cyclooxygenase, and blockade 
of local axon reflexes with tetrodotoxin (TTX) on Bk-induced responses of 
Based all: HulsmannAR, Raatgeep HR, Saxena PR, KeITebijn KF, De Jongste Jc. Bradykinin-
induced contraction of human peripheral airways mediated by both bradykinin B2 and 
thromboxane prostanoid receptors, Alii J Respir Crit Care Med 1994; 150: 1012-8, 
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human peripheral airways, which have been shown to contain many more Bk 
receptors than central airways 23. Furthermore, we measured the Bk-induced 
release of the cyclooxygenase products prostaglandin E2 (PGE2), prostaglandin 
I2 (PGI2) and thromboxane A2 (TxA2). Because in the guinea pig trachea the 
direction of Bk -induced responses are dependent on aitway tone 4, we also studied 
the effect of Bk on ailways precontracted with methacholine. Finally, we 
examined the effects of the selective B2 receptor antagonist Hoe 140 (D-Arg-
[Hyp3,Thi5,D-Tic7,Oic8j bradykinin) 16 and the thromboxane (TP)-receptor 
blocking drug GR32191 (Vapiprost) 22 to elucidate whether these receptors are 
important in Bk-induced responses of human isolated airways. 
9.2 MATERIALS AND METHODS 
Tissue preparatioll 
Human lung tissue was obtained from 23 male and 6 female patients (mean age 
65.8 y; range 46 to 77 y) who underwent thoracotomy for bronchial carcinoma. 
None of the patients had characteristics of asthma. The premedication was the 
same for all patients: atropine, thiopental, fentanyl, 0/N20, halothane, and 
pancuronium. Immediately after surgical resection, a macroscopically nOlmal 
part of the lung tissue was immersed in carbogenated (95% 02 and 5% CO2) 
Krebs-Henseleit buffer at room temperature (composition in mM: NaCI 118, 
KCI4.7, CaCI2 2.5, MgS04 1.2, KH2P04 1.2, NaHC03 25, glucose 5.55). The 
tissue remained in fresh carbogenated buffer throughout the dissection proce-
dure and during the experiments. Bronchioles with an inner diameter of 0.8 to 
2.0 mm (generation 8 to 13) were carefully dissected and cut spirally to obtain a 
bronchial strip preparation. The tissues were studied at 37"C in double-jacketed 
10 ml siliconized organ baths containing carbogenated Krebs-Henseleit buffer. 
Thin surgical silk threads (6/0) were tied to the ends of the strips. One thread 
was attached to a glass hook at the bottom of the organ bath and the other to the 
arm of a high-precision isotonic angular position transducer (Type 3810/60; 
Penny and Giles Ltd., Christchurch, UK) which was connected to a digital volt-
meter (Multimeter 73; Fluke, Everett, WA, USA) and a pen recorder (BD40; 
Kipp, Delft, The Netherlands). The preparations contracted against a load of 
250 mg, which has been shown to be optimal for human bronchial strips 20. 
When indicated, the epithelium was removed by gentle rubbing of the luminal 
surface with a wet gauze. To quantify the effect of rubbing the epithelium, all 
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strips were examined histologically and the percentage of the basement mem-
brane covered with epithelium was estimated by an observer who was unaware 
of the previous treatment of the preparations. The integrity of the basement 
membrane and the underlying smooth muscle was also examined. The study 
was approved by the Ethical Committee of the Rotterdam University Hospital. 
Drugs 
Methacholine bromide (Janssen Phmmaceutica, Beerse, Belgium), EDTA (Sigma 
Chemical Co., SI. Louis, MO, USA), and the peptidase inhibitor phosphoramidon 
(Peninsula Laboratories Inc., Behnont, CA, USA) were dissolved in 0.9% NaC!. 
Bradykinin (Bachem California, TOll"alICe, CA, USA), Hoe 140 (gift from Dr 
K.J. Wirth, Hoechst AG, Frankfurt, Germany), GR32191 (gift from Dr B.M. 
Bain, Glaxo Group Research, Ltd., Greenford, Middlesex, UK), and TTX (Sigma) 
were dissolved in distilled water. Indomethacin (Bufa, Uitgeest, The Nether-
lands) was prepared in methanol. L-Isoproterenol sulfate (Janssen) was dissolved 
in distilled water containing ascorbic acid (88 mgll). Standard PGE2, 6-keto 
POI,,,, and TxB2 (Sigma) and the 3H-Iabeled PGE2, 6-keto POI,,,, and TxB2 
(Amersham, Amersham, Buckinghamshire, UK) were dissolved in ethanol. 
Antibodies were purchased from Advance Magnetics, Inc. (Cambridge, MA, 
USA) and dissolved in radioimmunoassay buffer. 
9.3 EXPERIMENTAL PROTOCOLS 
Before all experiments, the preparations were contracted twice with methacholine 
(10.5 and 1O-4M) to assess contractile function and to ensure a stable function 
for the rest of the day 10. Cumulative concentration-response curves (CCRCs) to 
bradykinin were made with a dose range of 10-10 to 1O-5M, by logarithmic incre-
ments. After completion of the experiments, the preparations were washed and 
fully relaxed by adding L-isoproterenol (1O-4M) and ethylenediaminetetraacetic 
acid (EDTA; 4xlO-3M). 
Effect of bradykinin on ai/ways with spontaneolls intrinsic tone 
From each patient (n=8) four pairs of airways were studied. Each pair consisted 
of one aiIway with and one without epithelium. 
The fIrst, second, and third pairs were iucubated with either phosphoramidon 
(5xlO-6M), or indomethacin (5xlO-7M) or a combiuation of phosphoramidon 
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(5xlO-6M) and indomethacin (5xlO-7M), respectively. The fomth pair served as 
a control. After 20 min of incubation, a CCRC to Bk was made. 
Effect of bradykillill Oil precolltracted ainvays 
From each patient (n=6) four pairs of airways were studied. Each pair consisted 
of one airway with and one without epithelium. The airways were precontracted 
to a submaximallevel with methacholine (3xlO-6M). After a stable precontraction 
level was obtained, the first, second, and third pairs were incubated with either 
phosphoramidon (5xlO-6M), or indomethacin (5xlO-7M) or a combination of 
phosphoramidon (5xlO-6M) and indomethacin (5xlO-7M), respectively. The 
fourth pair served as a control. After 20 min of incubation, a CCRC to Bk was 
made. 
Determillatioll of B,-receptor alltagollist potellcy 
Four intact airway preparations from each of six patients were used. Phosphor-
amidon (5xlO-6M) was added to all airway preparations. Three airways were 
incubated with the B2 receptor antagonist Hoe 140 16 at the concentrations 10-8, 
10-7, and 1O.6M, respectively. The fourth airway served as a control. A CCRC to 
Bk was made 20 min after incubation with the antagonist. 
Determillatioll of thromboxalle prostalloid receptor alltagollist potellcy 
Six intact airway preparations from each of eight patients were used. Phosphor-
amidon (5xlO-6M) was added to all airway preparations. Four airways were 
incubated with the TP-receptor antagonist GR32l9l (Vapiprost) 22 at the con-
centrations 3xlO-8, 10-7, 3xlO-7, and 1O-6M, respectively. The fifth airway was 
incubated with GR32191 (3xlO-7M) and indomethacin (5xlO-7M). The sixth 
airway served as a control. A CCRC to Bk was made 20 min after incubation 
with the antagonist. 
Effect of blockillg Ileural cOllductallce Oil Bk-illciuceci respollses 
These experiments were perfOlmed in the presence of phosphoramidon (5xlO-6M) 
to prevent degradation of potentially released tachykinins. Paired intact airways 
of eight patients were incubated with the nerve conductance blocker tetrodotoxin 
(TTX,3 I-lg/ml) or with the vehicle for TTX (distilled water; control). After 20 
min, a CCRC to Bk was made. 
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Release of prostanoids by airway preparations 
Radioimmunoassay ofPOE2, 6-keto POFla (the stable metabolite of PGI2) , and 
TxB2 (the stable metabolite of TxA2) was pelfOlmed in the organ bath fluid 
(10 mI) derived from five of the experiments on intact and epithelinm-denuded 
airways with spontaneous intrinsic tone. Baseline POE2, PGI2 and TxA2 release 
was determined by collecting the organ bath fluid after a 3D-min period. In 
addition, the release of these prostanoids was measured in the organ bath fluid 
after making the CCRCs to Bk (which also took 30 min) in the absence and 
presence of indomethacin. Organ bath fluids were applied to Sep-Pak CIS 
cartridges (Waters Associates, Millford, MA, USA) and rinsed with 5 mI of 
water. The prostanoids were extracted with 2.5 ml methanol and stored at _20°C 
until they were analyzed as a single batch. After the experiments, the wet weight 
of the preparations was measured. The presence of POE2, 6-keto POFI « and 
TxB2 was detelmined in 0.5 ml aliquots using tritiated radioimmunoassay kits. 
The separation of free and bound tracer was accomplished with dextran-coated 
charcoal. The sensitivity of the assays was approximately 2 pg per tube. The 
cross-reactivity of the POE2 assay with POF2a, 6-keto POFIa, and thromboxane 
B2 was <0.01, <0.01 and <0.1 %, respectively. The cross-reactivity of the 6-keto 
PGIw assay with POF2a, POE2, and thromboxane B2 was <0.01, <1.0 and <0.1 %, 
respectively. The cross-reactivity of the TxB2 assay with POF2a, POE2, and 6-keto 
POIla was <0.01, <1.0 and <0.01 %, respectively3s. The amounts ofPOE2, 6-keto 
POlw and TxB2 were expressed as pg/mg wet tissue weight. 
Data analysis 
The CCRCs were analyzed to obtain -log EC50 (the negative logarithm of the 
agonist concentration that caused 50% of the maximal effect) and SlIlax (maxi-
mal contractile response to bradykinin expressed as a percentage of the maximal 
contraction to methacholine lOAM). Baseline contractile state (BCS) was ex-
pressed as a percentage of the difference between the maximal contraction to 
methacholine 1O-4M and the maximal relaxation in the presence of EDTA 
(4xlO-3M) and isoproterenol (lOAM). The Precontraction level after 3xlO-6M 
methacholine was expressed as a percentage of the maximal contraction to 
methacholine. The -log ECso was calculated using a software module for non-
linear curve fitting. The curves were fit to a four-parameter logistic function 9. 
Means of -log ECso' BCS, precontraction level and Smax of the CCRCs were 
compared with paired Student's t tests (two-sided, a=0.05). The concentrations 
of POE2, 6-keto POFla, and TxB2 in the organ bath fluid of the different treat-
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Figure 1. Mean CCRC to bradykinin (Bk) of human peripheral airways (n=8) in the absence 
(A) and presence (B) of indomethacin (5xlO"M): closed symbols represent intact 
airways, open symbols depict epithelium-denuded airways, triangles indicate that 
phosphorarnidon is added. Bk-induced contraction is expressed as a percentage 
of the maximal contraction to methacholine (lO-4.NI). Vertical bars represent SEM. 
ment groups (control, and after stimulation with Bk in the presence or absence 
of indomethacin) were also compared by paired Student's t tests (two-sided, 
0:=0.05). All data are expressed as mean ± standard error of the mean (SEM). 
9.4 RESULTS 
Histologic check of epitheliulIl rellloval 
In rubbed strips 6.2 ± 1.8% of the basement membrane was covered with epi-
thelium, whereas in unrubbed strips this was 88.1 ± 2.5% (p<O.OOOI). After 
rubbing, the basement membrane was intact and no histologic evidence of smooth 
muscle damage was found. 
Effect of bradykinin on ainvays with spontaneous intrinsic tone 
Bk contracted seven of the eight intact airway strips without phosphoramidon 
and six of the eight strips with phosphoramidon; the remaining three strips (from 
three different patients) relaxed to Bk. All epithelium-denuded strips contracted 
to Bk (n=8, each with or without phosphoramidon). 
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Table 1. Sensitivity (-logEC,o)' baseline contractile state (BCS), and maximal contraction 
to bradykinin of human peripheral airway strips (n;8). 
Baseline Maximal 
-log EC,o contractile state (%) contraction (%) 
Intact 6.96±0.25 38.9±4.5 40.2± 8.3 
Without epithelium 7.82 ±0.25' 46.0± 5.1 43.8 ±5.2 
Intact, with phosphoramidon 7.14±0.21 46.1 ± 4.1 49.0± 9.2 
Without epithelium, 
with phosphoramidon 8.03 ± O.l3't 48.3 ± 3.5 54.3 ± 9.2 
* p<O.05 compared with intact airways, 
t p<0.05 compared with epithelium-denuded airways. 
The values of -log ECso' BCS, and Smax of the airways that contracted to Bk 
are listed in table I, and the CCRCs of these experiments are shown in figure 1 a. 
Removal of the epithelium resulted in a significant 7 -fold increase in the sensi-
tivity to Bk. The addition of phosphoramidon tended to increase the sensitivity 
to Bk in both intact and epithelium-denuded airways although this change was 
not statistically significant. No difference was found in BCS and Smax between 
the different treatment groups. 
Treatment of the airways with indomethacin largely inhibited the responses to 
Bk (figure Ib). The maximal contraction to IO·sM Bk was 5.8, 11.1,9.8, and 
10.9% of the maximal contraction to methacholine for intact airways, intact 
airways incubated with phosphoramidon, epithelium-denuded airways, and epi-
thelium-denuded airways incubated with phosphoramidon, respectively. Indo-
methacin did not alter the BCS of the airway preparations. 
Effect of bradykillill 011 precolltracted ainvays 
Mter precontraction with methacholine, Bk relaxed the airways of three patients 
(from 73.7 ± 3.2 to 48.1 ± 5.8% and from 91.9 ± 304 to 69.7 ± 3.9% of Smax for 
intact and epithelium-denuded airways, respectively). In contrast, the airways 
of the other three patients contracted when Bk was added (from 74.5 ± 4.8 to 
88.5 ± 4.8% and from 81.2 ± 2.1 to lOlA ± 1.2% of Smax forintact and epithe-
lium-denuded airways, respectively). The presence of phosphoramidon did not 
change the direction of the response (relaxation or contraction) within patients. 
Addition of indomethacin completely abolished both contractile and relaxation 
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Figure 2. Mean CCRC to bradykinin (Bk) of human peripheral airways (n=6) in Ihe presence 
of the selective B2 receptor blocking drug Hoe 140 at the concentrations 1O,8M 
(open triangles), 1O"M (closed diamonds) and 1O,6M (open squares). Closed 
circles represent control airways not incubated with Hoe 140. Bk-induced con-
tractions are expressed as a percentage of the maximal contraction to methacholine 
(1O'4M). 
responses to Bk in all airways, irrespective of the presence or absence of phos-
phoramidon. Because of the small number of observations (n=3, for each curve), 
no statistics were performed. 
Detel1llination of B2 receptor antagonist potency 
The effect of Hoe 140 (10'8, 10'7 and 1O,6M) on Bk-induced contraction is shown 
in figure 2. Hoe 140 produced a significant rightward shift of the CCRCs to Bk 
(-log EC50 values: 7.28 ± 0.14, 6.75 ± 0.12, 6.31 ± 0.17, and 5.54 ± 0.13 for 
control, 10,8, 10'7, and 1O,6M Hoe 140, respectively). Furthermore, a decrease 
in Smax and a loss of parallelism was found. 
Detel1llination ofthl'OlIIboxane pl'Ostanoid receptor antagonist potency 
In figure 3 the effect of GR32191 (3xlO,8, 10-7, 3xlO,7, and 1O,6M) on Bk-
induced contraction is shown. In the presence of GR32191 airways relaxed to 
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Bk. Mean Bk-induced maximal relaxations tended to increase with increasing 
concentrations ofGR32l91. Relaxation to Bk in the presence ofGR32l9l was 
abolished when indomethacin was added. 
Effect of blocking neural conductance 011 Bk-induced responses 
The sensitivity and Smax to Bk in the presence and absence of TTX were not 
significantly different (-logEC5o ' 7.26 ± 0.20 and 7.32 ± 0.20; Smax, 38.4 ± 5.6 
and 36.8 ± 5.2% of maximal contraction forTTX and controls, respectively, ns). 
Release ofprostanoids by ainvay preparations 
The release of PGE2, PGI2, and TxA2 by airway preparations before and after 
exposure to bradykinin in the presence or absence of indomethacin is shown in 
figure 4. Following stimulation with Bk, significantly more PGE2, PGI2, and 
TxA2 was released from both intact and epithelium-denuded airways than in the 
control period. The release of the prostanoids following stimulation with Bk 
was largely inhibited in the presence of indomethacin, although in epithelium-
denuded airways in the presence of indomethacin significantly more PGI2 and 
TxA2 were produced after stimulation with Bk than in the control period without 
Bk. After stimulation with Bk, the epithelium-denuded airways produced sig-
nificantly more PGE2 and TxA2 and tended to produce more PGI2 per mg 
wet weight than intact airways. In both intact and epithelium-denuded airways, 
the release ofPGI2 and PGE2 was significantly greater than the release of TXAz. 
In intact airways, the release of PGI2 was significantly greater than the release 
ofPGE2· 
9.5 DISCUSSION 
Our experiments showed that Bk contracted intact and epithelium-denuded 
human peripheral airways with spontaneous intrinsic tone. Precontracted air-
ways were either relaxed or further contracted. Removal of the epithelium in-
creased the sensitivity to Bk, and the addition of phosphoramidon tended to 
increase the sensitivity to Bk in both intact and epithelium-denuded airways. 
Bk-induced responses and Bk-induced release of prostanoids were largely 
inhibited in the presence of indomethacin. The B2-receptor antagonist Hoe 140 
and the TP- receptor blocking drug GR32191 antagonized Bk-induced 
bronchoconstriction, suggesting B2 receptor-mediated release of prostanoids that 
contracted airways via the TP-receptor. 
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Figure 3. Mean CCRC to bradykinin (Bk) of human peripheral airways (n=8) in the presence 
of the thromboxane prostanoid (TP)-receptor blocking drug GR32191 at the 
concentrations 3 x 1O-8M (closed triangles), IO-'M (open triangles), 3xlO-'M 
(closed diamonds) and 10'" M (open diamonds). Open squares represent Bk-
induced responses in the presence of 3xlO-'M of GR3219 and 5xlO-'M of 
indomethacin. Closed circles represent controls not incubated with GR32191 or 
indomethacin. Bk-induced contractions are expressed as a percentage of the 
maximal contraction to methacholine (lOAM). 
In earlier studies of human isolated central airways, only small contractile or 
relaxant effects of Bk were found 3 15 33. The density of Bk receptors on periph-
eral airway smooth muscle is much higher than on smooth muscle of central 
airways, however, and therefore the effects of Bk may be greater on peripheral 
airways 23. Our results show that Bk indeed has a potent contractile effect on 
human peripheral airways with spontaneons intrinsic tone and confirm studies 
by Molimard and colleagues 25. Smooth muscle relaxation to Bk has been 
described in both human and guinea pig airways. Tllis relaxation was converted 
into contraction after removal of the epithelium and after addition of indomethacin 
or phosphoramidon, suggesting that the epithelium protects the underlying 
smooth muscle by producing relaxant prostanoids or nitric oxide or by degrading 
Bk via NEP3414. 
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Figllre 4. Release of the prostanoids PGE, (A), PGI, (B), and TxA, (C) by the airway 
preparations in 30 nUn with or without bradykinin stimulation (10,10 to IO"M) in 
the presence or absence of indomethacin (n=5). Closed bars represent intact 
airways, open bars represent epithelium-denuded airways. Indo = indomethacin 
is added (5xlO,7M). * p<0.05 compared with both the control period and after 
stimulation in the presence of indomethacin. # P<O.05 compared with intact 
airways. ** p<O.05 compared with the control pedod. 
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In the present study, indomethacin largely inhibited the response of human 
peripheral airways to Bk, but no change in direction of the response was seen. 
Measurement of the production of prostanoids supports our functional studies: 
the release of PGE2, PGI2, and TxA2 was increased by Bk and was largely pre-
vented by indomethacin. In the guinea pig trachea stimulated with Bk, PGE2 
release was much greater than PGI2 release 4. In the present study in human 
airways PGI2 release was somewhat greater than PGE2 release. TxA2 release 
was approximately four times lower than PGE2 and PGI2 release. These results 
confitm an earlier study of the release of prostanoids by human bronchi, in 
which PGI2 was also the predominant prostanoid released and TxAz release was 
much lower than PGE2 and PGIz release 32. It is remarkable that epithelium-
denuded ahway preparations released even more prostanoids. This contrasts 
with the results obtained by Bramley and associates 4, who observed a decrease 
in the production of prostanoids in epithelium-denuded guinea pig tracheas, and 
suggests that in human airways prostanoids are produced not only by the aitway 
epithelium, as was shown earlier 30, but also by nonepithelial tissues. 
In our experiments, addition of phosphoramidon tended to increase the sensi-
tivity of the airways to Bk. Addition of phosphoramidon to intact airways, 
however, was not as effective as removal of the epithelium (figure la), perhaps 
because the epithelium acted as a ban-ier or because other Bk-degrading enzymes, 
such as angiotensin converting enzyme (ACE), may be present on the epithe-
lium 13. Aitway reactivity to Bk in mildly asthmatic subjects remained unchanged 
after inhibition of ACE II, however, suggesting that in human ahways ACE is 
not important in the degradation of Bk. The tendency of phosphoramidon to 
increase the sensitivity to a bronchoactive peptide in epithelium-denuded aitways 
was also found in an earlier study by our group 17 and suggests that NEP is also 
present below the epithelium. In the guinea pig trachea, the direction of Bk-
induced responses depends not only on the presence of epithelium and the addi-
tion of indomethacin or phosphoramidon but also on the tone of the aitway 
preparation. 
Rubbed guinea pig tracheas precontracted with acetylcholine were relaxed by 
Bk4. In the present study, precontracted human peIipheral ahways either relaxed 
or contracted to Bk. The direction of the respoilse was consistent within a single 
patient and was not changed by the removal of the epithelium or the addition of 
phosphoramidon. Indomethacin inhibited both the relaxing and the contractile 
effect. It therefore seems possible that the release of a patient-specific ratio of 
contractile and relaxing prostanoids detennines whether precontracted airways 
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relax or contract to Bk in a particular patient. We found that GR32191 reversed 
Bk-induced contraction, indicating that the contractile effects of prostanoids 
released by Bk are mediated through the TP- receptor. Although TxA2 is the 
most potent agonist for the TP-receptor 6, the prostanoids PGD2, PGF2", PGE2, 
and PGI2 also possess TP-receptor agonist activity 6-8 and may therefore con-
tribute to bronchoconstriction. Not only did GR32191 inhibit Bk-induced 
contraction, but in the presence of higher concentrations of GR32191 airways 
relaxed to Bk. This relaxation was abolished by indomethacin, indicating that 
cyclooxygenase products are involved. Thus, it seems that functional antago-
nism between the TP receptor and relaxant prostanoid receptors determines the 
direction of the response to Bk. We did not investigate the identity of these 
relaxant receptors but studies in animals suggest that both the EP 2 and the IP 
receptor may be involved 7. 
In the present study, increasing concentrations of Hoe 140 produced a decrease 
in Smax and loss of parallelism of Bk-induced contractions. This was also found 
by other investigators in both human 25 and guinea pig airways 28 34 and con-
films that Bk-induced contractions are mediated through the B2 receptor. From 
these experiments it was concluded that Hoe 140 is a noncompetitive antago-
nist, or altematively, a B3 receptor is involved 28 34. In the present study, however, 
we showed that Bk acts as an indirect agonist, initiating the release of prostanoids. 
Therefore, it is still possible that Hoe 140 is a competitive antagonist because a 
competitive antagonist may produce a decrease in Smax and loss of parallelism 
to an indirect agonist 21 . 
In animal airways, Bk-induced responses involve the release oftachykinins 192431. 
In human peripheral airways, which contain many fewer tachykinin-containing 
nerves 24, no evidence for Bk-induced tachykinin release was found in a study 
by Molimard and coworkers 25, and this is confirmed by the present study. 
Tachykinins may also cause bronchoconstriction by stimulation of sensory nerve 
endings, resulting in a cholinergic reflex bronchoconstriction. The finding that 
in humans inhalation of a cholinergic antagonist before bronchoprovocation with 
Bk reduced the Bk-induced bronchoconstriction 15 supports such an indirect 
mechanism. Obviously, a central cholinergic reflex cannot be demonstrated in 
isolated airways. 
We conclude that Bk contracts intact and epithelium-denuded human peripheral 
airways; precontracted ainvays are either relaxed or further contracted. The sen-
sitivity to Bk increases after removal of epithelium, indicating a protective role 
of the epithelium against Bk-induced responses. The bronchoactive effects of 
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Bk are mediated through the B2 receptor and involve the release of prostanoids 
that contract human aitways via the TP receptor. 
Bk may contribute to asthma by increasing microvascular leakage 29 and by 
inducing hypersecretion of mucus I. In addition, the present study showed that 
Bk also has a potent indirect contractile effect on human peripheral aitways. We 
found that Bk is particularly effective in epithelium-denuded airways. Because 
epithelial damage is a characteristic of asthma and the Bk concentration is elevated 
in the bronchoalveolar fluid of asthmatic patients after allergen challenge 5, endo-
genous Bk may indeed contribute to bronchoconstriction in asthma. 
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Chapter 10 
Capsaicin induces Bronchoconstriction and Neurally-mediated 
Tachykinin Release in Human Isolated Airways 
10,1 lmRODUCTION 
The sensory neuropeptides or tachykinins substance P (SP) and neurokinin A 
(NKA) have been localized to nomnyelinated sensory nerve fibers (C-fibers) in 
human airways and may be the neurotransmitters of the excitatOlY non-adrenergic, 
non-cholinergic (eNANC) nervous system 2 1720, SP preferentially interacts with 
neurokinin 1 (NK1) receptors and NKA with N~ receptors, both of which have 
been demonstrated in human airways 21, 
Tachykinins induce aitway smooth muscle contraction, mucus secretion, vascu-
lar hyperpermeability and dilation of tracheal and bronchial blood vessels, and 
stimulate and attract inflammatory cells in both animal and human airways 2 17 
1930, Because of these effects, which are collectively known as 'neurogenic 
inflammation', tachykinins have been implicated in the pathophysiology of 
asthma 217 3D, Indeed, SP-immunoreactive nerves are more abundant in the air-
ways from patients with asthma than in nonasthmatic subjects 25 and elevated 
SP concentrations have been found in the sputum and bronchoalveolar lavage 
fluid of patients with asthma 24 31. 
Sensory nerve fibers can be activated by capsaicin, the pungent agent in chili 
peppers, and this may result in antidromic conduction with release of tachy-
kinins 13 28 3D, This type of conduction of impulses without passing through a 
cell body is called an 'axon reflex' 30. Although it has been hypothesized that 
axon reflexes with local release of tachykinins may playa role in asthma 3, this 
mechanism has not been demonstrated in human airways. In the present study, 
we investigated the effects of the nerve conductance blocker tetrodotoxin (TI'X), 
Based 01/: Hulsmann AR, Raatgeep HR, Zijlstra FJ, Saxena PR, De Jongste JC. Capsaicin 
induces bronchoconstriction and neurallYMmediated tachykinin release in human isolated air-
ways. Submitted 
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the anti-asthmatic drug sodium cromoglycate (SCG) which may inhibit eNANC 
responses, and the selective neurokini~ (N~)-receptor antagonist SR48968 9 
on capsaicin-induced responses of human isolated airways. In addition, we meas-
ured the capsaicin-induced release of SP and NKA from human aiIways by 
radioimmunoassay, in the absence or presence of TIX, SCG and SR48968. 
10.2 MATERIALS AND METHODS 
Tissue preparation 
Human lung tissue was obtained from 9 male and 2 female patients (mean age 
63.8 y; range 43 to 76 y), who underwent thoracotomy for bronchial carcinoma. 
None of the patients had characteristics of asthma. The premedication was the 
same for all patients: atropine, thiopental, fentanyl, 0/N20, halothane, and 
pancuronium. Immediately after surgical resection, a macroscopically nonnal 
part of the lung tissue was iInmersed in carbogenated (95% 02 and 5% CO2) 
Krebs-Henseleit buffer at 4°C (composition in mM: NaCI 118, KCI4.7, CaCI2 
2.5, MgS04 1.2, KH2P04 1.2, NaHC03 25, glucose 5.55). The tissue remained 
in cooled fresh carbogenated buffer throughout the dissection procedure. 
Cartilaginous bronchi with an inner diameter of 3 to 6 mm (generation 4 to 7) 
were carefully dissected and cut spirally to obtain a bronchial strip preparation. 
The tissues were studied at 3TC in double-jacketed 10 ml siliconized organ 
baths containing carbogenated Krebs-Henseleit buffer. Thin surgical silk threads 
(6/0) were tied to the ends of the strips. One thread was attached to a glass hook 
at the bottom of the organ bath and the other to the arm of a high-precision 
isotonic angular position transducer (Type 3810/60; Penny and Giles Ltd., 
Christchurch, UK), which was connected to a digital voltmeter (Multimeter 73; 
Fluke, Everett, WA, USA) and a pen recorder (BD40; Kipp, Delft, The Nether-
lands). The preparations contracted against a load of 500 mg. The study was 
approved by the Ethical Committee of the Rotterdam University Hospital. 
Radioimmunoassay (RIA) of SP and NKA 
The organ bath fluids (10 ml) were applied to reverse-phase C l8 Sep-Pak 
cartridges (Waters Associates, Millford, MA, USA) and rinsed with 5 ml of 
distilled water. Tachykinins were extracted with 10 ml of 70% acetonitrile in 
0.1 % trifluoroacetic acid, lyophilized, and kept at -80°C until they were analyzed 
as a single batch. This protocol results in the recovery of 80-85% of SP and 
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NKA 22. All the reagents were diluted in RIA buffer (0.1 % BSA, 0.1 % Triton 
X-IOO, 0.01% thimerosal and 19 mM monobasic and 81 mM dibasic sodium 
phosphate, pH=7.4). Lyophilized samples were reconstituted and standards SP 
ranging from I to 1000 pg per tube and standards NKA ranging from I to 128 
pg per tube were prepared. Samples and standards 100 J.Il were pipetted in indi-
vidual tubes and 100 J.Il of rabbit anti-SP or anti-NKA was added. After an over-
night incubation at 4°C, 0.01 /.lCi 125I_SP or !25I_NKA (10,000 to 15,000 cpm) 
was added to each tube. After a second overnight incubation at 4°C, 100 J.Il of 
goat anti-rabbit y-globulin and 100 J.Il of nonimmune rabbit serum were added 
for 2 hours at room temperature. Thereafter, the antigen-antibody complex was 
precipitated with 0.5 ml of 20% polyethylene glycol (MW 6000) and centri-
fuged at 1700 g for 20 min at 4°C. The supernatant was decanted and the radio-
activity in the pellet was measured in count.min·! using a gamma counter (Packard 
Minaxi Autogamma 5000, Packard Instrument Company, Downers Grove, IL, 
USA). 
The detection limit of the SP- and the NKA assay was approximately 2 pg and 
I pg per tube, respectively. The cross-reactivity of the SP antiserum with SP 
[3-11], SP [4-11], SP [5-11], neuropeptide K, neurokinin A and neurokinin B 
was 100, 100, 100, <0.01, <0.01 and 0%, respectively. The cross-reactivity of 
the NKA antiserum with neurokinin B, SP, physalaemin and neuropeptide Y 
was 80, 0.05, 0.02, and 0%, respectively. The RIA was not influenced by phos-
phoramidon and captopril. The amounts of SP and NKA in airway tissue are 
expressed as fmol/g wet weight. 
Drugs 
Methacholine bromide (Janssen Pharnlaceutica, Beerse, Belgium), EDTA (Sigma 
Chemical Co., St. Louis, MO, USA), and the peptidase inhibitors phosphor-
amidon (Sigma) and captopril (Squibb & Sons, Inc., Princeton, NJ, USA), were 
dissolved in 0.9% NaC!. TTX (Sigma) and sodium cromoglycate (Sigma) were 
dissolved in distilled water. SR48968 (gift from Dr. X. Emonds-Alt, Sanofi 
Recherche, Montpellier, France) was dissolved in ethanol. L-isoprotereno! sulfate 
(Janssen) was dissolved in distilled water containing ascorbic acid (88 mgt!). 
125I_SP and anti-SP rabbit serum were obtained from Amersham International 
pic, Amersham, Buckinghamshire, UK and standard SP from Bachem Pharma-
ceuticals, Torrance, CA, USA. 125I_NKA, anti-NKA, standard NKA, nonnal 
rabbit serum and goat anti-rabbit y-globulin antibodies were purchased from 
Peninsula Laboratories Inc., Belmont, CA, USA. 
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10.3 EXPERIMENTAL PROTOCOLS 
Before the experiments, the preparations were contracted twice with methacholine 
(10-5 and 1O-4M) to assess contractile function and to ensure a stable function 
for the rest of the day 4. After washout, all preparations were incubated with the 
neutral endopeptidase (NEP) inhibitor phosphoramidon (l0-5M) and the 
angiotensin converting enzyme (ACE) inhibitor captopril (1O-5M) to prevent 
degradation of potentially released tachykinins 5. Then, airways were pretreated 
with either TTX (1O-5M), SCG (l0-5M), SR48968 (l0-7M), or vehicle. After 20 
min of incubation, a cumulative concentration response curve (CCRC) to 
capsaicin (10-9 to 1O-5M, by logarithmic increments) was made. During each 
experiment, one airway served as a control that enabled us to detelmine base-
line SP release without stimulation with capsaicin. After making the CCRC to 
capsaicin, the organ bath fluid was collected for the measurement of SP and 
NKA, released by the airway preparations. Finally, the airways were washed 
and fully relaxed by adding L-isoproterenol (1O-4M) and ethylene-diamine-
tetraacetic acid (EDTA; 4xlO-3M) and wet tissue weight was determined. 
Data analysis 
The contractile responses to capsaicin are expressed as a percentage of the 
maximal contraction to methacholine 1O-4M. CCRCs for capsaicin-induced 
bronchoconstriction in the various treatment groups were compared with non-
parametric ANOVA (Ktuskal-Wallis test). The concentrations of SP and NKA 
in the organ bath fluid of the various treatment groups were compared using the 
Mann-Whitney U-test. All data are expressed as mean ± standard error of the 
mean (SEM) and values of p <0.05 were considered significant. 
10.4 REsULTS 
Capsaicin (10-9 to 1O-5M) induced a concentration-dependent contraction in 29 
of 34 airway preparations. The contractile state of three airways was not changed 
by capsaicin and two airways relaxed to capsaicin (both had been pretreated 
with SR48968). 
Maximal contraction (Smax) to 1O-5M capsaicin was 9.4 ± 3.0% of the maximal 
contraction to methacholine 1O-4M (figure I, n=7). TTX (l0-5M) and SCG 
(l0-5M) did not affect capsaicin-induced bronchoconstriction (Smax: 9.2 ± 3.3 
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Figure 1. Mean CCRC to capsaicin of human airways (n= 7) in the presence of vehicle 
(closed circles), in the presence of IO-'M tetrodotoxin (closed squares) and in the 
presence of IO-'M sodium cromoglycate (closed triangles). Open circles represent 
control airways not exposed to capsaicin. Capsaicin-induced responses are 
expressed as a percentage of maximal contraction to methacholine (104 M). 
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Figure 2. Mean CCRC to capsaicin of human airways (n=6) in the absence (open circles) 
or presence (closed circles) of the NK2 receptor antagonist SR48968. Capsaicin-
induced responses are expressed as a percentage of maximal contraction to 
methacholine (104 M). ' p<0.05. 
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and 10.2 ± 1.9% of the maximal contraction to methacholine, respectively, 
figure I, n=7). SR48968 significantly inhibited capsaicin-indnced contraction; 
Smax was only 2.6 ± 2.5% of maximal contraction to methacholine (figure 2, 
n=6). The tone of control airways did not change during the experiment (figure 
1). The amounts of SP and NKA released by the airway preparations are shown 
in figure 3. Capsaicin-induced release of both SP and NKA was significantly 
decreased by TTX, but not by SCG or SR48968. In the organ bath fluid of 
control airways, small amounts of SP could be detected, but no NKA. 
10.5 DISCUSSION 
In the present study we found that capsaicin caused concentration-dependent 
contractions and release of SP and NKA in human isolated aitways. Capsaicin-
induced bronchoconstriction could be inhibited by the selective N~-receptor 
antagonist SR48968, but not by TTX or SCG. Capsaicin-induced release of 
tachykinins could be suppressed by TTX, but not by SCG or SR48968. 
Lundberg and colleagues 19 were the first to describe capsaicin-induced con-
tractions in human aitways and suggested that the contractions were caused by 
capsaicin-induced release of SP. In a later study, capsaicin contracted airway 
smooth muscle contraction in only half of the human airways tested 5. Addition 
of the NEP inhibitor phosphoramidon, however, resulted in capsaicin-induced 
contraction of all airway preparations, suggesting that contractile effects of 
endogenous tachykinins were modulated by NEP 5. In the present study, both 
phosphoramidon and the ACE-inhibitor captopril were present in the organ baths 
to prevent degradation of endogenously released tachykinins. Captopril was 
added because ACE degrades SP and this enzyme has been localized on 
endothelium of blood vessels in human airways 14. In our experiments, most 
airway preparation contracted to capsaicin although maximal responses were 
small and variable. In addition, capsaicin-induced contractions were associated 
with an increase in tachykinin release by these aiIways, and this suggests acti-
vation of C-fibers by capsaicin, with release of tachykinins. 
We found that the capsaicin-induced release of tachykinins could by inhibited 
by the nerve conductance blocker TTX. Capsaicin binds to a specific membrane 
receptor and causes depolarization of sensory nerve endings with release of 
tachykinins 8, a process which cannot be inhibited by TTX 27. However, capsaicin 
may also cause antidromic impulse conduction to branches of the axon. This 
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Figure 3. Capsaicin-induced release of the tachykinins substance P (A) and neurokinin A 
(B) by human airways incubated with vehicle, tetrodotoxin (TTX), sodium cromo-
glycate (SCG), or SR48968. Control columns represent airways not exposed to 
capsaicin. '" p<O.OS compared with control ainvays. ** p<O.OS compared with 
airways pretreated with vehicle, SCG, or SR48968. 
'axon reflex' is TTX-sensitive 18. Because TTX inhibited capsaicin-induced 
release of tachykinins, our experiments suggest the generation of an axon reflex 
by capsaicin in human airways. In the guinea pig, evidence for axon reflex bron-
choconstriction via afferent C-fibers was also found both iu vitro and in vivo 1234. 
In a recent study of asthmatic patients, bradykinin-induced bronchoconstriction 
could be inhibited by the tachykinin receptor antagonist FK-224, suggesting 
local tachykinin release II. In the present study, capsaicin-induced bronchocon-
striction could not be inhibited by TTX. We cannot explain this finding. Perhaps, 
the concentration of SP and NKA near the smooth muscle was too low to cause 
significant bronchoconstriction in the absence of TTX. 
Sodium cromoglycate (SCG) has been shown to suppress bradykinin- and 
capsaicin-induced excitation of C-fibers in dogs 6. In vivo studies in asthmatic 
patients showed that inhalation of SCG protected against bradykinin-induced 
bronchoconstriction suggesting that SCG prevents activation of C-fibers by 
bradykinin 1032. In rodent isolated tracheas, however, bradykinin-induced release 
of substance P and eNANC neural bronchoconstrictor responses to electrical 
field stimulation (EFS) were not or only partially inhibited by SCG 26 32. In the 
present study we could not demonstrate an inhibitory effect of SCG effect on 
capsaicin-induced bronchoconstriction and release of tachykinins in human 
isolated ahways. It is possible, however, that a higher concentration of SCG 
inhibits capsaicin-induced release of tachykinins because in the guinea pig 
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trachea 10-4 M of sca decreased eNANC bronchoconstrictor responses by 9% 32. 
It can be questioned, however, whether such concentrations are relevant to treat-
ment in vivo. 
In the guinea pig trachea, capsaicin or EFS-induced eNANC bronchoconstriction 
is mediated via the NK2-receptor 29. Tachykinin-induced contraction of the rat 
trachea, on the other hand, is caused by NKI-receptor activation 15. In the present 
study, we found that the selective nonpeptide N~-receptor antagonist SR48968 
abolished capsaicin-induced bronchoconstriction. Previous studies of human air-
ways using selective agonists and SR48968 have also shown that tachykinin-
induced contractions are mediated by NK2-receptor activation I 23. Moreover, 
although SP preferentially binds to the NKI-receptor, SP-induced contraction 
of human isolated airways was also mediated by the N~-receptor I. These func-
tional studies are supported by radioligand binding studies with 123I-SP which 
localized NKI-receptors to microvascular endothelium but not to airway smooth 
muscle of human airways 33. Thus, although in our experiments capsaicin released 
larger amounts of SP than NKA, bronchoconstriction could mainly be due to 
N~-receptor activation only. 
In conclusion, we found that capsaicin causes constriction of human ahways 
and releases SP and NKA from these airways. The nerve conductance blocker 
TIX inhibited capsaicin-induced release of tachykinins suggesting that axon 
reflexes are involved. In vivo, these axon reflexes may not only cause broncho-
constriction, but also mucus secretion, vasodilation, vascular hyperpermeability 
and stimulation and chemotaxis of inflammatory cells, effects which are collec-
tively known as neurogenic inflammation. Recently, the relevance of neurogenic 
inflammation for human airway disease has been questioned because of lack of 
evidence that axon reflexes leading to a release of tachykinins, actually takes 
place in human airways 16. The findings in the present study suggests that release 
of neuropeptides via axon reflex mechanisms takes place in human bronchi, but 
the functional relevance of this release remains to be elucidated. 
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Chapter 11 
General Discussion and Directions for Future Research 
11.1 INTRODUCTION 
As discussed in chapters 1 and 2, the level of airway responsiveness in asth-
matic patients is related to the extent of epithelial damage in these patients. 
However, the relationship between epithelial damage and airway responsive-
ness is not clear. Several mechanisms have been proposed including reduced 
production of epithelium-derived relaxing factors, decreased metabolization of 
contractile agonists by epithelial peptidases, increased airway permeability 
providing easy access ofbronchoactive mediators and exposure of intraepithelial 
sensory (peptidergic) nerves with reflex bronchoconstriction. The objectives of 
our studies were: 
1. To assess the modulatory role of the airway epithelium on airway responsive-
ness, and to elucidate the mechanism of this epithelial modulation. 
2. To investigate the presence and functional importance of peptidergic nerves 
and axon reflexes in human isolated airways. 
This chapter encomprisis a critical evaluation of our methodology and findings. 
11.2 LIMITATION OF THE ApPLIED METHODS 
Modulation of airway responsiveness by the epithelium has been reported by 
many authors in many species, including man. In 1991, Busk and Vanhoutte 
reviewed the literature on epithelium-dependent responses of isolated airways 
and they cited 26 studies on the effects of contractile and 23 studies on the 
effects of relaxing agonists II . In most of these studies the differences in respon-
siveness between intact airways and airways without epithelium were too small 
to explain the airway increased responsiveness found in asthmatic patients. This 
may lead to the conclusion that the epithelium does not play an important modu-
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latory role in the responsiveness of airway smooth muscle. Or, even more dis-
appointing, that the results of many of these studies may be explained by bias 
because in vitro studies are not performed blinded 20. The methodology used in 
most of the in vitro studies reviewed by Busk and Vanhoutte requires a critical 
reevaluation. Most authors used airway stdp or dng preparations for their studies. 
The modulatory role of the epithelium was assessed by comparing intact airway 
preparations with preparations from which the epithelium had been mechani-
cally removed. As explained in chapters 4, 5 and 6 of this thesis this method has 
important shortcomings: In these preparations a stimulus cannot be selectively 
applied to the mucosal side of the airway preparation. Because the stimulus can 
reach the airway smooth muscle via the serosal side and the cutting edges of the 
preparation, the modulatory role ofthe epithelium may be underestimated when 
airway strips or rings are used. Furthermore, mechanical rubbing used by all 
authors to denude airways from their epithelium may have side effects: Franconi 
and coworkers reported that mechanical rubbing of the epithelium may release 
proteases from mast cells present in the airway preparation 25. Since mast cell 
proteases may increase airway responsiveness 90, it is possible that the 
hyperresponsiveness of epithelium-denuded airways is partly caused by the 
release of proteases during mechanical rubbing. 
Recently, the shortcomings of the conventional airway strip and ring prepara-
tions were partly solved by the use of perfused airway tubes. These preparations 
provide the opportunity to apply stimuli selectively to the mucosal side of the 
airway preparation 37. Large differences between serosal and mucosal stimula-
tion with contractile and relaxing agonists have been reported in rodent 6880, 
bovine 66 76, and human 38 75 airways. Thus, the experiments performed with 
perfused airways indeed suggest that the airway epithelium modulates airway 
responsiveness. 
Although the perfused airway tube preparation offers the opportunity to study 
the modulatory role of the epithelium this model is still imperfect: The subepi-
thelial or mucosal microvascular plexus is not perfused. This plexus, interspersed 
between the epithelium and the airway smooth muscle, receives a large amount 
ofthe bronchial blood flow 2151103. Inhaled allergens and bronchoactive mediators 
and cytokines produced by the airway epithelium may be washed away and 
metabolized by this bloodstream before they reach the airway smooth muscle. 
In addition, many of the mediators and cytokines produced by the epithelium 
cause vasodilation and increase microvascular permeability which may contri-
bute to bronchial obstruction in asthma 193484. Therefore, products released by 
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the airway epithelium may have a more important modulatory role on the 
tracheobronchial circulation than on airway smooth muscle responsiveness. 
However, this modulatory role cannot be assessed with the currently available 
in vitro models. 
11.3 EPITHELIUM AS A DIFFUSION BARRIER 
In chapters 1 and 2 of this thesis it was explained that impaument of barrier 
function may be anunportant factor causing airway hyperresponsiveness after 
epithelial damage: In animal studies a strong correlation between airway 
responsiveness and auway pemleability was found both ill vitro and ill vivo 776105. 
In addition, several authors reported that the extent of epithelial damage in bron-
chial biopsies from asthmatic patients correlated with the level of airway 
responsiveness in these patients 42 74. 
AiIway responsiveness in vivo is usually assessed by bronchoprovocation with 
aerolized histamine or methacholine. After inhalation these drugs must pass the 
airway epithelium to reach the airway smooth muscle. In the experiments 
described in chapter 7 of this thesis we found that the ainvay epithelium forms 
a barrier against penetration of hydrophilic drugs. Since both histamille and 
metl1acholine are hydrophilic drugs, it is easy to understand that epithelial damage 
may lead to hyperresponsiveness to these drugs because the aiIway smooth 
muscle can be reached more easily. Indeed, the expetiments described in chap-
ters 6 and 7 show that epithelial damage produced by the oxidant hydrogen 
peroxide (H20 2) or the cationic protein poly-L-arginine (which is similar to 
MBP produced by eosinophils in asthmatic airways) resulted in an increase of 
both aiIway responsiveness and permeability to hydrophilic drugs. We also found 
that both airway responsiveness (chapter 6, figure 3) and airway penlleability 
(chapter 7, figure 4) illcreased with decreasing airway size. These findings SUppOit 
a causal relationship between airway responsiveness and airway permeability. 
Ainvay hyperresponsiveness induced by viI'al infections and allergens may also 
be pattly explained by a change in barrier function of the epithelium: During 
acute viral respiratory tract infections, ainvay epithelial cells become necrotic. 
This will not only obstruct the airways by cellular debris and edema but also 
increase airway pelmeability 31. Similarly, the proteolytic activity of the allergen 
Der pI of tI1e house dust mite may cause epithelial damage and iIlcrease airway 
permeability 33. 
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There are, however, arguments against epithelial damage as the main mechanism 
of bronchial hyperresponsiveness: In some studies of bronchial biopsies from 
asthmatic patients no structural damage to the airway epithelium was found 
although the patients were hyperresponsive to inhaled methacholine 50 54, Simi-
larly, exposure of laboratOlY animals to oxidants and cationic proteins caused 
airway hyperresponsiveness without apparent epithelial damage 16 98, In this 
study, airway hyperresponsiveness was probably produced by the release of 
bronchoactive mediators such as prostanoids and bradykinin 1683, Furthermore, 
airway hyperresponsiveness after physical exercise or hyperventilation cannot 
easily be explained by a change in barrier function, Instead, hyperosmolarity 
due to evaporation of mucosal surface water and bronchial vasodilation and 
hyperemia of the tracheobronchial circulation during rewarming may play a 
role 63 64, It can be hypothesized, however, that intact airway epithelium protects 
against exercise-induced asthma by preventing evaporation and cooling of the 
airways, Finally, the function of the epithelial barrier is not only to restrict access 
ofbronchoactive substances or allergens from outside but also to prevent leakage 
of exudate/transudate from the tissues into the airways, Indeed, epithelial dam-
age may lead to plasma exudation and this may contribute to airway 
hyperresponsiveness 8182, Thus, our studies show that epithelial damage increases 
both airway permeability and airway responsiveness, However, it may well be 
that other factors add to airway hyperresponsiveness in asthmatic patients, 
11.4 EPITHELIAL DEGRADATION OF NEUROTRANSMITTERS AND CHEMICALS 
As discussed in chapter 2 the membrane-bound peptidases neutral endopeptidase 
(NEP) and angiotensin converting enzyme (ACE), have been demonstrated on 
human airway epithelium 5 44 52, Both NEP and ACE degrade a large variety of 
peptides including the tachykinins neurokinin A (NKA) and substance P (SP), 
kinins such as bradykinin (Bk), and the putative iNANC neurotransmitter 
vasoactive intestinal peptide (VIP) 6 69, Epithelial damage or loss or inhibition 
of these peptidases may not only cause hyperresponsiveness of human airways 
to the abovementioned peptides 5 1394 but also enllance 'neurogenic inflamma-
tion' 669, 
In chapters 8 and 9 of this thesis, we described the effects of epithelium removal 
and inhibition of membrane-bound peptidases on airway responsiveness to Bk 
and VIP, Although peptidase inhibition increased airway responsiveness to both 
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peptides, removal of the epithelium produced a larger effect. This indicates that 
apart from epithelial peptidases other factors protect against an increase in air-
way responsiveness to peptide agonists, for instance an epithelial barrier that 
impedes the diffusion of Bk and VIP. Altematively, other epithelial enzymes 
which were not inhibited in our experiments may be involved in degrading Bk 
and VIP. In rat lung microsomes, for instance, the enzymes aminopeptidase P 
and dipeptidylaminopeptidase IV have been demonstrated and these enzymes 
compete with angiotensin converting enzyme (ACE) in the degradation of Bk 77. 
The matter is further complicated by the recent demonstration that in rat lungs 
chronic inhibition of either ACE or neutral endopeptidase (NEP) may result in 
induction of both enzymes 32. These processes, however, may require several 
days and may, therefore, not confound our studies of isolated airways. 
We also found that peptidase inhibitors increased airway responsiveness to both 
the contracting peptide Bk and the relaxing peptide VIP in epithelium-denuded 
airways. This suggests that these peptides are also degraded by non-epithelial 
peptidases. As discussed in chapter 9, these non-epithelial peptidases may be 
produced by mast cells, T-cells and macrophages, or they may be present on the 
endothelium or airway smooth muscle itself6 89. In vivo, asthmatic patients are 
hyperresponsive to inhaled tachykinins 14 1745 although no reduction of NEP 
activity was found 14. Considering our findings in vitro it can be hypothesized 
that epithelial damage may be a major factor causing hyperresponsiveness to 
tachykinins in asthmatic patients. The effect of NEP-inhibitors in vivo may be 
explained by sufficient residual epithelial and nonepithelial sources of NEP in 
these patients. Thus although epithelial peptidases modulate airway responsive-
ness to inhaled and, probably, endogenous peptides, ainvay responsiveness in 
asthmatic patients cannot be simply explained by a deficiency of epithelial 
peptidases. 
11.5 GENERATION OF RELAXING SUBSTANCES BY THE EPITHELIUM 
The discovery of endothelium-derived relaxing factor (EDRF, now identified as 
nitric oxide (NO) 67) in the vasculature led to the hypothesis that a similar factor 
might be produced by the airway epithelium. In asthma, epithelium-derived re-
laxing factor (EpDRF) would not be produced in sufficient amounts to keep the 
airway smooth muscle in a relaxed state. Several putative candidates for EpDRF 
have been suggested including prostanoids 23 97 and, more recently, NO 61 71. 
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In the experiments described in chapter 9 we found that bradykinin-induced 
contractions of human airways were mediated via the release of prostanoids 
from human airways. After removal of the epithelium even greater amounts of 
prostanoids were produced by a nonepithelial source. In addition, we found that 
although greater amounts of the bronchodilatory prostanoids PGJ2 and PGE2 
were produced, human airway smooth muscle was contracted by a predominant 
effect of smaller amounts of thromboxane (TxA2). A similar pattem of prostanoid 
release has been reported in hydrogen peroxide-induced bronchoconstriction of 
human airways 83. Because of this predominant effect of TxA2 and the produc-
tion of prostanoids by nonepithelial sources, it is not likely that in human airways 
epithelium-derived prostanoids will act as EpDRF. 
Recently, it has been reported that NO synthesis inhibitors increased histamine-
induced constriction of the guinea pig trachea 61 71. In epithelium-denuded 
airways, histamine-induced bronchoconstriction could not be enhanced by NO 
synthesis inhibitors suggesting that epithelium-derived NO relaxed the ailway 
smooth muscle in this preparation. These in vitro studies, however, do not prove 
that epithelial NO is EpDRF: Fil'stly, NO synthesis inhibitors not only inhibit 
the production of nitric oxide but also the release of prostanoids 88. Because in 
the guinea pig lung, prostanoids released by the epithelium relax the airway 
smooth muscle 8 97, experiments with NO synthesis inhibitors may be confounded 
by an effect of epithelial prostanoids. Secondly, it should be remembered that in 
blood vessels, the NO-producing endothelial cells directly face the vascular 
smooth muscle. NO will reach the vascular smooth muscle cells easily despite 
its short half life. In airways, the epithelial cells do not face the airway smooth 
muscle because the subepithelial vascular plexus is between the epithelial cells 
and airway smooth muscle. In vivo, NO produced by airway epithelial cells has 
to travel a large distance to reach ailway smooth muscle, and, moreover, it has 
to pass a dense vascular plexus with a large blood flow 21 79 !O3. Because NO 
eagerly binds to hemoglobin 67, and NO relaxes airway smooth muscle only at 
high concentrations !O7, it is not likely that in vivo epithelial NO will reach 
airway smooth muscle in sufficient amounts to produce airway smooth muscle 
relaxation. Indeed, in both animals and humans inhaled NO has a potent dila-
tory effect on pulmonalY vessels, whereas only a slight bronchodilating effect is 
found 2235. 
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11.6 MODULATION OF AIRWAY RESPONSIVENESS BY PEPTIDERGIC NERVES 
The sensory neuropeptides or tachykinins substance P (SP) and neurokinin A 
(NKA) have been localized to unmyelinated sensory nelve fibers (C-fibers or 
peptidergic nerves) in animal and human airways and may be the neurotrans-
mitters of the excitatory non-cholinergic, non-adrenergic nelVOUS system 246 56.59, 
Excitation of these nerve fibers by chemical and physical stimuli may produce 
retrograde (antidromic) impulses that results in local release of tachykinins 3 40 
538791, In rodent airways, tachykinins induce airway smooth muscle contrac-
tion, mucus secretion, vascular hyperpenneability and dilation of tracheal and 
bronchial blood vessels, and stimulate and attract inflammatory cells 240 53 59 87 91 , 
Because of these effects, which are collectively known as 'neurogenic inflam-
mation' 41, tachykinins have been implicated in the pathophysiology of astllllla 
24691, Indeed, in the guinea pig endogenous release of tachykinins contribute to 
chemical- (Bk, histamine, capsaicin, toluene diisocyanate, and cigarette smoke) 
and allergen-induced hyperresponsiveness 4 36 40 5387. 
In the human lung, exogenous tachykinins cause bronchoconstriction 13 174555, 
mucus hypersecretion 85, plasma extravasation 9, influx of inflanunatory cells 9 
and hyperresponsiveness to inhaled methacholine IS, Compared to rodent air-
ways, human airways contain less tachykinin-containing nerve fibers 56·59 and 
less tachykinin receptors 12 101, Recently, however, an increased SP-immuno-
reactivity in bronchoalveolar fluid and sputum has been reported in asthmatic 
aitways 70 95. Furthermore, inhalation of a tachykinin receptor antagonist partly 
prevented Bk-induced bronchoconstriction 39, Although these studies suggest 
that endogenous tachykinins are involved, they do not prove that in human aitways 
these tachykinins are released by peptidergic nerves, In the experiments described 
in chapters 9 and 10, we investigated the effect of Bk and capsaicitl on human 
isolated airways, In contrast to the experiments in guinea pig and dog airways 40 
48, we could not demonstrate excitation of peptidergic nerves by Bk. Instead, in 
human aitways Bk-induced bronchoconstriction appeared to be mediated through 
the release of prostaglandins, 
In the experiments described in chapter 10, we used capsaicin to stimulate C-fibers 
in human isolated airways, We found that capsaicin caused small contractile 
responses in human isolated airways, This contrasts with the much larger effect 
of capsaicin in the guinea pig trachea 40 59 87, However, the guinea pig may be 
the only species in which a potent capsaicin-induced bronchoconstriction can 
be found, In the rat trachea, for example, capsaicin induces small contractile 
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responses, similar to the contractions that we found in human airways 47. The 
small contractile effect of capsaicin in human isolated aitways also contrasts 
with the potent bronchoconstrictive effect of inhaled capsaicin in asthmatic 
patients 2665. This indicates that apart from local axon reflexes other broncho-
constrictive mechanisms are induced by capsaicin. Since peptidergic nerves have 
been demonstrated in the vicinity of vagal nerve fibers it is possible that 
tachykinins released by capsaicin elicit a cholinergic reflex bronchoconstriction 
in asthmatic subjects 26 65. 
We found that capsaicin evokes the release of the tachykinins substance P (SP) 
and neurokinin A (NKA) from human airways. The release of the tachykinins 
could be inhibited by TTX, indicating that local axon reflexes may be involved. 
Although in our experiments with human airways these axon reflexes did not 
produce important bronchoconstriction they may produce other features of 
'neurogenic inflammation' such as microvascular leakage, mucus hypersecretion, 
tracheobronchial vasodilatation, aspecific bronchial hyperresponsiveness, and 
attraction and activation of inflal11l11atory cells. Both microvascular leakage and 
tracheobronchial vasodilatation may increase airway wall thickness which may 
contribute to ainvay obstruction 1934818499. In addition, the neurogenic inflam-
matory process may increase airflow obstruction by inducing the production of 
histamine by mast cells 30 and the proliferation of airway smooth muscle cells 73. 
11.7 CONCLUSIONS 
The results from the experiments described in this thesis show that in human 
airways: 
1. The airway epithelium modulates airway responsiveness. Also, airway re-
sponsiveness and airway permeability increase with decreasing airway size 
and epithelial damage causes an increase of both airway responsiveness and 
permeability. Therefore, airway permeability may be an important factor de-
termining airway responsiveness. 
2. In human airways removal of the epithelium has a greater effect on airway 
responsiveness than inhibition of epithelial peptidases. In addition, peptidases 
are not only present on the epithelium but also on other tissues. Therefore, 
epithelial peptidases probably do not playa key role in the modulation of 
airway responsiveness. 
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Figure 1. Schematic representation of several aspects of bronchial responsiveness. The 
accentuated boxes refer to the contribution of the experiments described in this 
thesis. 
3. Excitation of sensory nerves causes a small contractile response and release 
of tachykinins in human airways. The release of tachykinins could be inhi-
bited with the nerve conductance blocker TTX indicating that local axon 
reflexes are involved. 
The results of the studies described in this thesis are embedded in figure I 
which shows a concept of the mechanisms that may be relevant for the 
pathogenesis of bronchial hyperresponsiveness in asthma. 
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11.8 DIRECTIONS FOR FUTURE RESEARCH 
Classically, airway smooth muscle contraction has been regarded as the primary 
cause of airflow limitation in patients with asthma. Smooth muscle contraction 
was thought to be caused by increase in smooth muscle responsiveness and/or 
abnormalities in the autonomic control of the airways. Later, it appeared that 
inflammatOlY cells in the airway wall playa key role in the pathophysiology of 
asthma. Mediators and cytokines released by these inflammatory cells cause 
epithelial shedding, smooth muscle contraction, enhanced mucus production, 
and increased vascular permeability and edema, processes which contribute to 
bronchial obstmction in asthma. 
Recently, it was recognized that the tracheobronchial circulation may play an 
important role in the modulation of airway responsiveness. It is involved in the 
conditioning of inspired air, and the clearance and distribution of inflammatory 
mediators and migratory cells 21 100 103. In addition, vasodilation and plasma 
leakage in the bronchial mucosa of asthmatic patients may increase airway wall 
thickness which may directly contribute to airway narrowing 21 34 81. Despite 
many animal studies of the physiology of the tracheobronchial circulation, the 
physiology of the tracheobronchial circulation in humans and its contribution to 
the pathophysiology of asthma is poorly understood. Furthermore, the role of 
the tracheobronchial circulation in the absorption, distribution and delivery of 
inhaled or infused antiasthmatic drugs remains to be established. To investigate 
these questions, a ventilated and perfused human lung preparation should be 
developed. Isolated lung models have been used in laboratory animals to stndy 
lung mechanics 49, hypoxic vasoconstriction in the lung 43, pu!monaty capillary 
transit time I, uptake and metabolism of drugs and mediators by the lung 10, and 
the effects of infused inflammatory cells 86. Such a model would enable us to 
study the effects of infused mediators and cytokines and perhaps even inflam-
matory cells derived from asthmatic patients, on lung function and airway 
responsiveness of lungs from nonasthmatic subjects. Release of mediators and 
cytokines could be measured in the effluent. Because central cholinergic reflexes 
are eradicated in such a model, local axon reflexes (via peptidergic nerves) in 
the airways and axon reflexes between airways and the pulmonary vasculatnre 
could be stndied. Furthermore, the release of epithelium-derived relaxing factors, 
their uptake and clearance by the airway vasculatnre and their effect on aitway 
smooth muscle tone could be studied in this model. Although human whole 
lungs are rarely available, the use of lung lobes may enable the development of 
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a ventilated, perfused human lung model. If possible, branches of the bronchial 
artery should also be cammlated and perfused with whole blood or synthetic 
oxygen carriers such as fluorocarbons 29 because K-H solution may not contain 
enough oxygen to supply the tissues. 
More recently, there is a renewed interest in the role of airway smooth muscle in 
the pathophysiology of asthma: In the vasculature, hyperplasia and hypertrophy 
are prominent responses after mechanical injury. This process called 'remodel-
ling' is regulated by a variety of growth factors, mediators, and cytokines derived 
from fibroblasts, platelets, endothelial cells, and smooth muscle cells themselves 
27. It has been hypothesized that similar remodelling may play a role in the 
repair phase of airway mucosal damage in asthma 92. Airway smooth muscle 
hyperplasia and hypertrophy will increase airway wall thickness which may 
contribute to airway hyperresponsiveness in asthma 104. Meanwhile, it has been 
shown that histamine, bradykinin, endothelin, thromboxane, leukotrienes and 
substance P stimulate airway smooth muscle proliferation in vitro 28 72 73 78. 
Glucocorticoids, l3-adrenergic receptor agonists, and nitric oxide (NO), on the 
other hand, may inhibit proliferation of isolated aiJway smooth muscle 24 93 96106. 
Interestingly, levels of the abovementioned mediators are increased in the 
bronchoal veolar lavage fluid of asthmatics and decrease during treatment with 
glucocorticoids and l3-agonists 186270 102. At present, however, it is not clear 
whether airway smooth muscle hyperplasia and hypertrophia actually occur in 
asthma. In addition, the cells responsible for the production of growth factors 
have not been identified. Although the damaged epithelium may playa central 
role in airway remodelling, other cells, for instance inflammatory cells, may be 
involved. Furthermore, it can be hypothesized that non-adrenergic, non-
cholinergic (NANC) neural mechanisms are involved: Proliferation of airway 
smooth muscle is stimulated by the eNANC transmitter substance P 73, and 
inhibited by the iNANC neurotransmitters NO and VIP 60 93. If so, treatment 
with inhaled glucocorticoids early in the course of the disease may prevent the 
process of airway remodelling. Further research into the determinants and effects 
of airway remodelling may well provide important clues for understanding bron-
chial hyperresponsiveness, and give new insight that may lead to alternative 
treatment strategies. 
In the past decades the fields of epidemiology, pathology, physiology and phar-
macology advanced our knowledge of the pathophysiology of asthma. More 
recently, molecular biology was introduced and this branch of science provides 
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a promising future for asthma research. Although molecular biology may indeed 
contribute to our knowledge, one should recognize that asthma (or bronchial 
hyperresponsiveness) is a functional abnOlmality of the airways which has a 
heterogeneous etiology. Functional studies both in the laboratOlY and in clinical 
practice remain indispensable for putting the pieces together in the puzzle called 
a081la. 
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12.1 SUMMARY 
In chapter 1 asthma is defined as a chronic inflammatory disorder of the air-
ways with widespread, variable airflow obstlUction associated with an increase 
in ahway responsiveness to a variety of stimuli. The clinical symptoms of asthma 
are recurrent exacerbations of cough, dyspnea, wheezing, and chest tightness, 
often provoked by exogenous factors. Histological examination of asthmatic 
ahways shows damage or loss of the epithelium which may be caused by the 
release of oxidants and cationic proteins by inflammatory cells present in the 
airway wall. Although the extent of epithelial damage is related to the level of 
airway responsiveness, the relationship between epithelial damage and airway 
responsiveness is not clear. Several mechanisms have been proposed including 
reduced production of epithelium-derived relaxing factors, decreased metabo-
lization of contractile agonists by epithelial peptidases, increased aiJway per-
meability providing easy access of bronchoactive mediators and exposure of 
intra-epithelial sensory (peptidergic) nerves with reflex bronchoconstriction. The 
aim of our studies was to investigate the modulatory role of the epithelium on 
the responsiveness of human isolated airways. We assessed the effect of epithelial 
damage produced by oxidants and cationic proteins on airway responsiveness 
and ahway permeability. In addition, we assessed the role of epithelial peptidases 
in aiJway responsiveness to contracting and relaxing pep tides. Finally, we tried 
to demonstrate a retrograde local axon reflex mechanism via sensory (peptidergic) 
nerves (the so-called 'axon reflex') in human isolated airways. 
Chapter 2 describes the stmcture, physiology, and pathophysiology of the air-
way mucosa in asthma. Human airway epithelium consists of ciliated, secretory 
cells and basal cells closely attached to each other and to the basement mem-
brane. The epithelium forms a barrier against leakage of solutes and penetration 
of inhaled material into the airways. Both, membrane-bound and cystolic enzymes 
(peptidases) degrade bronchoactive mediators and peptides and intra- and 
extracellular antioxidant systems inactivate reactive oxygen species. Human air-
way epithelial cells produce biologically active compounds such as arachidonic 
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acid metabolites, nitric oxide and cytokines that may modulate the function of 
neighbouring cells and tissues. The chronic inflammatory process in asthmatic 
airways leads to epithelial injury which is associated with an increase in airway 
responsiveness. The relationship between epithelial damage and airway 
hyperresponsiveness is not clear. The basement membrane consists of collagen 
and glycoproteins. It provides support to the epithelial cells and may constitute 
a barrier to macromolecules and noninflammatory cells. In asthma, the base-
ment membrane zone is thickened by deposition of collagen III and V probably 
produced by myofibroblasts. The lamina propria contains a dense vascular plexus 
that consumes a considerable part of the total airway blood flow. The lamina 
propria provides nutrients to the epithelium and may have an important role in 
the conditioning of inspired air, and the clearance and distribution of inflamma-
tory mediators. In pathologic conditions such as asthma, the mucosal micro-
circulation is the source of plasma exudate and inflammatOlY cells. 
In chapter 3 the autonomic innervation of human airways is described. The 
human tracheobronchial tree is i1mervated via efferent and afferent autonomic 
nerves that regulate airway smooth muscle tone, airway secretions, bronchial 
circulation, and microvascular permeability. The parasympathetic or cholinergic 
nervous system is the dominant autonomic pathway in human airways. Stimu-
lation of cholinergic nerves causes bronchoconstriction, mucus secretion, and 
bronchial vasodilatation by stimulation of specific (muscarinic) receptors via 
release of the neurotransmitter acetylcholine. Although oxidants and viral 
infections may impair prejunctional (inhibitOly) muscarinic receptors, resulting 
in increased postganglionic acetylcholine release, there is no direct evidence for 
an increase in basal cholinergic tone in asthma. The adrenergic or sympathetic 
nervous system may control the airways via sympathetic nerves which release 
noradrenaline and by circulating catecholamines released from the adrenal 
medulla. In contrast to the dense parasympathetic innervation, the sympathetic 
innervation of the human airways is sparse. However, sympathetic nerves sup-
plying blood vessels may have an important role in the control of tracheobronchial 
blood flow. Despite the sparse sympathetic innervation, adrenergic receptors 
(mainly B-adrenergic receptors) are abundant in human airways. Stimulation of 
B-receptors results in relaxation of airway smooth muscle, and this is therefore 
used in the therapy of asthma. Although a reduced B-adrenergic receptor func-
tion has been postulated in asthma, no evidence for this has been found thusfar. 
Recently, a functional third part of the autonomic nervous system called the 
non-adrenergic, non-cholinergic (NANC) nervous system has been demonstrated 
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in human airways. This nervous system has inhibitory (iNANC) and excitatory 
components (eNANC). Calcitonine gene related peptide (CORP) and the 
tachykinins substance P and neurokinin A are the major transmitters of the 
eNANC nerves whereas vasoactive intestinal peptide (VIP) and nitric oxide 
(NO) may be neurotransmitters of the iNANC nervous system. Receptors for 
CORP, the tachykinins and VIP have been demonstrated in human auways. NO 
diffuses through the the cell membrane and increases intracellular cOMPo 
Although both an increase in eNANC responses and a decrease in iNANC 
responses have been described in asthmatic patients, the functional relevance of 
NANC nerves in human ahways remains to be elucidated. 
Chapter 4 provides an overview of the models that have been developed to 
study airway function in vitro, emphasizing human ahway preparations. The 
easily prepared airway strip and ring preparations are described first. The potential 
damage during preparation and the interference with auway stmcture are im-
pOltant disadvantages in these preparations. Lung parenchymal strips, described 
next, were designed to study responsiveness of small airways. However, 
parenchymal strips are anatomically complex, and responsiveness is determined 
by the relative amounts of airway and vascular smooth muscle. Airway tube 
preparations, in which luminal and serosal stimulation can be separated, enable 
us to study the modulatory role of the airway epithelium in vitro. In the isolated 
perfused lung preparation, the interaction between between the airways and 
vasculary systems can be studied. This model has yet not been used to study 
human lungs in vitro. Next, methodological aspects such as tissue handling and 
storage, recording of responses, removal of the epithelium and electrical field 
stimulation are discussed in some detail. The responses of isolated airway strips 
and rings are recorded under isometric or isotonic conditions. In perfused air-
way tubes responsiveness can be measured under auxotonic conditions as a 
change in perfusion pressure or flow. The effect of airway epithelium on airway 
smooth muscle responsiveness is commonly examined in epithelium-denuded 
ahway preparations. Although mechanical removal of the epithelium is widely 
used, more physiological methods to mimic the epithelial damage found in asthma 
may be preferable and these methods are described in detail. 
Finally, the methodology of electric field stimulation (EFS) is described. EFS 
stimulates airway smooth muscle indirectly via activation of autonomic nerves. 
In chapter 5 we describe an in vitro model developed at our laboratory, that 
allows for independent stimulation from either the serosal or the mucosal side 
of human peripheral airways. Segments of human peripheral airways were 
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perfused with a Krebs-Henseleit (K -H) solution at a constant pressure, and 
responsiveness was measured as a change in flow rate. Pressurelflow relation-
ships indicated laminar flow over a wide pressure range, and a working pressure 
of 6 cm H20 was chosen because this is a physiological transpulmonary pres-
sure. When stepwise stretching the airway to 180% of its length, we noted an 
increase in baseline flow and a decrease in flowreduction after 10.5 M metha-
choline. At 140% of the length, accurate and reproducible measurements of the 
sensitivity (EC50) to methacholine were obtained, and airway closure did not 
occur. A one-way analysis of variance (ANOVA) revealed that the between-
patients differences accounted for 91 % of the total variability for -log EC50. 
We conclude that this in vitro model offers interesting possibilities to evaluate 
the modulatory effects of the human airway epithelium. In addition, the model 
provides the opportunity to study human small airway mechanical properties 
and secretory functions. 
The perfused airway tube model was used in the experiments described in 
chapter 6 in order to investigate the modulatory role of the airway epithelium. 
Damage to the epithelium was induced with luminally applied hydrogen peroxide 
(H20 2), and changes in responsiveness to the agonists histamine, methacholine, 
and salbutamol were measured during both luminal and serosal stimulation. To 
examine whether intact epithelium acts as a barrier to luminally applied hista-
mine, the histamine concentration was measured in the organ baths containing 
luminally perfused airway tubes with intact or damaged epithelium. The sensi-
tivity of airway tubes to both histamine and methacholine was significantly lower 
with mucosal stimulation than with serosal stimulation. No difference was found 
in the sensitivity to salbutamol between mucosally and serosally stimulated air-
ways. The modulation of the sensitivity to contractile agonists by the epithe-
lium increased with increasing airway size, and was abolished after treatment 
with H20 2. Light microscopic examination ofH20 2-treated aitway preparations 
revealed damage to the columnar ciliated epithelial cells, with preservation of 
basal cells. The penetration of histamine through the airway wall was similar in 
intact and H20 2-treated airways. From these results we concluded that oxidative 
damage to the airway epithelium may lead to hyperresponsiveness to inhaled 
stiruuli. However, this may not be due to a change in barrier function of the 
damaged epithelium. 
In the experiments described in chapter 7, we used the perfused airway tube 
model to study the effects of the oxidant HP2 and the MBP analogue poly-L-
arginine on permeability and morphology of human, non-asthmatic, peripheral 
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auways. In addition, we examined whether airway penneability depends on air-
way size. Human airway tubes were luminally perfused with Krebs-Henseleit 
buffer containing the hydrophilic tracer lIIIn_DTPA, or the lipophilic tracer 
14C-antipyrine ('4C-AP). Permeability of the auways was calculated from the 
fluxes of the tracer molecules across the airway wall. After experiments, Jight-
and electronmicroscopic examination of the airway epithelium was performed. 
Baseline penneability to 14C_AP was 5 times greater than to lIIIn-DTPA. Luminal 
exposure of the airways to H20 2 produced a significant 6-fold increase in 
permeability to lIIIn_DTPA but not to 14C_AP, indicating opening of paracellular 
pathways. These findings contrasted with the results of the experiments in Chapter 
6 where luminal exposure of the airways to H20 2 did not increase airway 
permeability to histamine (a hydrophilic drug of similar size as lllIn-DTPA). 
However, in the experiments described in Chapter 6 we measured cumulative 
concentrations of histamine in the organ baths and tlus may be less sensitive 
than measurements of permeability to a radioactive tracer at 15 min intervals 
used in Chapter 7. Luminal exposure to poly-L-arginine for 3 hand 16 h pro-
duced a significant 4.5- and 7-fold increase in permeability to lllIn-DTPA, 
respectively. Histological examination of epithelium exposed to H20 2 or poly-
L-arginine showed focal loss of superficial cells with preservation of basal cells. 
Baseline airway permeability increased sigluficantly with decreasing airway size. 
We concluded that oxidant- and cationic protein-induced epithelial damage in-
crease airway permeability and may at least partly explain the ulcreased respon-
siveness to inhaled stimuli in asthma. 
The metabolization of the bronchodilating peptide vasoactive intestinal peptide 
(VIP) by epithelial and subepithelial peptidases was studied in chapter 8. Intact 
or epithelium-denuded strips of central and peripheral airways were incubated 
with or without peptidase inhibitors. After precontraction with lustamine cumu-
lative concentration response curves to VIP were obtained. Both intact central 
and peripheral airways showed only nunor relaxations to VIP irrespective of the 
precontraction level. Removal of the epithelium and addition of peptidase in-
hibitors additively increased the sensitivity (>20-fold) and maximal response to 
VIP in both central and peripheral airways. We concluded that VIP relaxes both 
central and peripheral human airways but only in the absence of epithelium and! 
or the presence of peptidase inhibitors, and that the epithelium does not seem to 
be the only source of peptidase activity. 
In animal airways, it has been shown that the inflammatory peptide bradykinin 
(Bk) stimulates peptidergic nerves resulting in local axon reflexes with release 
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of tachykinins. The mechanism of Bk-induced airway narrowing in humans is 
not clear. In the experiments presented in chapter 9, we investigated the effects 
of epithelium removal, inhibition of the enzymes neutral endopeptidase (NEP) 
and cyclooxygenase, and blockade of nervous conductance with tetrodotoxin 
(TTX) on Bk-induced responses of human isolated peripheral airways. Responses 
to Bk were recorded from airways with spontaneous intrinsic tone and from 
airways precontracted with methacholine. Furthennore, we measured the Bk-
induced release of the prostanoids PGE2, PGI2, and TxA2 from airways with 
and without epithelium in the absence and presence of indomethacin. Finally, 
we examined the effect of the bradykinin B2-receptor antagonist Hoe 140 and 
the thromboxane prostanoid (TP) receptor blocking drug GR32191 on Bk-
induced responses. Bk contracted intact and epithelium-denuded airways with 
spontaneous intrinsic tone, whereas precontracted airways either relaxed or con-
tracted to Bk. Removal of the epithelium increased the sensitivity to Bk 7-fold 
without changing the direction of the response. The NEP inhibitor 
phosphoramidon tended to increase the sensitivity to Bk (ns) and did not change 
the direction of the response. Both contractile and relaxation responses to Bk 
and the release of the prostanoids PGE2, PGI2 and TxA2 by the airway tissues 
were largely inhibited by indomethacin, whereas TTX had no effect. PGE2, PGI2, 
and Tx~ were released by both intact and epithelium-denuded airways. Bk-
induced responses were antagonized by both Hoe 140 and GR32l91. It was 
concluded that Bk is a potent constrictor of human peripheral airways, espe-
cially in the absence of epithelium. Involvement of local axon reflexes with 
release of tachykinins could not be demonstrated. The effect of Bk on human 
airway smooth muscle is, therefore, mediated via the B2 receptor and involves 
the release of prostanoids that contract airways via the TP receptor. 
Sensory nerve fibers (peptidergic nerves) can be activated by capsaicin and this 
may result in antidrOinic conduction (axon reflex) with release of tachykinins 
that cause bronchoconstriction and 'neurogenic inflammation'. In chapter 10 
we investigated the effects of neural conduction blocker tetrodotoxin (TTX), 
the anti-asthmatic drug sodium cromoglycate (SCG) and the neurokinin2 (NK2) 
receptor antagonist SR48968 on capsaicin-induced contractile responses of 
human isolated airways, and we measured release of tachykinins from these 
airways. Airway strip preparations were mounted in organ baths and isotonic 
concentration response curves to capsaicin were made. The organ bath fluid 
was collected and the release of SP and NKA was measured by 
radioimmunoassay. Maximal isotonic shOitening (Smax) to 1O-5M capsaicin was 
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9.4 ± 3.0% of the maximal shortening to methacholine. TTX and sca did not 
affect capsaicin-induced bronchocon-striction. SR48968 significantly decreased 
capsaicin-induced contraction to 2.6 ± 2.5% of maximal contraction. Capsaicin-
induced release of both SP and NKA was significantly reduced by TTX but not 
by sca or SR48968. In conclusion, we found capsaicin-induced bronchocon-
striction and release of tachykinins in human ainvays. Our finding that the nervous 
conductance blocker TTX inhibited capsaicin-induced tachykinin release 
suggests that tachykinins were released by a local axon reflex mechanism and 
this is the first time that such a mechanism is demonstrated in human airways. 
In vivo, these axon reflexes may contribute to 'neurogenic inflammation'. 
12.2 SAMENVAITING 
In hoofdstuk 1 wordt astma gedefinieerd als een chronische luchtwegontsteking 
met vernauwing en een toename van de prikkelbaarheid van de luchtwegen. De 
vernauwing van de luchtwegen ontstaat onder meer doordat spierweefsel in de 
luchtwegwand samentrekt en tevens door verdikking van de ontstoken Iucht-
wegen. Astma is een veel voorkomende aandoening: ongeveer 10-15% van de 
bevolking lijdt aan de ziekte. Bovendien vertoont de frequentie van voorkomen 
een stijgende tendens. De verschijnseIen van astma zijn: hoesten, piepende 
adernhaling, kortademigheid en een beklemd gevoel op de bors!. De kIachten 
zijn wisseIend aanwezig en worden vaak veroorzaakt door prikkels uit de 
omgeving van de patient zoaIs allergenen, mist of koude Iucht en door licha-
meIijke ins panning. Bij microscopisch onderzoek van de luchtwegen van 
astmapatienten wordt schade aan het Iuchtwegslijmvlies, een toename van het 
aantal slijmproducerende cellen en ontstekingscellen en een verdikking van de 
spierJaag in de wand van de Iuchtweg gevonden. De beschadiging van het 
sIijmvIies wordt waarschijnlijk vooral veroorzaakt door zuurstofradikaIen en 
etsende eiwitten die gemaakt worden door ontstekingscellen in de luchtwegwand. 
De mate van prikkeIbaarheid neemt evenredig toe met de mate van sIijm-
vliesschade aan de luchtwegen. Het intacte slijmvlies heeft dus een beschermende 
werking tegen prikkeIbaarheid van de luchtwegen. Het mechanisme van deze 
beschermende werking is echter onbekend. VerschiIlende theorieen zijn opgesteld 
die schema-tisch zijn weergegeven in figuur 1. Allereerst is het mogelijk dat het 
sIijmvlies voortdurend een stof afscheidt die het achterliggende spierweefsel 
ontspant waardoor de Iuchtwegen worden verwijd. Bij schade aan het slijmvlies, 
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Figllll/' 1. Mogelijke oorzaken van de bescherrnende invloed van het luchlwegslijrnvlies op 
luchlwegspierweefsel. EpDRF = epithelium-derived-reJaxing-factor. 
zoals gevonden wordt bij de astmapatient, zal de produktie van de stof 
verminderen waardoor de luchtwegen vemauwen. Een andere theorie is dat het 
slijmvlies van de luchtwegen prikkelende stoffen onschadelijk maakt waardoor 
deze het achterliggende spierweefsel niet kunnen bereiken. Een derde 
mogelijkheid is dat het slijlllvlies ondoorlaatbaar is voor prikkelende stoffen. 
Beschadiging van het slijmvlies zal de doorlaatbaarheid verhogen waardoor 
prikkelende stoffen de spierlaag kunnen bereiken. Tenslotte is het mogelijk dat 
na beschadiging van het slijmvlies bepaalde zenuwuiteinden in de luchtwegwand 
worden blootgelegd. Deze zenuwuiteinden kunnen geprikkeld worden door 
ingeademde mediatoren en mediatoren gevormd door ontstekingscellen. De 
geprikkelde zenuwen zullen eiwitten afscheiden die het spierweefsel van de 
luchtweg doen salllentrekken en de slijlllproduktie en het ontstekingsproces in 
de luchtwegen stillluleren. Het doel van de in dit proefschrift beschreven 
experimenten was de beschelmende rol van het luchtwegslijmvlies te onder-
zoeken in menselijke luchtwegen. Wij onderzochten het effect van slijm-
vliesschade door de zuurstofradikaal waterstofperoxyde en door etsende eiwitten 
op de prikkelbaarheid en doorlaatbaarheid van luchtwegen. Voorts werd de 
afbraak van prikkelende stoffen door het luchtwegslijlllvlies bestudeerd. Tenslotte 
onderzochten wij of prikkeling van zenuwuiteinden in het slijmvlies bijdraagt 
aan luchtwegvernauwing. 
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luchtweg lumen 
Figllllr 2. Schematische weergave van een doorsnede door de luchtwegwand in de menselijke 
long. 
In hoofdstuk 2 worden de stmktuur en funktie van het luchtwegslijmvlies en de 
afwijkingen hiervan bij astma beschreven. Het slijmvlies bestaat uit verschillende 
lagen. Allereerst een laag cellen (epitheelcellen) die stevig aaneen gehecht zijn 
en de binnenkant van de luchtweg bekieden (figuur 2). Deze cellen zijn verankerd 
in een laag die de basaal membraan genoemd wordt. De epitheelcellen vormen 
een baniere tegen vochtlekkage vanuit de weefsels en bitmendringen van prikkels 
van buiten. Voorts kunnen epitheelcellen bepaalde prikkelende stoffen en 
zuurstofradikalen afbreken en produceren zij stoffen die de funk tie van naburige 
weefsels en cellen zoals spierweefsel, ontstekingscellen, bloedvaten en zenuwen 
belnvloeden. Bij astmapatienten zijn de epitheelcellen vaak beschadigd hetgeen 
gepaard gaat met een toename van de prikkelbaarheid van de Iuchtwegen. Onder 
de laag epitheelcellen zit een dicht netwerk van bloedvaten en -vaatjes. Via dit 
netwerk worden de epitheelcellen gevoed en worden afbraakprodukten en 
prikkelende stoffen afgevoerd. Tevens wordt de ingeademde Iucht verwarmd en 
bevochtigd. In Iuchtwegen van astmatische personen worden veel meer ont-
stekingscellen gevonden die aangevoerd worden via het vaatnetwerk. De 
ontstekingscellen treden door de vaatwand heen naar het omliggende weefsel 
van de luchtwegwand waar zij het ontstekingsproces onderhouden. 
Hoofdstuk 3 beschrijft het onwillekeurige zenuwstelsel van de menselijke long. 
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Dit zenuwstelsel reguleelt de spierspanning, bloedsomloop, slijmproduktie en 
wellicht deels het ontstekingsproces in de long. Het parasympatische gedeelte 
van dit zenuwstelsel heef! een overheersende roi. Stimulatie van parasympatische 
zenuwen leidt tot vernauwing van luchtwegen door samentrekken van spier-
weefsel en overmatige afscheiding van slijm en verwijding van bloedvaten. Deze 
effecten ontstaan doordat uit parasympatische zenuwen de stof acetylcholine 
vrijkomt die aangrijpt op een specifieke plaats (de zogenaamde receptor) op 
lichaamcellen volgens het sleutel-en-slot principe. 
Het sympatische gedeelte van het onwillekeurige zenuwstelse1 heef! bij de mens 
in tegenstelling tot bij sommige diersoorten, geen invloed op het spierweefsel 
van de luchtwegen. De bloedtoevoer in de menselijke long wordt echter weI 
deels bestuurd door het sympatische zenuwstelsel en dit kan indirekt de 
luchtwegen bei'nvloeden. 
Onlangs werd een derde component van het onwillekeurige zenuwstelsel ontdekt 
in de luchtwegen van de mens. Dil zenuwstelsel, dat het non-adrenerge, non-
cholinerge (NANC) zenuwstelsel wordt genoemd, kan eiwilten produceren, 
genaamd tachykininen, die de luchtweg vernauwen en de slijmproduktie en het 
ontstekingsproces in de luchtwegen bevorderen. Bij astmapatienten zijn er 
mogelijk stoornissen in dit zenuwstelsel. 
Hoofdstuk 4 geef! een overzicht van de technieken die gebruikt worden om 
longweefsel buiten het lichaam te onderzoeken. Bij deze technieken worden 
cellen of weefsels na verwijdering uit het lichaam onderzocht in een zogenaamd 
weefselbad. Dit glazen bakje is gevuld met een vloeistof die het weefsel enkele 
uren in leven houdt. Voordeel van onderzoek van een weefsel buiten het lichaam 
is dat allerlei lichaamsprocessen (bijvoorbeeld de bloedsomloop of zenuw-
impulsen) die een waarneming kunnen verstoren worden uitgeschakeld. 
In Hoofdstuk 5 wordt een techniek beschreven, het zogenaamde luchtweg-
perfusiemodel, ontwikkeld in ons laboratorium, waarbij een prikkelende stof 
selektief aan de binnen- of buitenzijde van menselijke luchtwegen toegediend 
kan worden (zie figuur 1, hoofdstuk 5 en figuur 1, hoofdstuk 6). Zodoende is de 
rol van het slijmvlies, dat aIleen aan de binnenkant van de luchtweg aanwezig 
is, te onderzoeken. 
De in hoofdstuk 5 beschreven techniek werd in de experimenten beschreven in 
hoofdstuk 6 gebruikt om de beschermende rol van het luchtwegslijmvlies ten 
aanzien van prikkelbaarheid van luchtwegen te onderzoeken. In de helft van de 
te onderzoeken luchtwegen werd het slijmvlies beschadigd door blootstelling 
aan waterstofperoxyde. De andere luchtwegen werden intact gelaten. Daarna 
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werd aan aile luchtwegen aan de binnenzijde een prikkelende stof die de luchtweg 
vernauwt (histamine of methacholine) of verwijdt (salbutamol, een medicijn 
gebruikt bij de behandeling van astma) toegediend. De prikkelbaarheid van de 
luchtwegen die blootgesteld waren aan waterstofperoxyde bleek sterk verhoogd 
(5- tot lO-voudig) voor de stoffen die de luchtweg vernauwen doch niet voor het 
verwijdende medicijn salbutamol. Voorts bleek dat het beschelmende effect van 
het slijmvlies toeneemt met de luchtweggrootte. Microscopisch onderzoek van 
lnchtwegen blootgesteld aan waterstofperoxyde toonde beschadiging van slijm-
vlies zoals ook bij astmapatienten worden gezien. 
De in hoofdstuk 5 beschreven techniek werd ook gebruikt voor de experimenten 
beschreven in hoofdstuk 7 waarin het effekt van waterstofperoxyde en een 
synthetisch etsend eiwit op de doorlaatbaarheid van menselijke luchtwegen werd 
onderzocht. Zowel waterstofperoxyde als etsende eiwitten worden in de lucht-
wegen van astmapatienten in verhoogde mate geproduceerd door ontste-
kingscellen. De helft van de te onderzoeken luchtwegen werd aan de binnenkant 
(slijmvlieszijde) blootgesteld aan waterstofperoxyde het etsende eiwit. De andere 
luchtwegen werden niet blootgesteld. Daarna werd de doorlaatbaarheid van de 
luchtwegen voor een radioaktieve wateroplosbare stof en voor een radioaktieve 
vetoplosbare stof gemeten. De doorlaatbaarheid van de luchtwegen voor de 
vetoplosbare stofbleek in zowel blootgestelde als niet-blootgestelde luchtwegen 
hoog hetgeen niet verwonderlijk is daar bekend is dat veto pI os bare stoffen 
gemakkelijk weefselbarrieres passeren. De doorlaatbaarheid voor de water-
oplosbare stof nam 6- a 7-voudig toe na blootstelling aan waterstofperoxyde of 
het etsende eiwit. Daar wateroplosbare stoffen het slijmvlies aileen kunnen 
passeren tussen de epitheelcellen door (vetoplosbare stoffen gaan dwars door 
epitheelcellen heen) betekent deze bevinding dat waterstofperoxyde en etsende 
eiwitten opeuingen veroorzaken tussen de cellen. Met elektronen-microscopie 
konden wij dit inderdaad zichtbaar maken. Andere onderzoekers vonden deze 
openingen tussen epitheelcellen ook in de luchtwegen van astmapatienten. Uit 
de experimenten beschreven in hoofdstukken 6 en 7 mogen we dan ook con-
cluderen dat een toename van de doorlaatbaarheid, veroorzaakt door stoffen 
geproduceerd door ontstekingscellen in de luchtwegen zeker een bijdrage kan 
leveren aan de toe name van prikkelbaarheid van de luchtwegen voor stoffen die 
luchtwegvernauwing geven. 
In de experimenten beschreven in hoofdstuk 8 werd de rol van het luchtweg-
slijmvlies bij de afbraak van een in de long geproduceerd eiwit dat de luchtwegen 
normaal gesproken verwijdt, onderzocht. Oit eiwit genaamd vasoactief intestinaal 
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peptide (VIP) wordt mogelijk onvoldoende aangemaakt in de Inchtwegen van 
astmapatienten waardoor luchtwegvernauwing optreedt. Het bleek dat VIP 
luchtwegen aileen verwijdt na verwijdering van het slijmvlies en/of nadat de 
enzymen die VIP afbreken geremd worden met bepaalde medicamenten. Voorts 
bleek dat de enzymen die VIP afbreken niet aileen in het slijmvlies voorkomen 
maar ook in andere weefsels. Na schade aan slijmvlies (zoals bij astmapatienten 
gevonden word!) zal VIP dus nog steeds afgebroken kunnen worden. Gezien 
het geringe luchtweg-verwijdende effect van VIP in onze experimenten lijkt het 
onwaarschijnlijk dat een tekort aan VIP de luchtwegvernauwing bij astma-
patienten kan verklaren. Voorts is het onwaarschijnlijk dat het sJijmvlies een 
sleutelrol heeft bij de afbraak van prikkelende stoffen; ook andere weefsels blijken 
hiertoe in staat. 
In de ontstoken luchtwegen van astmapatienten wordt een grotere hoeveelheid 
bradykinine gevonden dan in luchtwegen van gezonde mensen. Bradykinine is 
een klein eiwit dat bij ontstekingsprocessen geproduceerd wordt door ontste-
kingscellen. Toediening van bradykinine per inhalatie aan astmapatienten 
veroorzaakt een vernauwing van de luchtwegen gelijkend op een astma-aanval 
terwijl dit bij gezonde personen niet gebeurt. Het mechanisme van lucht-
wegvernauwing door bradykinine is onduidelijk. In de experimenten beschreven 
in hoofds!uk 9 werd het mechanisme van luchtwegvernauwing door bradykinine 
onderzocht in luchtwegen met en zonder slijmvlies. Het bleek dat bradykinine 
zelf geen luchtwegvernauwing gaf maar dat het effect indirect plaatsvindt; 
bradykinine maakt stoffen vrij uit luchtwegen, vooral uit luchtwegen met bescha-
digd slijmvlies (zoals bij astmapatienten), die het spierweefsel van de luchtwegen 
doen samentrekken. Een van deze stoffen, thromboxaan, bleek de oorzaak van 
de luchtwegvernauwing: Na blokkade van de aangrijpingsplaats (receptor) van 
thromboxaan bleken de luchtwegen zelfs te verwijden onder invloed van prosta-
cycline, een stof die ook door bradykinine vrijgemaakt werd. Wellicht is de 
verhoogde afgifte van thromboxaan uit de luchtwegwand na slijmvliesbescha-
diging de belaugrijkste oorzaak van de luchtwegvernauwing door ingeademde 
bradykinine bij astmapatienten. 
In de experimenten beschreven in hoofdstuk 10 hebben \Vij de zenuwen van het 
onlangs ontdekte non-adrenerge, non-cholinerge (NANC) gedeeJte van het on-
willekeurige zenuwstelsel kunstmatig geprikkeld met capsai'cine, een stof 
afkomstig uit spaanse pepers. Tijdens de toediening van capsai'cine werd gemeten 
of er luchtwegvernauwing optrad en werd gemeten of er inderdaad eiwitten 
(tachykininen) werden vrijgemaakt door deze zenuwen. Tevens werd onderzocht 
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Figuur 3. Schematische weergave van de mechanismcn die mogelijk een rol spelen in de 
pathogenese van astma. De geaccentueerde kaders betreffen het in deze thesis 
beschreven onderzoek. 
of de luchtwegvernauwing en de produktie van tachykininen kon worden geremd 
met een stof die zenuwgeleiding blokkeert, een geneesmiddel dat geblUikt wordt 
bij astma, en een experimenteel geneesmiddel dat het aangrijpingspunt (receptor) 
van deze eiwitten op de lichaamscellen blokkeert. Wij vonden dat capsai'cine 
slechts een geringe luchtwegvernauwing geeft die niet te remmen was met het 
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middel dat zenuwgeleiding blokkeert en ook niet met het geneesmiddel dat 
gebruikt wordt bij astma. Het experimentele geneesmiddel kon luchtwegver-
nauwing voork6men en biedt wellicht mogeJijkheden voor de behandeling van 
astma. De produktie van tachykininen door de zenuwen kon worden geremd 
door het middel dat zenuwgeleiding blokkeert maar wederom niet door het 
geneesmiddel dat gebruikt wordt bij astma. Uit deze experimenten blijkt dus dat 
prikkeling van blootgelegde zenuwen slechts een geringe vernauwing geeft van 
de luchtwegen. Echter de geproduceerde tachykininen bevorderen wellicht de 
slijm-produktie en het ontstekingsproces in de luchtwegen. 
De conclusies uit de in dit proefschrift beschreven experimenten zijn als voIgt: 
I. Het luchtwegslijmvlies in de mens beschelmt het onderliggende spierweefsel 
tegen prikkels van buiten. 
2. Beschadiging van het luchtwegslijmvlies door stoffen die door ontstekings-
cellen gemaakt worden (zoals plaatsvindt bij astma) geeft een verhoging van 
zowel de prikkelbaarheid als de doorlaatbaarheid van de luchtweg voor 
prikkelende stoffen. Abnonnale doorlaatbaarheid lijkt een belangrijke oorzaak 
van de verhoogde luchtwegprikkelbaarheid na schade aan het slijmvlies. 
3. Eiwit afbrekende enzymen (peptidasen) op het luchtwegepitheellijken geen 
sleutelrol te spelen bij het voorkomen van prikkelbaarheid van de luchtwegen: 
Het verwijderen van het epitheel heeft een groter effect op de prikkelbaarheid 
van de luchtwegen. Bovendien zijn dergelijke enzymen ook aanwezig op 
andere weefsels. 
4. Bij prikkeling van zenuwuiteinden van het niet-adrenerge, niet-cholinerge 
(NANC) gedeeJte van het onwillekeurige zenuwstelsel treedt slechts een 
geringe samentrekking van gelsoleerde menselijke luchtwegen op. De afgifte 
van tachykininen door de geprikkelde zenuwen is te remmen met het zenuwgif 
tetrodotoxine, en dit suggereert dat de afgifte van tachykininen via lokale 
zenuwreflexen plaatsvindt. 
In figuur 3 worden de mechanismen die mogelijk een rol spelen bij de patho-
genese van astma schematisch weergegeven weergegeven. 
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